CHEBI ONTOLOGY - ANNOTATIONS |
|
The Chemical Entities of Biological Interest (ChEBI) ontology is downloaded weekly from EMBL-EBI at http://www.ebi.ac.uk/chebi/. The data is made available under the Creative Commons License (CC BY 3.0, http://creativecommons.org/licenses/by/3.0/). For more information see: Degtyarenko et al. (2008) ChEBI: a database and ontology for chemical entities of biological interest. Nucleic Acids Res. 36, D344–D350.
|
Term: | polyprenol |
|
Accession: | CHEBI:26199
|
browse the term
|
Definition: | Any member of the class of prenols possessing the general formula H-[CH2C(Me)=CHCH2]nOH in which the carbon skeleton is composed of more than one isoprene units. |
Synonyms: | related_synonym: | Formula=(C5H8)nC10H18O; polyprenols |
| alt_id: | CHEBI:8317 |
| xref: | KEGG:C06081 |
|
|
|
G |
Abcb1a |
ATP binding cassette subfamily B member 1A |
multiple interactions |
ISO |
geranylgeranyl pyrophosphate inhibits the reaction [kuwanon G results in increased expression of ABCB1 protein] |
CTD |
PMID:29355567 |
|
NCBI chr 4:25,357,467...25,529,941
Ensembl chr 4:25,158,362...25,442,709
|
|
G |
Abcg1 |
ATP binding cassette subfamily G member 1 |
multiple interactions |
ISO |
geranylgeranyl pyrophosphate inhibits the reaction [kuwanon G results in increased expression of ABCG1 protein] |
CTD |
PMID:29355567 |
|
NCBI chr20:9,126,687...9,182,948
Ensembl chr20:9,126,687...9,182,948
|
|
G |
Akt1 |
AKT serine/threonine kinase 1 |
multiple interactions |
ISO |
geranylgeranyl pyrophosphate inhibits the reaction [Simvastatin results in decreased expression of AKT1 mRNA] geranylgeranyl pyrophosphate inhibits the reaction [Simvastatin results in decreased phosphorylation of AKT1 protein] |
CTD |
PMID:18031796 PMID:33034787 |
|
NCBI chr 6:131,713,716...131,735,319
Ensembl chr 6:131,713,720...131,733,921
|
|
G |
Bcl2 |
BCL2, apoptosis regulator |
multiple interactions |
ISO |
geranylgeranyl pyrophosphate inhibits the reaction [Simvastatin results in decreased expression of BCL2 mRNA] |
CTD |
PMID:18031796 |
|
NCBI chr13:22,689,783...22,853,920
Ensembl chr13:22,684,989...22,853,743 Ensembl chr13:22,684,989...22,853,743
|
|
G |
Birc5 |
baculoviral IAP repeat-containing 5 |
multiple interactions |
ISO |
geranylgeranyl pyrophosphate inhibits the reaction [Lovastatin results in decreased expression of BIRC5 protein] |
CTD |
PMID:17472962 |
|
NCBI chr10:103,072,530...103,081,382
Ensembl chr10:103,073,408...103,081,380
|
|
G |
Bmp2 |
bone morphogenetic protein 2 |
multiple interactions |
ISO |
geranylgeranyl pyrophosphate inhibits the reaction [Simvastatin inhibits the reaction [TNF protein inhibits the reaction [BMP2 results in increased expression of RUNX2 mRNA]]] |
CTD |
PMID:18310456 |
|
NCBI chr 3:120,812,660...120,822,579
Ensembl chr 3:120,812,882...120,821,397
|
|
G |
Casp3 |
caspase 3 |
multiple interactions |
ISO EXP |
geranylgeranyl pyrophosphate inhibits the reaction [Atorvastatin results in increased activity of CASP3 protein]; geranylgeranyl pyrophosphate inhibits the reaction [cerivastatin results in increased activity of CASP3 protein]; geranylgeranyl pyrophosphate inhibits the reaction [Lovastatin results in increased activity of and results in increased cleavage of CASP3 protein]; geranylgeranyl pyrophosphate inhibits the reaction [Simvastatin results in increased activity of CASP3 protein] |
CTD |
PMID:15200425 PMID:16470222 PMID:18766339 |
|
NCBI chr16:45,662,910...45,681,171
Ensembl chr16:45,662,910...45,684,648
|
|
G |
Ccn2 |
cellular communication network factor 2 |
multiple interactions |
ISO |
geranylgeranyl pyrophosphate inhibits the reaction [Simvastatin inhibits the reaction [TGFB1 results in increased expression of CCN2 mRNA]] |
CTD |
PMID:15298857 |
|
NCBI chr 1:20,802,199...20,805,315
Ensembl chr 1:20,802,199...20,805,734
|
|
G |
Ccna2 |
cyclin A2 |
multiple interactions |
EXP |
geranylgeranyl pyrophosphate inhibits the reaction [Simvastatin results in decreased expression of CCNA2 protein] |
CTD |
PMID:26577051 |
|
NCBI chr 2:119,427,239...119,433,645
Ensembl chr 2:119,426,089...119,433,577
|
|
G |
Ccne1 |
cyclin E1 |
multiple interactions |
EXP |
geranylgeranyl pyrophosphate inhibits the reaction [Simvastatin results in decreased expression of CCNE1 protein] |
CTD |
PMID:26577051 |
|
NCBI chr 1:90,781,947...90,791,188
Ensembl chr 1:90,781,949...90,791,101
|
|
G |
Cd40 |
CD40 molecule |
multiple interactions |
ISO |
geranylgeranyl pyrophosphate inhibits the reaction [Simvastatin inhibits the reaction [IFNG results in increased expression of CD40 mRNA]]; geranylgeranyl pyrophosphate inhibits the reaction [Simvastatin inhibits the reaction [IFNG results in increased expression of CD40 protein]] |
CTD |
PMID:17507688 |
|
NCBI chr 3:153,790,372...153,805,279
Ensembl chr 3:153,790,449...153,805,534
|
|
G |
Cdk1 |
cyclin-dependent kinase 1 |
multiple interactions |
EXP |
geranylgeranyl pyrophosphate inhibits the reaction [Simvastatin results in decreased expression of CDK1 protein] |
CTD |
PMID:26577051 |
|
NCBI chr20:19,266,226...19,281,417
Ensembl chr20:19,266,248...19,281,408
|
|
G |
Cdk2 |
cyclin dependent kinase 2 |
multiple interactions |
EXP |
geranylgeranyl pyrophosphate inhibits the reaction [Simvastatin results in decreased expression of CDK2 protein] |
CTD |
PMID:26577051 |
|
NCBI chr 7:1,129,878...1,137,431
Ensembl chr 7:1,129,811...1,137,403
|
|
G |
Cdkn1a |
cyclin-dependent kinase inhibitor 1A |
multiple interactions |
ISO |
geranylgeranyl pyrophosphate inhibits the reaction [Simvastatin results in increased expression of CDKN1A protein] |
CTD |
PMID:18625202 |
|
NCBI chr20:7,149,177...7,159,727
Ensembl chr20:7,149,217...7,159,585
|
|
G |
Col1a1 |
collagen type I alpha 1 chain |
multiple interactions |
ISO |
geranylgeranyl pyrophosphate inhibits the reaction [Simvastatin results in decreased expression of COL1A1 mRNA] |
CTD |
PMID:16575855 |
|
NCBI chr10:79,883,622...79,900,625
Ensembl chr10:79,883,622...79,900,624
|
|
G |
Crp |
C-reactive protein |
multiple interactions |
ISO |
geranylgeranyl pyrophosphate inhibits the reaction [Simvastatin inhibits the reaction [CRP results in increased expression of RETN mRNA]]; geranylgeranyl pyrophosphate inhibits the reaction [Simvastatin inhibits the reaction [CRP results in increased secretion of RETN protein]] |
CTD |
PMID:18023360 |
|
NCBI chr13:85,135,384...85,175,178
Ensembl chr13:85,124,977...85,175,178
|
|
G |
Cyp17a1 |
cytochrome P450, family 17, subfamily a, polypeptide 1 |
multiple interactions |
EXP |
geranylgeranyl pyrophosphate inhibits the reaction [Simvastatin results in decreased expression of CYP17A1 mRNA] |
CTD |
PMID:21918126 |
|
NCBI chr 1:245,535,462...245,543,148
Ensembl chr 1:245,535,462...245,541,573
|
|
G |
Cyp7a1 |
cytochrome P450 family 7 subfamily A member 1 |
multiple interactions |
ISO |
geranylgeranyl pyrophosphate inhibits the reaction [resveratrol results in increased expression of CYP7A1 mRNA] |
CTD |
PMID:22607622 |
|
NCBI chr 5:19,376,979...19,386,676
Ensembl chr 5:19,376,974...19,386,688
|
|
G |
F3 |
coagulation factor III, tissue factor |
multiple interactions |
ISO |
geranylgeranyl pyrophosphate inhibits the reaction [Simvastatin results in decreased expression of F3 mRNA] |
CTD |
PMID:18031796 |
|
NCBI chr 2:209,827,061...209,838,666
Ensembl chr 2:209,826,959...209,838,668
|
|
G |
Fbxo32 |
F-box protein 32 |
multiple interactions |
ISO |
geranylgeranyl pyrophosphate inhibits the reaction [Lovastatin results in increased expression of FBXO32 mRNA]; geranylgeranyl pyrophosphate inhibits the reaction [Lovastatin results in increased expression of FBXO32 protein] |
CTD |
PMID:19406843 |
|
NCBI chr 7:89,731,428...89,764,997
Ensembl chr 7:89,730,232...89,765,436
|
|
G |
Foxo1 |
forkhead box O1 |
multiple interactions |
ISO |
geranylgeranyl pyrophosphate inhibits the reaction [Simvastatin results in decreased phosphorylation of and affects the localization of FOXO1 protein] |
CTD |
PMID:33034787 |
|
NCBI chr 2:136,312,168...136,390,603
Ensembl chr 2:136,312,168...136,387,790
|
|
G |
Ggps1 |
geranylgeranyl diphosphate synthase 1 |
decreases activity |
ISO |
geranylgeranyl pyrophosphate analog results in decreased activity of GGPS1 protein |
CTD |
PMID:16787319 |
|
NCBI chr17:51,263,262...51,282,471
Ensembl chr17:51,263,263...51,276,220
|
|
G |
Hmgcr |
3-hydroxy-3-methylglutaryl-CoA reductase |
multiple interactions |
ISO |
[Lovastatin results in decreased activity of HMGCR protein] which results in decreased abundance of geranylgeranyl pyrophosphate |
CTD |
PMID:17208200 |
|
NCBI chr 2:27,997,523...28,018,983
Ensembl chr 2:27,997,525...28,019,703
|
|
G |
Hras |
HRas proto-oncogene, GTPase |
multiple interactions |
ISO |
geranylgeranyl pyrophosphate inhibits the reaction [Simvastatin inhibits the reaction [Lipopolysaccharides results in increased activity of HRAS protein]] |
CTD |
PMID:18625914 |
|
NCBI chr 1:196,290,127...196,299,823
Ensembl chr 1:196,296,263...196,300,615
|
|
G |
Icam1 |
intercellular adhesion molecule 1 |
multiple interactions |
ISO |
geranylgeranyl pyrophosphate inhibits the reaction [Simvastatin promotes the reaction [IL1B protein results in increased expression of ICAM1 protein]] |
CTD |
PMID:10946302 |
|
NCBI chr 8:19,553,063...19,565,438
Ensembl chr 8:19,553,645...19,565,438
|
|
G |
Ifng |
interferon gamma |
multiple interactions |
ISO |
geranylgeranyl pyrophosphate inhibits the reaction [Simvastatin inhibits the reaction [IFNG results in increased expression of CD40 mRNA]]; geranylgeranyl pyrophosphate inhibits the reaction [Simvastatin inhibits the reaction [IFNG results in increased expression of CD40 protein]] |
CTD |
PMID:17507688 |
|
NCBI chr 7:53,903,339...53,907,375
Ensembl chr 7:53,903,337...53,907,375
|
|
G |
Il12b |
interleukin 12B |
multiple interactions |
ISO |
geranylgeranyl pyrophosphate inhibits the reaction [lipopolysaccharide, E coli O55-B5 results in increased expression of IL12B protein] |
CTD |
PMID:15187114 |
|
NCBI chr10:28,888,832...28,903,802
Ensembl chr10:28,893,008...28,902,903
|
|
G |
Il1a |
interleukin 1 alpha |
multiple interactions |
ISO EXP |
geranylgeranyl pyrophosphate inhibits the reaction [Simvastatin inhibits the reaction [[IL1A co-treated with PDGFB] results in increased expression of MMP9 mRNA]]; geranylgeranyl pyrophosphate inhibits the reaction [Simvastatin inhibits the reaction [[IL1A co-treated with PDGFB] results in increased secretion of MMP9 protein]] geranylgeranyl pyrophosphate inhibits the reaction [Simvastatin inhibits the reaction [IL1A results in decreased expression of NOS2 protein]]; geranylgeranyl pyrophosphate inhibits the reaction [Simvastatin inhibits the reaction [IL1A results in increased abundance of Nitric Oxide]] |
CTD |
PMID:15705589 PMID:15728660 |
|
NCBI chr 3:116,526,601...116,537,055
Ensembl chr 3:116,526,604...116,536,822
|
|
G |
Il1b |
interleukin 1 beta |
multiple interactions |
ISO |
geranylgeranyl pyrophosphate inhibits the reaction [Simvastatin inhibits the reaction [TNF results in increased secretion of IL1B protein]]; geranylgeranyl pyrophosphate inhibits the reaction [Simvastatin promotes the reaction [IL1B protein results in increased expression of ICAM1 protein]]; geranylgeranyl pyrophosphate inhibits the reaction [Simvastatin promotes the reaction [IL1B protein results in increased expression of SELE protein]] |
CTD |
PMID:10946302 PMID:17075836 |
|
NCBI chr 3:116,577,005...116,583,386
Ensembl chr 3:116,577,010...116,583,415
|
|
G |
Il6 |
interleukin 6 |
multiple interactions |
ISO |
geranylgeranyl pyrophosphate inhibits the reaction [Simvastatin inhibits the reaction [TNF results in increased expression of IL6 mRNA]]; geranylgeranyl pyrophosphate inhibits the reaction [Simvastatin inhibits the reaction [TNF results in increased secretion of IL6 protein]] geranylgeranyl pyrophosphate inhibits the reaction [Simvastatin promotes the reaction [[Lipopolysaccharides co-treated with TNF] results in increased expression of IL6 protein]] |
CTD |
PMID:16511915 PMID:17075836 PMID:17729120 |
|
NCBI chr 4:5,214,602...5,219,178
Ensembl chr 4:5,213,394...5,219,178
|
|
G |
Irf4 |
interferon regulatory factor 4 |
multiple interactions |
ISO |
geranylgeranyl pyrophosphate inhibits the reaction [Simvastatin results in decreased expression of IRF4 mRNA]; geranylgeranyl pyrophosphate inhibits the reaction [Simvastatin results in decreased expression of IRF4 protein] |
CTD |
PMID:33034787 |
|
NCBI chr17:33,721,800...33,742,570
Ensembl chr17:33,721,811...33,740,070
|
|
G |
Lep |
leptin |
multiple interactions |
ISO |
geranylgeranyl pyrophosphate inhibits the reaction [Simvastatin results in decreased expression of LEP mRNA]; geranylgeranyl pyrophosphate inhibits the reaction [Simvastatin results in decreased secretion of LEP protein] |
CTD |
PMID:19254925 |
|
NCBI chr 4:57,661,127...57,675,262
Ensembl chr 4:57,661,131...57,675,262
|
|
G |
Mapk1 |
mitogen activated protein kinase 1 |
multiple interactions |
ISO |
geranylgeranyl pyrophosphate inhibits the reaction [Atorvastatin results in decreased phosphorylation of MAPK1 protein]; geranylgeranyl pyrophosphate inhibits the reaction [Simvastatin inhibits the reaction [Lipopolysaccharides results in increased phosphorylation of MAPK1 protein]] |
CTD |
PMID:16470222 PMID:18625914 |
|
NCBI chr11:83,957,813...84,023,629
Ensembl chr11:83,957,813...84,023,616
|
|
G |
Mapk3 |
mitogen activated protein kinase 3 |
multiple interactions |
ISO |
geranylgeranyl pyrophosphate inhibits the reaction [Atorvastatin results in decreased phosphorylation of MAPK3 protein]; geranylgeranyl pyrophosphate inhibits the reaction [Simvastatin inhibits the reaction [Lipopolysaccharides results in increased phosphorylation of MAPK3 protein]] |
CTD |
PMID:16470222 PMID:18625914 |
|
NCBI chr 1:181,366,646...181,372,863
Ensembl chr 1:181,366,637...181,372,863
|
|
G |
Mbp |
myelin basic protein |
multiple interactions |
EXP |
geranylgeranyl pyrophosphate inhibits the reaction [Lovastatin results in increased expression of MBP mRNA] |
CTD |
PMID:20578043 |
|
NCBI chr18:75,855,878...75,966,404
Ensembl chr18:75,855,878...75,966,404
|
|
G |
Mmp1 |
matrix metallopeptidase 1 |
multiple interactions |
ISO |
geranylgeranyl pyrophosphate inhibits the reaction [Simvastatin inhibits the reaction [Lipopolysaccharides results in increased expression of MMP1]]; geranylgeranyl pyrophosphate inhibits the reaction [Simvastatin inhibits the reaction [Lipopolysaccharides results in increased secretion of MMP1 protein]]; geranylgeranyl pyrophosphate inhibits the reaction [Simvastatin results in decreased expression of MMP1 mRNA]; geranylgeranyl pyrophosphate inhibits the reaction [Simvastatin results in decreased expression of MMP1 protein]; geranylgeranyl pyrophosphate inhibits the reaction [Simvastatin results in decreased secretion of MMP1 protein] |
CTD |
PMID:17303772 PMID:18625914 |
|
NCBI chr 8:4,658,588...4,679,099
Ensembl chr 8:4,658,588...4,679,097
|
|
G |
Mmp9 |
matrix metallopeptidase 9 |
multiple interactions |
ISO EXP |
geranylgeranyl pyrophosphate inhibits the reaction [Simvastatin inhibits the reaction [[IL1A co-treated with PDGFB] results in increased expression of MMP9 mRNA]]; geranylgeranyl pyrophosphate inhibits the reaction [Simvastatin inhibits the reaction [[IL1A co-treated with PDGFB] results in increased secretion of MMP9 protein]]; geranylgeranyl pyrophosphate inhibits the reaction [Simvastatin inhibits the reaction [Tetradecanoylphorbol Acetate results in increased expression of MMP9 mRNA]]; geranylgeranyl pyrophosphate inhibits the reaction [Simvastatin inhibits the reaction [Tetradecanoylphorbol Acetate results in increased secretion of MMP9 protein]] geranylgeranyl pyrophosphate inhibits the reaction [Simvastatin inhibits the reaction [Smoke analog results in increased expression of MMP9 mRNA]]; geranylgeranyl pyrophosphate inhibits the reaction [Simvastatin inhibits the reaction [Smoke analog results in increased expression of MMP9]]; geranylgeranyl pyrophosphate inhibits the reaction [Simvastatin inhibits the reaction [Smoke analog results in increased secretion of MMP9 protein]] |
CTD |
PMID:15728660 PMID:19299917 |
|
NCBI chr 3:153,684,158...153,692,118
Ensembl chr 3:153,683,858...153,692,120
|
|
G |
Mstn |
myostatin |
multiple interactions |
ISO |
geranylgeranyl pyrophosphate inhibits the reaction [Simvastatin results in increased expression of MSTN mRNA]; geranylgeranyl pyrophosphate inhibits the reaction [Simvastatin results in increased expression of MSTN protein] |
CTD |
PMID:33034787 |
|
NCBI chr 9:48,452,533...48,458,933
Ensembl chr 9:48,452,533...48,458,933
|
|
G |
Mvk |
mevalonate kinase |
multiple interactions decreases chemical synthesis decreases activity |
ISO |
geranylgeranyl pyrophosphate inhibits the reaction [MVK protein results in increased hydrolysis of Adenosine Triphosphate]; geranylgeranyl pyrophosphate inhibits the reaction [MVK protein results in increased phosphorylation of Mevalonic Acid] MVK protein mutant form results in decreased chemical synthesis of geranylgeranyl pyrophosphate geranylgeranyl pyrophosphate results in decreased activity of MVK protein |
CTD |
PMID:9392419 PMID:24073415 |
|
NCBI chr12:42,141,391...42,158,893
Ensembl chr12:42,141,384...42,158,882
|
|
G |
Nfkbia |
NFKB inhibitor alpha |
multiple interactions |
ISO |
geranylgeranyl pyrophosphate inhibits the reaction [Simvastatin inhibits the reaction [TNF results in increased degradation of NFKBIA protein]] |
CTD |
PMID:17075836 |
|
NCBI chr 6:72,858,713...72,861,941
Ensembl chr 6:72,858,712...72,861,941
|
|
G |
Nos2 |
nitric oxide synthase 2 |
multiple interactions |
EXP |
geranylgeranyl pyrophosphate inhibits the reaction [Simvastatin inhibits the reaction [IL1A results in decreased expression of NOS2 protein]] |
CTD |
PMID:15705589 |
|
NCBI chr10:63,815,308...63,851,208
Ensembl chr10:63,815,308...63,851,210
|
|
G |
Nr1h3 |
nuclear receptor subfamily 1, group H, member 3 |
decreases activity |
ISO |
geranylgeranyl pyrophosphate results in decreased activity of NR1H3 protein |
CTD |
PMID:22607622 |
|
NCBI chr 3:77,158,808...77,168,907
Ensembl chr 3:77,158,808...77,168,722
|
|
G |
Nr4a3 |
nuclear receptor subfamily 4, group A, member 3 |
multiple interactions |
ISO |
geranylgeranyl pyrophosphate inhibits the reaction [Simvastatin results in decreased expression of NR4A3 mRNA] |
CTD |
PMID:16005304 |
|
NCBI chr 5:62,361,588...62,401,489
Ensembl chr 5:62,361,822...62,402,733
|
|
G |
Parp1 |
poly (ADP-ribose) polymerase 1 |
multiple interactions |
ISO |
geranylgeranyl pyrophosphate inhibits the reaction [Simvastatin promotes the reaction [TNFSF10 protein results in increased cleavage of PARP1 protein]]; geranylgeranyl pyrophosphate inhibits the reaction [TNFSF10 protein promotes the reaction [Simvastatin results in increased cleavage of PARP1 protein]] |
CTD |
PMID:21910007 |
|
NCBI chr13:92,307,593...92,339,406
Ensembl chr13:92,307,586...92,339,404
|
|
G |
Pdgfb |
platelet derived growth factor subunit B |
multiple interactions |
ISO |
geranylgeranyl pyrophosphate inhibits the reaction [Simvastatin inhibits the reaction [[IL1A co-treated with PDGFB] results in increased expression of MMP9 mRNA]]; geranylgeranyl pyrophosphate inhibits the reaction [Simvastatin inhibits the reaction [[IL1A co-treated with PDGFB] results in increased secretion of MMP9 protein]] |
CTD |
PMID:15728660 |
|
NCBI chr 7:111,539,444...111,557,984
Ensembl chr 7:111,540,345...111,557,984
|
|
G |
Plat |
plasminogen activator, tissue type |
multiple interactions |
EXP |
geranylgeranyl pyrophosphate inhibits the reaction [Lovastatin results in increased expression of PLAT protein] |
CTD |
PMID:10412747 |
|
NCBI chr16:69,240,582...69,265,177
Ensembl chr16:69,240,585...69,268,223
|
|
G |
Pon1 |
paraoxonase 1 |
multiple interactions |
ISO |
geranylgeranyl pyrophosphate inhibits the reaction [Simvastatin results in increased expression of PON1 mRNA] |
CTD |
PMID:14500290 |
|
NCBI chr 4:33,294,737...33,325,759
Ensembl chr 4:33,294,722...33,321,360
|
|
G |
Pparg |
peroxisome proliferator-activated receptor gamma |
multiple interactions |
EXP |
geranylgeranyl pyrophosphate inhibits the reaction [Lovastatin results in increased expression of PPARG mRNA] |
CTD |
PMID:20578043 |
|
NCBI chr 4:148,423,102...148,548,471
Ensembl chr 4:148,423,194...148,548,468
|
|
G |
Pten |
phosphatase and tensin homolog |
multiple interactions |
EXP |
geranylgeranyl pyrophosphate inhibits the reaction [Lovastatin results in increased expression of PTEN mRNA] |
CTD |
PMID:20578043 |
|
NCBI chr 1:230,630,443...230,697,070
Ensembl chr 1:230,630,338...230,696,838
|
|
G |
Rac1 |
Rac family small GTPase 1 |
multiple interactions |
ISO |
geranylgeranyl pyrophosphate inhibits the reaction [Atorvastatin inhibits the reaction [Glucose results in increased localization of RAC1 protein]]; geranylgeranyl pyrophosphate inhibits the reaction [Simvastatin inhibits the reaction [Lipopolysaccharides results in increased activity of RAC1 protein]]; geranylgeranyl pyrophosphate inhibits the reaction [Simvastatin inhibits the reaction [Lipopolysaccharides results in increased localization of RAC1 protein]] |
CTD |
PMID:17279352 PMID:18625914 |
|
NCBI chr12:11,037,028...11,057,251
Ensembl chr12:11,036,698...11,057,251
|
|
G |
Retn |
resistin |
multiple interactions |
ISO |
geranylgeranyl pyrophosphate inhibits the reaction [Simvastatin inhibits the reaction [CRP results in increased expression of RETN mRNA]]; geranylgeranyl pyrophosphate inhibits the reaction [Simvastatin inhibits the reaction [CRP results in increased secretion of RETN protein]] |
CTD |
PMID:18023360 |
|
NCBI chr12:1,710,881...1,712,621
Ensembl chr12:1,710,881...1,712,620
|
|
G |
Rhoa |
ras homolog family member A |
multiple interactions |
ISO |
geranylgeranyl pyrophosphate inhibits the reaction [Atorvastatin results in decreased activity of RHOA protein]; geranylgeranyl pyrophosphate inhibits the reaction [Atorvastatin results in increased localization of RHOA protein]; geranylgeranyl pyrophosphate inhibits the reaction [Simvastatin affects the localization of and results in decreased activity of RHOA protein]; geranylgeranyl pyrophosphate inhibits the reaction [Simvastatin inhibits the reaction [Lipopolysaccharides results in decreased activity of RHOA protein]]; geranylgeranyl pyrophosphate inhibits the reaction [Simvastatin inhibits the reaction [TNF results in increased activity of RHOA protein]]; geranylgeranyl pyrophosphate inhibits the reaction [Simvastatin results in decreased activity of RHOA protein]; geranylgeranyl pyrophosphate inhibits the reaction [Simvastatin results in increased localization of RHOA protein]; Simvastatin inhibits the reaction [geranylgeranyl pyrophosphate affects the localization of RHOA protein] geranylgeranyl pyrophosphate inhibits the reaction [Simvastatin inhibits the reaction [TNF affects the localization of RHOA protein]] |
CTD |
PMID:16005304 PMID:16470222 PMID:17075836 PMID:18031796 PMID:18310456 PMID:18625202 PMID:18625914 More...
|
|
NCBI chr 8:108,991,926...109,025,746
Ensembl chr 8:108,991,954...109,025,746
|
|
G |
Runx2 |
RUNX family transcription factor 2 |
multiple interactions |
ISO |
geranylgeranyl pyrophosphate inhibits the reaction [Simvastatin inhibits the reaction [TNF protein inhibits the reaction [BMP2 results in increased expression of RUNX2 mRNA]]] |
CTD |
PMID:18310456 |
|
NCBI chr 9:16,167,504...16,492,826
Ensembl chr 9:16,167,482...16,492,167
|
|
G |
Sele |
selectin E |
multiple interactions |
ISO |
geranylgeranyl pyrophosphate inhibits the reaction [Simvastatin promotes the reaction [IL1B protein results in increased expression of SELE protein]] |
CTD |
PMID:10946302 |
|
NCBI chr13:76,402,841...76,412,741
Ensembl chr13:76,403,304...76,412,741
|
|
G |
Sox10 |
SRY-box transcription factor 10 |
multiple interactions |
EXP |
geranylgeranyl pyrophosphate inhibits the reaction [Lovastatin results in increased expression of SOX10 mRNA] |
CTD |
PMID:20578043 |
|
NCBI chr 7:110,725,274...110,734,651
Ensembl chr 7:110,725,274...110,735,544
|
|
G |
Stat1 |
signal transducer and activator of transcription 1 |
multiple interactions increases expression |
ISO |
geranylgeranyl pyrophosphate inhibits the reaction [Simvastatin results in decreased expression of STAT1 mRNA]; geranylgeranyl pyrophosphate inhibits the reaction [Simvastatin results in decreased expression of STAT1 protein] geranylgeranyl pyrophosphate results in increased expression of STAT1 protein |
CTD |
PMID:17507688 |
|
NCBI chr 9:49,419,561...49,459,969
Ensembl chr 9:49,419,340...49,588,540
|
|
G |
Tgfb1 |
transforming growth factor, beta 1 |
multiple interactions |
ISO |
geranylgeranyl pyrophosphate inhibits the reaction [Simvastatin inhibits the reaction [TGFB1 results in increased expression of CCN2 mRNA]] |
CTD |
PMID:15298857 |
|
NCBI chr 1:81,196,532...81,212,848
Ensembl chr 1:81,196,532...81,212,847
|
|
G |
Tnf |
tumor necrosis factor |
multiple interactions |
ISO |
geranylgeranyl pyrophosphate inhibits the reaction [Simvastatin inhibits the reaction [TNF results in increased activity of RHOA protein]]; geranylgeranyl pyrophosphate inhibits the reaction [Simvastatin inhibits the reaction [TNF results in increased degradation of NFKBIA protein]]; geranylgeranyl pyrophosphate inhibits the reaction [Simvastatin inhibits the reaction [TNF results in increased expression of CXCL8 mRNA]]; geranylgeranyl pyrophosphate inhibits the reaction [Simvastatin inhibits the reaction [TNF results in increased expression of IL6 mRNA]]; geranylgeranyl pyrophosphate inhibits the reaction [Simvastatin inhibits the reaction [TNF results in increased secretion of IL1B protein]]; geranylgeranyl pyrophosphate inhibits the reaction [Simvastatin inhibits the reaction [TNF results in increased secretion of IL6 protein]] geranylgeranyl pyrophosphate inhibits the reaction [Simvastatin inhibits the reaction [TNF affects the localization of RHOA protein]]; geranylgeranyl pyrophosphate inhibits the reaction [Simvastatin inhibits the reaction [TNF protein inhibits the reaction [BMP2 results in increased expression of RUNX2 mRNA]]]; geranylgeranyl pyrophosphate inhibits the reaction [Simvastatin promotes the reaction [[Lipopolysaccharides co-treated with TNF] results in increased abundance of Nitric Oxide]]; geranylgeranyl pyrophosphate inhibits the reaction [Simvastatin promotes the reaction [[Lipopolysaccharides co-treated with TNF] results in increased expression of IL6 protein]] |
CTD |
PMID:16511915 PMID:17075836 PMID:17729120 PMID:18310456 |
|
NCBI chr20:3,622,011...3,624,629
Ensembl chr20:3,622,011...3,624,629
|
|
G |
Tnfsf10 |
TNF superfamily member 10 |
multiple interactions |
ISO |
geranylgeranyl pyrophosphate inhibits the reaction [Simvastatin promotes the reaction [TNFSF10 protein results in increased cleavage of PARP1 protein]]; geranylgeranyl pyrophosphate inhibits the reaction [TNFSF10 protein promotes the reaction [Simvastatin results in increased cleavage of PARP1 protein]] |
CTD |
PMID:21910007 |
|
NCBI chr 2:110,199,835...110,227,239
Ensembl chr 2:110,207,916...110,225,135
|
|
G |
Vegfa |
vascular endothelial growth factor A |
multiple interactions |
ISO |
geranylgeranyl pyrophosphate inhibits the reaction [Simvastatin results in increased expression of VEGFA mRNA] |
CTD |
PMID:18356691 |
|
NCBI chr 9:14,955,300...14,970,641
Ensembl chr 9:14,955,300...14,970,641
|
|
|
G |
Akt1 |
AKT serine/threonine kinase 1 |
multiple interactions |
ISO |
farnesyl pyrophosphate inhibits the reaction [Simvastatin results in decreased phosphorylation of AKT1 protein] |
CTD |
PMID:33034787 |
|
NCBI chr 6:131,713,716...131,735,319
Ensembl chr 6:131,713,720...131,733,921
|
|
G |
Birc5 |
baculoviral IAP repeat-containing 5 |
multiple interactions |
ISO |
farnesyl pyrophosphate inhibits the reaction [Lovastatin results in decreased expression of BIRC5 protein] |
CTD |
PMID:17472962 |
|
NCBI chr10:103,072,530...103,081,382
Ensembl chr10:103,073,408...103,081,380
|
|
G |
Bmp2 |
bone morphogenetic protein 2 |
multiple interactions |
ISO |
farnesyl pyrophosphate inhibits the reaction [Simvastatin inhibits the reaction [TNF protein inhibits the reaction [BMP2 results in increased expression of RUNX2 mRNA]]] |
CTD |
PMID:18310456 |
|
NCBI chr 3:120,812,660...120,822,579
Ensembl chr 3:120,812,882...120,821,397
|
|
G |
Casp3 |
caspase 3 |
multiple interactions |
ISO EXP |
farnesyl pyrophosphate inhibits the reaction [Lovastatin results in increased activity of and results in increased cleavage of CASP3 protein] farnesyl pyrophosphate inhibits the reaction [Simvastatin results in increased activity of CASP3 protein] |
CTD |
PMID:15200425 PMID:18766339 |
|
NCBI chr16:45,662,910...45,681,171
Ensembl chr16:45,662,910...45,684,648
|
|
G |
Cyp17a1 |
cytochrome P450, family 17, subfamily a, polypeptide 1 |
multiple interactions |
EXP |
farnesyl pyrophosphate inhibits the reaction [Simvastatin results in decreased expression of CYP17A1 mRNA] |
CTD |
PMID:21918126 |
|
NCBI chr 1:245,535,462...245,543,148
Ensembl chr 1:245,535,462...245,541,573
|
|
G |
Fnta |
farnesyltransferase, CAAX box, subunit alpha |
multiple interactions |
EXP |
[FNTA protein binds to FNTB protein] binds to [farnesyl pyrophosphate analog co-treated with KRAS protein] |
CTD |
PMID:10673434 |
|
NCBI chr16:66,065,131...66,083,460
Ensembl chr16:66,065,132...66,083,460
|
|
G |
Fntb |
farnesyltransferase, CAAX box, subunit beta |
multiple interactions |
EXP |
[FNTA protein binds to FNTB protein] binds to [farnesyl pyrophosphate analog co-treated with KRAS protein] |
CTD |
PMID:10673434 |
|
NCBI chr 6:95,536,540...95,619,587
Ensembl chr 6:95,470,683...95,619,586
|
|
G |
Fos |
Fos proto-oncogene, AP-1 transcription factor subunit |
multiple interactions |
ISO |
farnesyl pyrophosphate inhibits the reaction [Simvastatin results in decreased expression of FOS mRNA] |
CTD |
PMID:16005304 |
|
NCBI chr 6:105,121,170...105,124,036
Ensembl chr 6:105,121,170...105,124,036
|
|
G |
Foxo1 |
forkhead box O1 |
multiple interactions |
ISO |
farnesyl pyrophosphate inhibits the reaction [Simvastatin results in decreased phosphorylation of FOXO1 protein] |
CTD |
PMID:33034787 |
|
NCBI chr 2:136,312,168...136,390,603
Ensembl chr 2:136,312,168...136,387,790
|
|
G |
Hmgcr |
3-hydroxy-3-methylglutaryl-CoA reductase |
multiple interactions |
ISO |
[Lovastatin results in decreased activity of HMGCR protein] which results in decreased abundance of farnesyl pyrophosphate |
CTD |
PMID:17208200 |
|
NCBI chr 2:27,997,523...28,018,983
Ensembl chr 2:27,997,525...28,019,703
|
|
G |
Hras |
HRas proto-oncogene, GTPase |
multiple interactions |
ISO |
farnesyl pyrophosphate inhibits the reaction [Simvastatin inhibits the reaction [Lipopolysaccharides results in increased activity of HRAS protein]]; farnesyl pyrophosphate inhibits the reaction [Simvastatin inhibits the reaction [Lipopolysaccharides results in increased localization of HRAS protein]] |
CTD |
PMID:18625914 |
|
NCBI chr 1:196,290,127...196,299,823
Ensembl chr 1:196,296,263...196,300,615
|
|
G |
Icam1 |
intercellular adhesion molecule 1 |
multiple interactions |
ISO |
farnesyl pyrophosphate inhibits the reaction [Simvastatin promotes the reaction [IL1B protein results in increased expression of ICAM1 protein]] |
CTD |
PMID:10946302 |
|
NCBI chr 8:19,553,063...19,565,438
Ensembl chr 8:19,553,645...19,565,438
|
|
G |
Il12b |
interleukin 12B |
multiple interactions |
ISO |
farnesyl pyrophosphate inhibits the reaction [lipopolysaccharide, E coli O55-B5 results in increased expression of IL12B protein] |
CTD |
PMID:15187114 |
|
NCBI chr10:28,888,832...28,903,802
Ensembl chr10:28,893,008...28,902,903
|
|
G |
Il1b |
interleukin 1 beta |
multiple interactions |
ISO |
farnesyl pyrophosphate inhibits the reaction [Simvastatin promotes the reaction [IL1B protein results in increased expression of ICAM1 protein]]; farnesyl pyrophosphate inhibits the reaction [Simvastatin promotes the reaction [IL1B protein results in increased expression of SELE protein]] |
CTD |
PMID:10946302 |
|
NCBI chr 3:116,577,005...116,583,386
Ensembl chr 3:116,577,010...116,583,415
|
|
G |
Kras |
KRAS proto-oncogene, GTPase |
multiple interactions |
EXP |
[FNTA protein binds to FNTB protein] binds to [farnesyl pyrophosphate analog co-treated with KRAS protein] |
CTD |
PMID:10673434 |
|
NCBI chr 4:178,185,418...178,218,484
|
|
G |
Mapk1 |
mitogen activated protein kinase 1 |
multiple interactions |
ISO |
farnesyl pyrophosphate inhibits the reaction [Simvastatin inhibits the reaction [TNF results in increased phosphorylation of MAPK1 protein]] |
CTD |
PMID:18310456 |
|
NCBI chr11:83,957,813...84,023,629
Ensembl chr11:83,957,813...84,023,616
|
|
G |
Mapk3 |
mitogen activated protein kinase 3 |
multiple interactions |
ISO |
farnesyl pyrophosphate inhibits the reaction [Simvastatin inhibits the reaction [TNF results in increased phosphorylation of MAPK3 protein]] |
CTD |
PMID:18310456 |
|
NCBI chr 1:181,366,646...181,372,863
Ensembl chr 1:181,366,637...181,372,863
|
|
G |
Mapk8 |
mitogen-activated protein kinase 8 |
multiple interactions |
ISO |
farnesyl pyrophosphate inhibits the reaction [Simvastatin inhibits the reaction [TNF results in increased phosphorylation of MAPK8 protein]] |
CTD |
PMID:18310456 |
|
NCBI chr16:8,638,897...8,721,960
Ensembl chr16:8,638,924...8,721,981
|
|
G |
Mmp9 |
matrix metallopeptidase 9 |
multiple interactions |
EXP |
farnesyl pyrophosphate inhibits the reaction [Simvastatin inhibits the reaction [Smoke analog results in increased expression of MMP9 mRNA]]; farnesyl pyrophosphate inhibits the reaction [Simvastatin inhibits the reaction [Smoke analog results in increased secretion of MMP9 protein]] |
CTD |
PMID:19299917 |
|
NCBI chr 3:153,684,158...153,692,118
Ensembl chr 3:153,683,858...153,692,120
|
|
G |
Mvk |
mevalonate kinase |
decreases activity decreases chemical synthesis multiple interactions |
ISO |
farnesyl pyrophosphate results in decreased activity of MVK protein MVK protein mutant form results in decreased chemical synthesis of farnesyl pyrophosphate farnesyl pyrophosphate inhibits the reaction [MVK protein results in increased hydrolysis of Adenosine Triphosphate]; farnesyl pyrophosphate inhibits the reaction [MVK protein results in increased phosphorylation of Mevalonic Acid] |
CTD |
PMID:9392419 PMID:24073415 |
|
NCBI chr12:42,141,391...42,158,893
Ensembl chr12:42,141,384...42,158,882
|
|
G |
Pon1 |
paraoxonase 1 |
multiple interactions |
ISO |
farnesyl pyrophosphate inhibits the reaction [pitavastatin results in increased expression of PON1 mRNA]; farnesyl pyrophosphate inhibits the reaction [Simvastatin results in increased expression of PON1 mRNA] |
CTD |
PMID:14500290 PMID:15690306 |
|
NCBI chr 4:33,294,737...33,325,759
Ensembl chr 4:33,294,722...33,321,360
|
|
G |
Rac1 |
Rac family small GTPase 1 |
multiple interactions |
ISO |
farnesyl pyrophosphate inhibits the reaction [Simvastatin inhibits the reaction [Lipopolysaccharides results in increased activity of RAC1 protein]]; farnesyl pyrophosphate inhibits the reaction [Simvastatin inhibits the reaction [Lipopolysaccharides results in increased localization of RAC1 protein]] |
CTD |
PMID:18625914 |
|
NCBI chr12:11,037,028...11,057,251
Ensembl chr12:11,036,698...11,057,251
|
|
G |
Rhoa |
ras homolog family member A |
multiple interactions |
ISO |
farnesyl pyrophosphate inhibits the reaction [Simvastatin inhibits the reaction [Lipopolysaccharides results in decreased activity of RHOA protein]] farnesyl pyrophosphate inhibits the reaction [Simvastatin inhibits the reaction [TNF affects the localization of RHOA protein]] |
CTD |
PMID:18310456 PMID:18625914 |
|
NCBI chr 8:108,991,926...109,025,746
Ensembl chr 8:108,991,954...109,025,746
|
|
G |
Runx2 |
RUNX family transcription factor 2 |
multiple interactions |
ISO |
farnesyl pyrophosphate inhibits the reaction [Simvastatin inhibits the reaction [TNF protein inhibits the reaction [BMP2 results in increased expression of RUNX2 mRNA]]] |
CTD |
PMID:18310456 |
|
NCBI chr 9:16,167,504...16,492,826
Ensembl chr 9:16,167,482...16,492,167
|
|
G |
Sele |
selectin E |
multiple interactions |
ISO |
farnesyl pyrophosphate inhibits the reaction [Simvastatin promotes the reaction [IL1B protein results in increased expression of SELE protein]] |
CTD |
PMID:10946302 |
|
NCBI chr13:76,402,841...76,412,741
Ensembl chr13:76,403,304...76,412,741
|
|
G |
Tnf |
tumor necrosis factor |
multiple interactions |
ISO |
farnesyl pyrophosphate inhibits the reaction [Simvastatin inhibits the reaction [TNF affects the localization of RHOA protein]]; farnesyl pyrophosphate inhibits the reaction [Simvastatin inhibits the reaction [TNF protein inhibits the reaction [BMP2 results in increased expression of RUNX2 mRNA]]]; farnesyl pyrophosphate inhibits the reaction [Simvastatin inhibits the reaction [TNF results in increased phosphorylation of MAPK1 protein]]; farnesyl pyrophosphate inhibits the reaction [Simvastatin inhibits the reaction [TNF results in increased phosphorylation of MAPK3 protein]]; farnesyl pyrophosphate inhibits the reaction [Simvastatin inhibits the reaction [TNF results in increased phosphorylation of MAPK8 protein]] |
CTD |
PMID:18310456 |
|
NCBI chr20:3,622,011...3,624,629
Ensembl chr20:3,622,011...3,624,629
|
|
|
G |
Mvk |
mevalonate kinase |
decreases activity multiple interactions |
ISO |
dolichol monophosphate results in decreased activity of MVK protein dolichol monophosphate inhibits the reaction [MVK protein results in increased hydrolysis of Adenosine Triphosphate]; dolichol monophosphate inhibits the reaction [MVK protein results in increased phosphorylation of Mevalonic Acid] |
CTD |
PMID:9392419 |
|
NCBI chr12:42,141,391...42,158,893
Ensembl chr12:42,141,384...42,158,882
|
|
|
G |
Acaa1a |
acetyl-CoA acyltransferase 1A |
multiple interactions |
ISO |
[Farnesol analog co-treated with Oleic Acid] results in increased expression of ACAA1 mRNA |
CTD |
PMID:30611723 |
|
NCBI chr 8:119,079,401...119,088,626
Ensembl chr 8:119,079,775...119,088,624
|
|
G |
Acaa2 |
acetyl-CoA acyltransferase 2 |
multiple interactions increases expression |
ISO |
[Farnesol analog co-treated with Oleic Acid] results in increased expression of ACAA2 mRNA Farnesol analog results in increased expression of ACAA2 mRNA |
CTD |
PMID:30611723 |
|
NCBI chr18:68,345,136...68,373,246
Ensembl chr18:68,345,012...68,373,249
|
|
G |
Acadm |
acyl-CoA dehydrogenase medium chain |
multiple interactions |
ISO |
[Farnesol analog co-treated with Oleic Acid] results in increased expression of ACADM mRNA |
CTD |
PMID:30611723 |
|
NCBI chr 2:242,858,865...242,883,036
Ensembl chr 2:242,858,865...242,883,147
|
|
G |
Acads |
acyl-CoA dehydrogenase short chain |
multiple interactions increases expression |
ISO |
[Farnesol analog co-treated with Oleic Acid] results in increased expression of ACADS mRNA Farnesol analog results in increased expression of ACADS mRNA |
CTD |
PMID:30611723 |
|
NCBI chr12:41,493,650...41,502,897
Ensembl chr12:41,493,626...41,502,898
|
|
G |
Acat1 |
acetyl-CoA acetyltransferase 1 |
increases expression |
ISO |
Farnesol analog results in increased expression of ACAT1 mRNA |
CTD |
PMID:30611723 |
|
NCBI chr 8:53,979,813...54,008,861
Ensembl chr 8:53,979,813...54,008,855
|
|
G |
Acat2 |
acetyl-CoA acetyltransferase 2 |
increases expression |
ISO |
Farnesol analog results in increased expression of ACAT2 mRNA |
CTD |
PMID:30611723 |
|
NCBI chr 1:47,695,833...47,713,879
Ensembl chr 1:47,695,788...47,752,821
|
|
G |
Acot1 |
acyl-CoA thioesterase 1 |
multiple interactions |
ISO |
[Farnesol analog co-treated with Oleic Acid] results in increased expression of ACOT1 mRNA |
CTD |
PMID:30611723 |
|
NCBI chr 6:103,636,173...103,644,167
Ensembl chr 6:103,636,041...103,644,163
|
|
G |
Acot12 |
acyl-CoA thioesterase 12 |
increases expression multiple interactions |
ISO |
Farnesol analog results in increased expression of ACOT12 mRNA [Farnesol analog co-treated with Oleic Acid] results in increased expression of ACOT12 mRNA |
CTD |
PMID:30611723 |
|
NCBI chr 2:22,986,867...23,027,538
Ensembl chr 2:22,986,626...23,027,536
|
|
G |
Acot6 |
acyl-CoA thioesterase 6 |
multiple interactions |
ISO |
[Farnesol analog co-treated with Oleic Acid] results in decreased expression of ACOT6 mRNA |
CTD |
PMID:30611723 |
|
NCBI chr 6:103,732,372...103,741,446
Ensembl chr 6:103,732,372...103,741,446
|
|
G |
Acox1 |
acyl-CoA oxidase 1 |
multiple interactions |
ISO |
[Farnesol analog co-treated with Oleic Acid] results in increased expression of ACOX1 mRNA |
CTD |
PMID:30611723 |
|
NCBI chr10:101,406,197...101,431,252
Ensembl chr10:101,406,197...101,431,232
|
|
G |
Acox2 |
acyl-CoA oxidase 2 |
decreases expression increases expression |
ISO |
Farnesol analog results in decreased expression of ACOX2 mRNA Farnesol analog results in increased expression of ACOX2 mRNA |
CTD |
PMID:30611723 |
|
NCBI chr15:16,660,584...16,692,160
Ensembl chr15:16,660,272...16,692,160
|
|
G |
Acsl4 |
acyl-CoA synthetase long-chain family member 4 |
multiple interactions |
ISO |
[Farnesol analog co-treated with Oleic Acid] results in increased expression of ACSL4 mRNA |
CTD |
PMID:30611723 |
|
NCBI chr X:105,942,794...106,006,573
Ensembl chr X:105,942,799...106,006,427
|
|
G |
Acsl5 |
acyl-CoA synthetase long-chain family member 5 |
multiple interactions |
ISO |
[Farnesol analog co-treated with Oleic Acid] results in increased expression of ACSL5 mRNA |
CTD |
PMID:30611723 |
|
NCBI chr 1:254,289,513...254,336,608
Ensembl chr 1:254,292,521...254,336,607
|
|
G |
Agpat1 |
1-acylglycerol-3-phosphate O-acyltransferase 1 |
multiple interactions |
ISO |
[Farnesol analog co-treated with Oleic Acid] results in decreased expression of AGPAT1 mRNA |
CTD |
PMID:30611723 |
|
NCBI chr20:4,135,955...4,144,880
Ensembl chr20:4,135,957...4,145,278
|
|
G |
Akr1b10 |
aldo-keto reductase family 1 member B10 |
increases chemical synthesis |
ISO |
AKR1B10 protein results in increased chemical synthesis of Farnesol |
CTD |
PMID:21187079 |
|
NCBI chr 4:63,038,459...63,060,336
Ensembl chr 4:63,040,169...63,053,852
|
|
G |
Akr1c1 |
aldo-keto reductase family 1, member C1 |
increases expression |
ISO |
Farnesol results in increased expression of AKR1C1 mRNA |
CTD |
PMID:30806763 |
|
NCBI chr17:65,810,474...65,837,385
Ensembl chr17:65,810,475...65,837,326
|
|
G |
Akr1c3 |
aldo-keto reductase family 1, member C3 |
increases chemical synthesis multiple interactions |
ISO |
AKR1C3 protein results in increased chemical synthesis of Farnesol [Flurbiprofen results in decreased activity of AKR1C3 protein] which results in increased metabolism of Farnesol; [tolfenamic acid results in decreased activity of AKR1C3 protein] which results in increased metabolism of Farnesol |
CTD |
PMID:21187079 |
|
NCBI chr17:66,110,970...66,127,867
Ensembl chr17:66,110,963...66,127,873
|
|
G |
Apoa5 |
apolipoprotein A5 |
multiple interactions increases expression |
ISO |
[Farnesol analog co-treated with Oleic Acid] results in increased expression of APOA5 mRNA Farnesol analog results in increased expression of APOA5 mRNA |
CTD |
PMID:30611723 |
|
NCBI chr 8:46,561,180...46,563,818
Ensembl chr 8:46,561,229...46,563,816
|
|
G |
Apoc4 |
apolipoprotein C4 |
decreases expression |
ISO |
Farnesol analog results in decreased expression of APOC4 mRNA |
CTD |
PMID:30611723 |
|
NCBI chr 1:79,335,745...79,339,942
Ensembl chr 1:79,335,745...79,339,981
|
|
G |
Atf3 |
activating transcription factor 3 |
increases expression |
ISO |
Farnesol results in increased expression of ATF3 mRNA |
CTD |
PMID:27965148 |
|
NCBI chr13:102,751,278...102,800,520
Ensembl chr13:102,751,321...102,764,631
|
|
G |
Bak1 |
BCL2-antagonist/killer 1 |
increases expression |
ISO |
Farnesol results in increased expression of BAK1 protein |
CTD |
PMID:12530055 |
|
NCBI chr20:5,100,480...5,109,669
Ensembl chr20:5,100,480...5,109,264
|
|
G |
Casp3 |
caspase 3 |
increases activity decreases activity |
ISO EXP |
Farnesol results in increased activity of CASP3 protein Farnesol results in decreased activity of CASP3 protein |
CTD |
PMID:10733934 PMID:21453689 |
|
NCBI chr16:45,662,910...45,681,171
Ensembl chr16:45,662,910...45,684,648
|
|
G |
Cat |
catalase |
increases expression multiple interactions |
EXP ISO |
Farnesol results in increased expression of CAT protein Farnesol inhibits the reaction [Acetaminophen results in decreased activity of CAT protein] Farnesol inhibits the reaction [Tobacco Smoke Pollution results in decreased activity of CAT protein] |
CTD |
PMID:18793622 PMID:21453689 PMID:37458150 |
|
NCBI chr 3:89,842,393...89,874,577
Ensembl chr 3:89,842,399...89,874,478
|
|
G |
Ccl4 |
C-C motif chemokine ligand 4 |
increases secretion |
ISO |
Farnesol results in increased secretion of CCL4 protein |
CTD |
PMID:30806763 |
|
NCBI chr10:68,466,394...68,468,229
Ensembl chr10:68,452,052...68,468,231
|
|
G |
Ccna2 |
cyclin A2 |
decreases expression |
ISO |
Farnesol results in decreased expression of CCNA2 protein |
CTD |
PMID:17138864 |
|
NCBI chr 2:119,427,239...119,433,645
Ensembl chr 2:119,426,089...119,433,577
|
|
G |
Ccnb1 |
cyclin B1 |
decreases expression |
ISO |
Farnesol results in decreased expression of CCNB1 protein |
CTD |
PMID:17138864 |
|
NCBI chr 2:31,912,190...31,921,163
Ensembl chr 2:31,912,193...31,921,172
|
|
G |
Cdk2 |
cyclin dependent kinase 2 |
decreases expression multiple interactions |
ISO |
Farnesol results in decreased expression of CDK2 protein Farnesol promotes the reaction [CDKN1A protein binds to and results in decreased activity of CDK2 protein]; Farnesol promotes the reaction [CDKN1B protein binds to and results in decreased activity of CDK2 protein] |
CTD |
PMID:17138864 |
|
NCBI chr 7:1,129,878...1,137,431
Ensembl chr 7:1,129,811...1,137,403
|
|
G |
Cdkn1a |
cyclin-dependent kinase inhibitor 1A |
multiple interactions increases expression increases response to substance |
ISO |
Farnesol promotes the reaction [CDKN1A protein binds to and results in decreased activity of CDK2 protein] Farnesol results in increased expression of CDKN1A protein CDKN1A protein results in increased susceptibility to Farnesol |
CTD |
PMID:17138864 |
|
NCBI chr20:7,149,177...7,159,727
Ensembl chr20:7,149,217...7,159,585
|
|
G |
Cdkn1b |
cyclin-dependent kinase inhibitor 1B |
increases response to substance increases expression multiple interactions |
ISO |
CDKN1B protein results in increased susceptibility to Farnesol Farnesol results in increased expression of CDKN1B protein Farnesol promotes the reaction [CDKN1B protein binds to and results in decreased activity of CDK2 protein] |
CTD |
PMID:17138864 |
|
NCBI chr 4:167,760,067...167,765,177
Ensembl chr 4:167,760,181...167,764,982
|
|
G |
Cox10 |
cytochrome c oxidase assembly factor heme A:farnesyltransferase COX10 |
decreases expression |
ISO |
Farnesol analog results in decreased expression of COX10 mRNA |
CTD |
PMID:30611723 |
|
NCBI chr10:48,630,993...48,742,805
Ensembl chr10:48,630,676...48,746,667
|
|
G |
Cpt1a |
carnitine palmitoyltransferase 1A |
multiple interactions |
ISO |
[Farnesol analog co-treated with Oleic Acid] results in increased expression of CPT1A mRNA |
CTD |
PMID:30611723 |
|
NCBI chr 1:200,564,634...200,627,059
Ensembl chr 1:200,565,613...200,627,055
|
|
G |
Cyp19a1 |
cytochrome P450, family 19, subfamily a, polypeptide 1 |
increases activity |
EXP |
Farnesol results in increased activity of CYP19A1 protein |
CTD |
PMID:15840382 |
|
NCBI chr 8:54,552,978...54,580,375
Ensembl chr 8:54,553,165...54,580,758
|
|
G |
Cyp1a1 |
cytochrome P450, family 1, subfamily a, polypeptide 1 |
increases activity increases expression |
EXP ISO |
Farnesol results in increased activity of CYP1A1 protein Farnesol results in increased expression of CYP1A1 mRNA |
CTD |
PMID:15840382 PMID:30806763 |
|
NCBI chr 8:58,096,021...58,102,130
Ensembl chr 8:58,096,077...58,102,125
|
|
G |
Cyp1a2 |
cytochrome P450, family 1, subfamily a, polypeptide 2 |
increases activity multiple interactions |
EXP ISO |
Farnesol results in increased activity of CYP1A2 protein Farnesol analog inhibits the reaction [Oleic Acid results in decreased expression of CYP1A2 mRNA] |
CTD |
PMID:15840382 PMID:30611723 |
|
NCBI chr 8:58,075,367...58,082,255
Ensembl chr 8:58,075,367...58,082,312
|
|
G |
Cyp2a1 |
cytochrome P450, family 2, subfamily a, polypeptide 1 |
increases activity |
EXP |
Farnesol results in increased activity of CYP2A1 protein |
CTD |
PMID:15840382 |
|
NCBI chr 1:82,231,611...82,244,887
Ensembl chr 1:82,231,611...82,244,887
|
|
G |
Cyp2a2 |
cytochrome P450, family 2, subfamily a, polypeptide 2 |
increases activity |
EXP |
Farnesol results in increased activity of CYP2A2 protein |
CTD |
PMID:15840382 |
|
NCBI chr 1:82,263,833...82,289,487
Ensembl chr 1:82,263,833...82,289,487
|
|
G |
Cyp2a3 |
cytochrome P450, family 2, subfamily a, polypeptide 3 |
increases activity |
EXP |
Farnesol results in increased activity of CYP2A3 protein |
CTD |
PMID:15840382 |
|
NCBI chr 1:82,171,914...82,179,980
Ensembl chr 1:82,169,949...82,179,979
|
|
G |
Cyp2b1 |
cytochrome P450, family 2, subfamily b, polypeptide 1 |
increases activity |
EXP |
Farnesol results in increased activity of CYP2B1 protein |
CTD |
PMID:15840382 |
|
NCBI chr 1:81,518,387...81,544,999
Ensembl chr 1:81,518,408...81,542,052
|
|
G |
Cyp2b2 |
cytochrome P450, family 2, subfamily b, polypeptide 2 |
increases activity |
EXP |
Farnesol results in increased activity of CYP2B2 protein |
CTD |
PMID:15840382 |
|
NCBI chr 1:81,594,534...81,608,567
Ensembl chr 1:81,594,555...81,608,566
|
|
G |
Cyp2b3 |
cytochrome P450, family 2, subfamily b, polypeptide 3 |
multiple interactions increases expression |
ISO |
[Farnesol analog co-treated with Oleic Acid] results in increased expression of CYP2B6 mRNA; Farnesol analog inhibits the reaction [Oleic Acid results in decreased expression of CYP2B6 mRNA] Farnesol analog results in increased expression of CYP2B6 mRNA; Farnesol results in increased expression of CYP2B6 mRNA |
CTD |
PMID:30611723 |
|
NCBI chr 1:81,652,762...81,732,153
Ensembl chr 1:81,652,787...81,732,143
|
|
G |
Cyp2c11 |
cytochrome P450, subfamily 2, polypeptide 11 |
increases activity |
EXP |
Farnesol results in increased activity of CYP2C11 protein |
CTD |
PMID:15840382 |
|
NCBI chr 1:236,762,719...236,799,069
Ensembl chr 1:236,762,842...236,799,066
|
|
G |
Cyp2c12 |
cytochrome P450, family 2, subfamily c, polypeptide 12 |
increases activity |
EXP |
Farnesol results in increased activity of CYP2C12 protein |
CTD |
PMID:15840382 |
|
NCBI chr 1:238,699,859...238,757,011
Ensembl chr 1:238,699,854...238,757,019
|
|
G |
Cyp2e1 |
cytochrome P450, family 2, subfamily e, polypeptide 1 |
increases activity multiple interactions decreases expression |
EXP ISO |
Farnesol results in increased activity of CYP2E1 protein [Farnesol analog co-treated with Oleic Acid] results in increased expression of CYP2E1 mRNA; Farnesol analog inhibits the reaction [Oleic Acid results in increased expression of CYP2E1 mRNA] Farnesol analog results in decreased expression of CYP2E1 mRNA; Farnesol results in decreased expression of CYP2E1 mRNA |
CTD |
PMID:15840382 PMID:30611723 |
|
NCBI chr 1:195,840,330...195,850,728
Ensembl chr 1:195,840,058...195,864,023
|
|
G |
Cyp3a2 |
cytochrome P450, family 3, subfamily a, polypeptide 2 |
increases activity increases expression multiple interactions |
EXP ISO |
Farnesol results in increased activity of CYP3A2 protein Farnesol results in increased expression of CYP3A4 mRNA Farnesol analog inhibits the reaction [Oleic Acid results in decreased expression of CYP3A4 mRNA] |
CTD |
PMID:15840382 PMID:30611723 |
|
NCBI chr12:9,207,978...9,230,064
Ensembl chr12:9,015,383...9,285,008
|
|
G |
Cyp3a23-3a1 |
cytochrome P450, family 3, subfamily a, polypeptide 23-polypeptide 1 |
increases activity |
EXP |
Farnesol results in increased activity of CYP3A23-3A1 protein |
CTD |
PMID:15840382 |
|
NCBI chr12:9,256,159...9,285,020
Ensembl chr12:9,254,475...9,285,030 Ensembl chr12:9,254,475...9,285,030
|
|
G |
Cyp4a1 |
cytochrome P450, family 4, subfamily a, polypeptide 1 |
increases activity |
EXP |
Farnesol results in increased activity of CYP4A1 protein |
CTD |
PMID:15840382 |
|
NCBI chr 5:129,123,323...129,137,464
Ensembl chr 5:129,123,336...129,137,464
|
|
G |
Cyp4a2 |
cytochrome P450, family 4, subfamily a, polypeptide 2 |
increases activity |
EXP |
Farnesol results in increased activity of CYP4A2 protein |
CTD |
PMID:15840382 |
|
NCBI chr 5:128,922,355...128,934,188
Ensembl chr 5:128,923,615...128,934,165
|
|
G |
Cyp4a3 |
cytochrome P450, family 4, subfamily a, polypeptide 3 |
increases activity |
EXP |
Farnesol results in increased activity of CYP4A3 protein |
CTD |
PMID:15840382 |
|
NCBI chr 5:129,097,571...129,115,488
Ensembl chr 5:129,097,926...129,115,463
|
|
G |
Decr1 |
2,4-dienoyl-CoA reductase 1 |
multiple interactions |
ISO |
[Farnesol analog co-treated with Oleic Acid] results in decreased expression of DECR1 mRNA |
CTD |
PMID:30611723 |
|
NCBI chr 5:29,411,172...29,439,054
Ensembl chr 5:29,411,172...29,439,018
|
|
G |
Dgat1 |
diacylglycerol O-acyltransferase 1 |
decreases expression |
ISO |
Farnesol analog results in decreased expression of DGAT1 mRNA |
CTD |
PMID:30611723 |
|
NCBI chr 7:108,223,860...108,235,413
Ensembl chr 7:108,218,524...108,234,299
|
|
G |
Dgat2 |
diacylglycerol O-acyltransferase 2 |
multiple interactions |
ISO |
[Farnesol analog co-treated with Oleic Acid] results in increased expression of DGAT2 mRNA |
CTD |
PMID:30611723 |
|
NCBI chr 1:153,454,078...153,484,432
Ensembl chr 1:153,454,080...153,484,428
|
|
G |
Dnajb4 |
DnaJ heat shock protein family (Hsp40) member B4 |
increases expression |
ISO |
Farnesol results in increased expression of DNAJB4 mRNA |
CTD |
PMID:27965148 |
|
NCBI chr 2:241,129,346...241,159,272
Ensembl chr 2:241,130,340...241,159,089
|
|
G |
Ech1 |
enoyl-CoA hydratase 1 |
increases expression |
ISO |
Farnesol analog results in increased expression of ECH1 mRNA |
CTD |
PMID:30611723 |
|
NCBI chr 1:84,114,494...84,120,788
Ensembl chr 1:84,112,751...84,120,795
|
|
G |
Egf |
epidermal growth factor |
multiple interactions |
ISO |
Farnesol analog inhibits the reaction [EGF protein results in increased activity of RHOA protein]; Farnesol analog results in decreased susceptibility to [INS protein co-treated with EGF protein] |
CTD |
PMID:24587105 |
|
NCBI chr 2:218,219,408...218,302,359
Ensembl chr 2:218,219,415...218,302,064
|
|
G |
Elovl6 |
ELOVL fatty acid elongase 6 |
multiple interactions |
ISO |
[Farnesol analog co-treated with Oleic Acid] results in increased expression of ELOVL6 mRNA |
CTD |
PMID:30611723 |
|
NCBI chr 2:218,063,682...218,174,767
Ensembl chr 2:218,063,804...218,171,186
|
|
G |
Fabp1 |
fatty acid binding protein 1 |
increases expression |
ISO |
Farnesol analog results in increased expression of FABP1 mRNA |
CTD |
PMID:30611723 |
|
NCBI chr 4:103,191,015...103,194,791
Ensembl chr 4:103,191,006...103,194,788
|
|
G |
Fabp4 |
fatty acid binding protein 4 |
increases expression |
ISO |
Farnesol results in increased expression of FABP4 mRNA |
CTD |
PMID:30806763 |
|
NCBI chr 2:91,580,879...91,585,567
Ensembl chr 2:91,580,885...91,585,578
|
|
G |
Fasn |
fatty acid synthase |
multiple interactions |
ISO |
[Farnesol analog co-treated with Oleic Acid] results in increased expression of FASN mRNA |
CTD |
PMID:30611723 |
|
NCBI chr10:106,072,093...106,090,259
Ensembl chr10:106,072,091...106,090,261
|
|
G |
Fdft1 |
farnesyl diphosphate farnesyl transferase 1 |
increases expression |
ISO |
Farnesol analog results in increased expression of FDFT1 mRNA |
CTD |
PMID:30611723 |
|
NCBI chr15:37,412,143...37,440,198
Ensembl chr15:37,412,146...37,440,287
|
|
G |
Fnta |
farnesyltransferase, CAAX box, subunit alpha |
multiple interactions |
ISO |
[Farnesol analog co-treated with Oleic Acid] results in increased expression of FNTA mRNA |
CTD |
PMID:30611723 |
|
NCBI chr16:66,065,131...66,083,460
Ensembl chr16:66,065,132...66,083,460
|
|
G |
Fntb |
farnesyltransferase, CAAX box, subunit beta |
decreases expression |
ISO |
Farnesol analog results in decreased expression of FNTB mRNA |
CTD |
PMID:30611723 |
|
NCBI chr 6:95,536,540...95,619,587
Ensembl chr 6:95,470,683...95,619,586
|
|
G |
Gpat4 |
glycerol-3-phosphate acyltransferase 4 |
multiple interactions |
ISO |
[Farnesol analog co-treated with Oleic Acid] results in increased expression of GPAT4 mRNA |
CTD |
PMID:30611723 |
|
NCBI chr16:68,819,031...68,852,903
Ensembl chr16:68,819,079...68,852,901
|
|
G |
Gpt |
glutamic--pyruvic transaminase |
multiple interactions |
ISO |
Farnesol inhibits the reaction [Acetaminophen results in increased expression of GPT protein] |
CTD |
PMID:37458150 |
|
NCBI chr 7:108,416,646...108,419,495
Ensembl chr 7:108,416,642...108,419,494
|
|
G |
Gsr |
glutathione-disulfide reductase |
increases activity multiple interactions increases expression |
EXP ISO |
Farnesol results in increased activity of GSR protein Farnesol inhibits the reaction [Acetaminophen results in decreased activity of GSR protein] Farnesol results in increased expression of GSR protein |
CTD |
PMID:15840382 PMID:21453689 PMID:37458150 |
|
NCBI chr16:58,482,209...58,525,256
Ensembl chr16:58,482,505...58,525,661
|
|
G |
Hadha |
hydroxyacyl-CoA dehydrogenase trifunctional multienzyme complex subunit alpha |
increases expression multiple interactions |
ISO |
Farnesol analog results in increased expression of HADHA mRNA [Farnesol analog co-treated with Oleic Acid] results in increased expression of HADHA mRNA |
CTD |
PMID:30611723 |
|
NCBI chr 6:26,187,969...26,227,605
Ensembl chr 6:26,187,956...26,227,869
|
|
G |
Hadhb |
hydroxyacyl-CoA dehydrogenase trifunctional multienzyme complex subunit beta |
increases expression multiple interactions |
ISO |
Farnesol analog results in increased expression of HADHB mRNA [Farnesol analog co-treated with Oleic Acid] results in increased expression of HADHB mRNA |
CTD |
PMID:30611723 |
|
NCBI chr 6:26,153,572...26,187,668
Ensembl chr 6:26,153,578...26,184,869
|
|
G |
Hmgcr |
3-hydroxy-3-methylglutaryl-CoA reductase |
multiple interactions increases expression decreases activity |
ISO EXP |
[Farnesol analog co-treated with Oleic Acid] results in increased expression of HMGCR mRNA Farnesol results in increased expression of HMGCR protein Farnesol results in decreased activity of HMGCR protein |
CTD |
PMID:12477733 PMID:16332721 PMID:30611723 |
|
NCBI chr 2:27,997,523...28,018,983
Ensembl chr 2:27,997,525...28,019,703
|
|
G |
Hmox1 |
heme oxygenase 1 |
increases expression |
ISO |
Farnesol results in increased expression of HMOX1 mRNA |
CTD |
PMID:30806763 |
|
NCBI chr19:13,466,287...13,474,082
Ensembl chr19:13,467,244...13,474,079
|
|
G |
Hras |
HRas proto-oncogene, GTPase |
multiple interactions |
ISO |
Farnesol inhibits the reaction [Simvastatin results in decreased farnesylation of and affects the localization of HRAS protein] |
CTD |
PMID:12477733 |
|
NCBI chr 1:196,290,127...196,299,823
Ensembl chr 1:196,296,263...196,300,615
|
|
G |
Icam1 |
intercellular adhesion molecule 1 |
increases expression |
ISO |
Farnesol results in increased expression of ICAM1 mRNA |
CTD |
PMID:30806763 |
|
NCBI chr 8:19,553,063...19,565,438
Ensembl chr 8:19,553,645...19,565,438
|
|
G |
Ikbkb |
inhibitor of nuclear factor kappa B kinase subunit beta |
multiple interactions |
ISO |
Farnesol inhibits the reaction [Acetaminophen results in increased expression of IKBKB mRNA] |
CTD |
PMID:37458150 |
|
NCBI chr16:69,319,487...69,373,251
Ensembl chr16:69,319,554...69,373,250
|
|
G |
Il16 |
interleukin 16 |
increases secretion |
ISO |
Farnesol results in increased secretion of IL16 protein |
CTD |
PMID:30806763 |
|
NCBI chr 1:137,617,702...137,718,022
Ensembl chr 1:137,617,944...137,718,130
|
|
G |
Il1a |
interleukin 1 alpha |
increases expression |
ISO |
Farnesol results in increased expression of IL1A mRNA |
CTD |
PMID:30806763 |
|
NCBI chr 3:116,526,601...116,537,055
Ensembl chr 3:116,526,604...116,536,822
|
|
G |
Il1b |
interleukin 1 beta |
multiple interactions |
ISO |
Farnesol inhibits the reaction [[MVK gene mutant form results in increased susceptibility to Lipopolysaccharides] which results in increased expression of IL1B protein] Farnesol inhibits the reaction [[Alendronate co-treated with Lipopolysaccharides] results in increased expression of IL1B protein]; Farnesol inhibits the reaction [Acetaminophen results in increased expression of IL1B protein] |
CTD |
PMID:20304105 PMID:37458150 |
|
NCBI chr 3:116,577,005...116,583,386
Ensembl chr 3:116,577,010...116,583,415
|
|
G |
Il1r2 |
interleukin 1 receptor type 2 |
increases expression |
ISO |
Farnesol results in increased expression of IL1R2 mRNA |
CTD |
PMID:30806763 |
|
NCBI chr 9:42,384,280...42,424,726
Ensembl chr 9:42,384,433...42,424,725
|
|
G |
Il6 |
interleukin 6 |
multiple interactions |
ISO |
Farnesol inhibits the reaction [Acetaminophen results in increased expression of IL6 mRNA] |
CTD |
PMID:37458150 |
|
NCBI chr 4:5,214,602...5,219,178
Ensembl chr 4:5,213,394...5,219,178
|
|
G |
Ins2 |
insulin 2 |
multiple interactions |
ISO |
Farnesol analog results in decreased susceptibility to [INS protein co-treated with EGF protein] |
CTD |
PMID:24587105 |
|
NCBI chr 1:197,843,277...197,992,522
Ensembl chr 1:197,843,281...197,864,775
|
|
G |
Lipc |
lipase C, hepatic type |
increases expression |
ISO |
Farnesol analog results in increased expression of LIPC mRNA |
CTD |
PMID:30611723 |
|
NCBI chr 8:71,509,633...71,635,663
Ensembl chr 8:71,509,635...71,635,464
|
|
G |
Lpin1 |
lipin 1 |
multiple interactions |
ISO |
[Farnesol analog co-treated with Oleic Acid] results in increased expression of LPIN1 mRNA |
CTD |
PMID:30611723 |
|
NCBI chr 6:39,309,198...39,417,034
Ensembl chr 6:39,312,748...39,417,097
|
|
G |
Lpin3 |
lipin 3 |
decreases expression |
ISO |
Farnesol analog results in decreased expression of LPIN3 mRNA |
CTD |
PMID:30611723 |
|
NCBI chr 3:149,533,719...149,558,494
Ensembl chr 3:149,534,051...149,558,327
|
|
G |
Mlxipl |
MLX interacting protein-like |
multiple interactions |
ISO |
[Farnesol analog co-treated with Oleic Acid] results in decreased expression of MLXIPL mRNA |
CTD |
PMID:30611723 |
|
NCBI chr12:21,541,608...21,577,120
Ensembl chr12:21,543,576...21,577,112
|
|
G |
Mmp3 |
matrix metallopeptidase 3 |
increases expression |
ISO |
Farnesol results in increased expression of MMP3 mRNA |
CTD |
PMID:30806763 |
|
NCBI chr 8:4,640,397...4,653,963
Ensembl chr 8:4,640,416...4,653,961
|
|
G |
Mvk |
mevalonate kinase |
decreases activity multiple interactions |
ISO |
Farnesol results in decreased activity of MVK protein Farnesol inhibits the reaction [[MVK gene mutant form results in increased susceptibility to Lipopolysaccharides] which results in increased expression of IL1B protein]; Farnesol inhibits the reaction [MVK gene mutant form results in increased susceptibility to Lipopolysaccharides]; Farnesol inhibits the reaction [MVK protein results in increased hydrolysis of Adenosine Triphosphate]; Farnesol inhibits the reaction [MVK protein results in increased phosphorylation of Mevalonic Acid] |
CTD |
PMID:9392419 PMID:20304105 |
|
NCBI chr12:42,141,391...42,158,893
Ensembl chr12:42,141,384...42,158,882
|
|
G |
Myl9 |
myosin light chain 9 |
multiple interactions |
ISO |
Farnesol analog inhibits the reaction [lysophosphatidic acid results in increased phosphorylation of MYL9 protein] |
CTD |
PMID:24587105 |
|
NCBI chr 3:145,281,943...145,288,333
Ensembl chr 3:145,281,937...145,288,333
|
|
G |
Nqo1 |
NAD(P)H quinone dehydrogenase 1 |
increases activity |
EXP |
Farnesol results in increased activity of NQO1 protein |
CTD |
PMID:15840382 |
|
NCBI chr19:35,295,633...35,310,528
Ensembl chr19:35,295,573...35,310,557
|
|
G |
Nr0b2 |
nuclear receptor subfamily 0, group B, member 2 |
decreases expression multiple interactions |
ISO |
Farnesol analog results in decreased expression of NR0B2 mRNA [Farnesol analog co-treated with Oleic Acid] results in decreased expression of NR0B2 mRNA |
CTD |
PMID:30611723 |
|
NCBI chr 5:145,779,294...145,782,609
Ensembl chr 5:145,779,294...145,782,609
|
|
G |
Nr1h4 |
nuclear receptor subfamily 1, group H, member 4 |
multiple interactions decreases expression |
ISO |
Farnesol binds to and results in increased activity of NR1H4 protein Farnesol analog results in decreased expression of NR1H4 mRNA |
CTD |
PMID:15491415 PMID:30611723 |
|
NCBI chr 7:23,846,122...23,942,085
Ensembl chr 7:23,846,122...23,942,047
|
|
G |
Pck1 |
phosphoenolpyruvate carboxykinase 1 |
multiple interactions decreases expression |
ISO |
[Farnesol analog co-treated with Oleic Acid] results in increased expression of PCK1 mRNA Farnesol analog results in decreased expression of PCK1 mRNA |
CTD |
PMID:30611723 |
|
NCBI chr 3:161,930,256...161,936,205
Ensembl chr 3:161,930,256...161,936,191
|
|
G |
Pdss1 |
decaprenyl diphosphate synthase subunit 1 |
increases expression |
ISO |
Farnesol analog results in increased expression of PDSS1 mRNA |
CTD |
PMID:30611723 |
|
NCBI chr17:85,059,953...85,098,739
Ensembl chr17:85,060,106...85,098,730
|
|
G |
Plin2 |
perilipin 2 |
increases expression multiple interactions |
ISO |
Farnesol analog results in increased expression of PLIN2 mRNA [Farnesol analog co-treated with Oleic Acid] results in increased expression of PLIN2 mRNA |
CTD |
PMID:30611723 |
|
NCBI chr 5:101,156,648...101,211,738
Ensembl chr 5:101,154,411...101,242,319
|
|
G |
Ppara |
peroxisome proliferator activated receptor alpha |
multiple interactions |
ISO |
[Farnesol analog co-treated with Oleic Acid] results in increased expression of PPARA mRNA; Farnesol inhibits the reaction [cerivastatin promotes the reaction [Bezafibrate results in increased activity of [PPARA protein binds to RXRA protein]]] |
CTD |
PMID:11779144 PMID:30611723 |
|
NCBI chr 7:116,832,405...116,900,878
Ensembl chr 7:116,832,756...116,895,346
|
|
G |
Pparg |
peroxisome proliferator-activated receptor gamma |
multiple interactions increases expression |
ISO |
[Farnesol analog co-treated with Oleic Acid] results in increased expression of PPARG mRNA Farnesol analog results in increased expression of PPARG mRNA |
CTD |
PMID:30611723 |
|
NCBI chr 4:148,423,102...148,548,471
Ensembl chr 4:148,423,194...148,548,468
|
|
G |
Ppargc1a |
PPARG coactivator 1 alpha |
multiple interactions |
EXP |
Farnesol inhibits the reaction [Atorvastatin inhibits the reaction [TNF protein results in decreased expression of PPARGC1A protein]] |
CTD |
PMID:22343369 |
|
NCBI chr14:58,860,752...59,516,525
Ensembl chr14:58,861,144...59,512,656
|
|
G |
Rabggta |
Rab geranylgeranyltransferase subunit alpha |
multiple interactions |
ISO |
[Farnesol analog co-treated with Oleic Acid] results in decreased expression of RABGGTA mRNA |
CTD |
PMID:30611723 |
|
NCBI chr15:29,206,328...29,213,398
Ensembl chr15:29,206,157...29,213,348
|
|
G |
Rabggtb |
Rab geranylgeranyltransferase subunit beta |
multiple interactions |
ISO |
[Farnesol analog co-treated with Oleic Acid] results in decreased expression of RABGGTB mRNA |
CTD |
PMID:30611723 |
|
NCBI chr 2:242,844,758...242,850,951
Ensembl chr 2:242,844,762...242,851,050
|
|
G |
Rac1 |
Rac family small GTPase 1 |
multiple interactions |
ISO |
Farnasol inhibits the reaction [Ropivacaine decreases activity of RAC1 protein in esophageal carcinoma cells] |
RGD |
PMID:29777701 |
RGD:155230817 |
NCBI chr12:11,037,028...11,057,251
Ensembl chr12:11,036,698...11,057,251
|
|
G |
Rhoa |
ras homolog family member A |
multiple interactions |
EXP ISO |
Farnesol inhibits the reaction [Lovastatin affects the localization of RHOA protein] Farnesol analog inhibits the reaction [EGF protein results in increased activity of RHOA protein]; Farnesol analog inhibits the reaction [lysophosphatidic acid results in increased activity of RHOA protein] |
CTD |
PMID:9398081 PMID:24587105 |
|
NCBI chr 8:108,991,926...109,025,746
Ensembl chr 8:108,991,954...109,025,746
|
|
G |
Rhoc |
ras homolog family member C |
multiple interactions |
ISO |
Farnesol analog inhibits the reaction [lysophosphatidic acid results in increased activity of RHOC protein] |
CTD |
PMID:24587105 |
|
NCBI chr 2:192,287,065...192,293,292
Ensembl chr 2:192,287,130...192,295,306
|
|
G |
Rxra |
retinoid X receptor alpha |
multiple interactions |
ISO |
Farnesol inhibits the reaction [cerivastatin promotes the reaction [Bezafibrate results in increased activity of [PPARA protein binds to RXRA protein]]] |
CTD |
PMID:11779144 |
|
NCBI chr 3:10,989,832...11,076,366
Ensembl chr 3:10,989,832...11,073,712
|
|
G |
Scd |
stearoyl-CoA desaturase |
multiple interactions |
ISO |
[Farnesol analog co-treated with Oleic Acid] results in decreased expression of SCD mRNA |
CTD |
PMID:30611723 |
|
NCBI chr 1:243,269,745...243,282,878
Ensembl chr 1:243,269,747...243,282,562
|
|
G |
Serpinb3 |
serpin family B member 3 |
increases expression |
ISO |
Farnesol results in increased expression of SERPINB3 mRNA |
CTD |
PMID:30806763 |
|
NCBI chr13:23,274,120...23,280,660
Ensembl chr13:23,274,484...23,313,682
|
|
G |
Slc25a20 |
solute carrier family 25 member 20 |
multiple interactions |
ISO |
[Farnesol analog co-treated with Oleic Acid] results in increased expression of SLC25A20 mRNA |
CTD |
PMID:30611723 |
|
NCBI chr 8:109,365,056...109,386,512
Ensembl chr 8:109,365,002...109,386,512
|
|
G |
Slc27a1 |
solute carrier family 27 member 1 |
multiple interactions |
ISO |
[Farnesol analog co-treated with Oleic Acid] results in increased expression of SLC27A1 mRNA |
CTD |
PMID:30611723 |
|
NCBI chr16:18,278,984...18,300,173
Ensembl chr16:18,278,984...18,296,063
|
|
G |
Slc27a2 |
solute carrier family 27 member 2 |
increases expression |
ISO |
Farnesol analog results in increased expression of SLC27A2 mRNA |
CTD |
PMID:30611723 |
|
NCBI chr 3:113,804,728...113,842,208
Ensembl chr 3:113,804,728...113,842,208
|
|
G |
Slc7a11 |
solute carrier family 7 member 11 |
increases expression |
ISO |
Farnesol results in increased expression of SLC7A11 mRNA |
CTD |
PMID:30806763 |
|
NCBI chr 2:134,382,002...134,517,622
Ensembl chr 2:133,963,107...134,517,536
|
|
G |
Tnf |
tumor necrosis factor |
multiple interactions increases expression |
EXP ISO |
Farnesol inhibits the reaction [Atorvastatin inhibits the reaction [TNF protein results in decreased expression of PPARGC1A protein]] Farnesol inhibits the reaction [Acetaminophen results in increased expression of TNF protein] Farnesol results in increased expression of TNF mRNA |
CTD |
PMID:22343369 PMID:30806763 PMID:37458150 |
|
NCBI chr20:3,622,011...3,624,629
Ensembl chr20:3,622,011...3,624,629
|
|
G |
Ugt1a1 |
UDP glucuronosyltransferase family 1 member A1 |
increases glucuronidation |
ISO |
UGT1A1 protein results in increased glucuronidation of Farnesol |
CTD |
PMID:15320866 |
|
NCBI chr 9:88,801,344...88,808,465
Ensembl chr 9:88,713,184...88,808,465
|
|
G |
Ugt1a2 |
UDP glucuronosyltransferase 1 family, polypeptide A2 |
increases glucuronidation |
ISO |
UGT1A3 protein results in increased glucuronidation of Farnesol |
CTD |
PMID:15320866 |
|
NCBI chr 9:88,791,216...88,808,465
Ensembl chr 9:88,713,184...88,808,465
|
|
G |
Ugt1a5 |
UDP glucuronosyltransferase family 1 member A5 |
increases glucuronidation |
ISO |
UGT1A4 protein results in increased glucuronidation of Farnesol |
CTD |
PMID:15320866 |
|
NCBI chr 9:88,762,250...88,808,465
Ensembl chr 9:88,713,184...88,808,465
|
|
G |
Ugt1a6 |
UDP glucuronosyltransferase family 1 member A6 |
increases glucuronidation |
ISO |
UGT1A6 protein results in increased glucuronidation of Farnesol |
CTD |
PMID:15320866 |
|
NCBI chr 9:88,747,213...88,808,465
Ensembl chr 9:88,713,184...88,808,465
|
|
G |
Ugt1a9 |
UDP glucuronosyltransferase family 1 member A9 |
increases glucuronidation |
ISO |
UGT1A9 protein results in increased glucuronidation of Farnesol |
CTD |
PMID:15320866 |
|
NCBI chr 9:88,696,981...88,808,465
Ensembl chr 9:88,713,184...88,808,465
|
|
G |
Ugt2b7 |
UDP glucuronosyltransferase family 2 member B7 |
increases glucuronidation |
ISO |
UGT2B7 protein results in increased glucuronidation of Farnesol |
CTD |
PMID:15320866 |
|
NCBI chr14:20,896,682...20,919,604
Ensembl chr14:20,896,682...20,919,604
|
|
|
G |
Akt1 |
AKT serine/threonine kinase 1 |
multiple interactions |
ISO |
farnesyl pyrophosphate inhibits the reaction [Simvastatin results in decreased phosphorylation of AKT1 protein] |
CTD |
PMID:33034787 |
|
NCBI chr 6:131,713,716...131,735,319
Ensembl chr 6:131,713,720...131,733,921
|
|
G |
Birc5 |
baculoviral IAP repeat-containing 5 |
multiple interactions |
ISO |
farnesyl pyrophosphate inhibits the reaction [Lovastatin results in decreased expression of BIRC5 protein] |
CTD |
PMID:17472962 |
|
NCBI chr10:103,072,530...103,081,382
Ensembl chr10:103,073,408...103,081,380
|
|
G |
Bmp2 |
bone morphogenetic protein 2 |
multiple interactions |
ISO |
farnesyl pyrophosphate inhibits the reaction [Simvastatin inhibits the reaction [TNF protein inhibits the reaction [BMP2 results in increased expression of RUNX2 mRNA]]] |
CTD |
PMID:18310456 |
|
NCBI chr 3:120,812,660...120,822,579
Ensembl chr 3:120,812,882...120,821,397
|
|
G |
Casp3 |
caspase 3 |
multiple interactions |
ISO EXP |
farnesyl pyrophosphate inhibits the reaction [Lovastatin results in increased activity of and results in increased cleavage of CASP3 protein] farnesyl pyrophosphate inhibits the reaction [Simvastatin results in increased activity of CASP3 protein] |
CTD |
PMID:15200425 PMID:18766339 |
|
NCBI chr16:45,662,910...45,681,171
Ensembl chr16:45,662,910...45,684,648
|
|
G |
Cyp17a1 |
cytochrome P450, family 17, subfamily a, polypeptide 1 |
multiple interactions |
EXP |
farnesyl pyrophosphate inhibits the reaction [Simvastatin results in decreased expression of CYP17A1 mRNA] |
CTD |
PMID:21918126 |
|
NCBI chr 1:245,535,462...245,543,148
Ensembl chr 1:245,535,462...245,541,573
|
|
G |
Fnta |
farnesyltransferase, CAAX box, subunit alpha |
multiple interactions |
EXP |
[FNTA protein binds to FNTB protein] binds to [farnesyl pyrophosphate analog co-treated with KRAS protein] |
CTD |
PMID:10673434 |
|
NCBI chr16:66,065,131...66,083,460
Ensembl chr16:66,065,132...66,083,460
|
|
G |
Fntb |
farnesyltransferase, CAAX box, subunit beta |
multiple interactions |
EXP |
[FNTA protein binds to FNTB protein] binds to [farnesyl pyrophosphate analog co-treated with KRAS protein] |
CTD |
PMID:10673434 |
|
NCBI chr 6:95,536,540...95,619,587
Ensembl chr 6:95,470,683...95,619,586
|
|
G |
Fos |
Fos proto-oncogene, AP-1 transcription factor subunit |
multiple interactions |
ISO |
farnesyl pyrophosphate inhibits the reaction [Simvastatin results in decreased expression of FOS mRNA] |
CTD |
PMID:16005304 |
|
NCBI chr 6:105,121,170...105,124,036
Ensembl chr 6:105,121,170...105,124,036
|
|
G |
Foxo1 |
forkhead box O1 |
multiple interactions |
ISO |
farnesyl pyrophosphate inhibits the reaction [Simvastatin results in decreased phosphorylation of FOXO1 protein] |
CTD |
PMID:33034787 |
|
NCBI chr 2:136,312,168...136,390,603
Ensembl chr 2:136,312,168...136,387,790
|
|
G |
Hmgcr |
3-hydroxy-3-methylglutaryl-CoA reductase |
multiple interactions |
ISO |
[Lovastatin results in decreased activity of HMGCR protein] which results in decreased abundance of farnesyl pyrophosphate |
CTD |
PMID:17208200 |
|
NCBI chr 2:27,997,523...28,018,983
Ensembl chr 2:27,997,525...28,019,703
|
|
G |
Hras |
HRas proto-oncogene, GTPase |
multiple interactions |
ISO |
farnesyl pyrophosphate inhibits the reaction [Simvastatin inhibits the reaction [Lipopolysaccharides results in increased activity of HRAS protein]]; farnesyl pyrophosphate inhibits the reaction [Simvastatin inhibits the reaction [Lipopolysaccharides results in increased localization of HRAS protein]] |
CTD |
PMID:18625914 |
|
NCBI chr 1:196,290,127...196,299,823
Ensembl chr 1:196,296,263...196,300,615
|
|
G |
Icam1 |
intercellular adhesion molecule 1 |
multiple interactions |
ISO |
farnesyl pyrophosphate inhibits the reaction [Simvastatin promotes the reaction [IL1B protein results in increased expression of ICAM1 protein]] |
CTD |
PMID:10946302 |
|
NCBI chr 8:19,553,063...19,565,438
Ensembl chr 8:19,553,645...19,565,438
|
|
G |
Il12b |
interleukin 12B |
multiple interactions |
ISO |
farnesyl pyrophosphate inhibits the reaction [lipopolysaccharide, E coli O55-B5 results in increased expression of IL12B protein] |
CTD |
PMID:15187114 |
|
NCBI chr10:28,888,832...28,903,802
Ensembl chr10:28,893,008...28,902,903
|
|
G |
Il1b |
interleukin 1 beta |
multiple interactions |
ISO |
farnesyl pyrophosphate inhibits the reaction [Simvastatin promotes the reaction [IL1B protein results in increased expression of ICAM1 protein]]; farnesyl pyrophosphate inhibits the reaction [Simvastatin promotes the reaction [IL1B protein results in increased expression of SELE protein]] |
CTD |
PMID:10946302 |
|
NCBI chr 3:116,577,005...116,583,386
Ensembl chr 3:116,577,010...116,583,415
|
|
G |
Kras |
KRAS proto-oncogene, GTPase |
multiple interactions |
EXP |
[FNTA protein binds to FNTB protein] binds to [farnesyl pyrophosphate analog co-treated with KRAS protein] |
CTD |
PMID:10673434 |
|
NCBI chr 4:178,185,418...178,218,484
|
|
G |
Mapk1 |
mitogen activated protein kinase 1 |
multiple interactions |
ISO |
farnesyl pyrophosphate inhibits the reaction [Simvastatin inhibits the reaction [TNF results in increased phosphorylation of MAPK1 protein]] |
CTD |
PMID:18310456 |
|
NCBI chr11:83,957,813...84,023,629
Ensembl chr11:83,957,813...84,023,616
|
|
G |
Mapk3 |
mitogen activated protein kinase 3 |
multiple interactions |
ISO |
farnesyl pyrophosphate inhibits the reaction [Simvastatin inhibits the reaction [TNF results in increased phosphorylation of MAPK3 protein]] |
CTD |
PMID:18310456 |
|
NCBI chr 1:181,366,646...181,372,863
Ensembl chr 1:181,366,637...181,372,863
|
|
G |
Mapk8 |
mitogen-activated protein kinase 8 |
multiple interactions |
ISO |
farnesyl pyrophosphate inhibits the reaction [Simvastatin inhibits the reaction [TNF results in increased phosphorylation of MAPK8 protein]] |
CTD |
PMID:18310456 |
|
NCBI chr16:8,638,897...8,721,960
Ensembl chr16:8,638,924...8,721,981
|
|
G |
Mmp9 |
matrix metallopeptidase 9 |
multiple interactions |
EXP |
farnesyl pyrophosphate inhibits the reaction [Simvastatin inhibits the reaction [Smoke analog results in increased expression of MMP9 mRNA]]; farnesyl pyrophosphate inhibits the reaction [Simvastatin inhibits the reaction [Smoke analog results in increased secretion of MMP9 protein]] |
CTD |
PMID:19299917 |
|
NCBI chr 3:153,684,158...153,692,118
Ensembl chr 3:153,683,858...153,692,120
|
|
G |
Mvk |
mevalonate kinase |
decreases activity decreases chemical synthesis multiple interactions |
ISO |
farnesyl pyrophosphate results in decreased activity of MVK protein MVK protein mutant form results in decreased chemical synthesis of farnesyl pyrophosphate farnesyl pyrophosphate inhibits the reaction [MVK protein results in increased hydrolysis of Adenosine Triphosphate]; farnesyl pyrophosphate inhibits the reaction [MVK protein results in increased phosphorylation of Mevalonic Acid] |
CTD |
PMID:9392419 PMID:24073415 |
|
NCBI chr12:42,141,391...42,158,893
Ensembl chr12:42,141,384...42,158,882
|
|
G |
Pon1 |
paraoxonase 1 |
multiple interactions |
ISO |
farnesyl pyrophosphate inhibits the reaction [pitavastatin results in increased expression of PON1 mRNA]; farnesyl pyrophosphate inhibits the reaction [Simvastatin results in increased expression of PON1 mRNA] |
CTD |
PMID:14500290 PMID:15690306 |
|
NCBI chr 4:33,294,737...33,325,759
Ensembl chr 4:33,294,722...33,321,360
|
|
G |
Rac1 |
Rac family small GTPase 1 |
multiple interactions |
ISO |
farnesyl pyrophosphate inhibits the reaction [Simvastatin inhibits the reaction [Lipopolysaccharides results in increased activity of RAC1 protein]]; farnesyl pyrophosphate inhibits the reaction [Simvastatin inhibits the reaction [Lipopolysaccharides results in increased localization of RAC1 protein]] |
CTD |
PMID:18625914 |
|
NCBI chr12:11,037,028...11,057,251
Ensembl chr12:11,036,698...11,057,251
|
|
G |
Rhoa |
ras homolog family member A |
multiple interactions |
ISO |
farnesyl pyrophosphate inhibits the reaction [Simvastatin inhibits the reaction [Lipopolysaccharides results in decreased activity of RHOA protein]] farnesyl pyrophosphate inhibits the reaction [Simvastatin inhibits the reaction [TNF affects the localization of RHOA protein]] |
CTD |
PMID:18310456 PMID:18625914 |
|
NCBI chr 8:108,991,926...109,025,746
Ensembl chr 8:108,991,954...109,025,746
|
|
G |
Runx2 |
RUNX family transcription factor 2 |
multiple interactions |
ISO |
farnesyl pyrophosphate inhibits the reaction [Simvastatin inhibits the reaction [TNF protein inhibits the reaction [BMP2 results in increased expression of RUNX2 mRNA]]] |
CTD |
PMID:18310456 |
|
NCBI chr 9:16,167,504...16,492,826
Ensembl chr 9:16,167,482...16,492,167
|
|
G |
Sele |
selectin E |
multiple interactions |
ISO |
farnesyl pyrophosphate inhibits the reaction [Simvastatin promotes the reaction [IL1B protein results in increased expression of SELE protein]] |
CTD |
PMID:10946302 |
|
NCBI chr13:76,402,841...76,412,741
Ensembl chr13:76,403,304...76,412,741
|
|
G |
Tnf |
tumor necrosis factor |
multiple interactions |
ISO |
farnesyl pyrophosphate inhibits the reaction [Simvastatin inhibits the reaction [TNF affects the localization of RHOA protein]]; farnesyl pyrophosphate inhibits the reaction [Simvastatin inhibits the reaction [TNF protein inhibits the reaction [BMP2 results in increased expression of RUNX2 mRNA]]]; farnesyl pyrophosphate inhibits the reaction [Simvastatin inhibits the reaction [TNF results in increased phosphorylation of MAPK1 protein]]; farnesyl pyrophosphate inhibits the reaction [Simvastatin inhibits the reaction [TNF results in increased phosphorylation of MAPK3 protein]]; farnesyl pyrophosphate inhibits the reaction [Simvastatin inhibits the reaction [TNF results in increased phosphorylation of MAPK8 protein]] |
CTD |
PMID:18310456 |
|
NCBI chr20:3,622,011...3,624,629
Ensembl chr20:3,622,011...3,624,629
|
|
|
G |
Abcc2 |
ATP binding cassette subfamily C member 2 |
multiple interactions |
EXP |
geraniol inhibits the reaction [Fructose results in decreased expression of ABCC2 mRNA]; geraniol inhibits the reaction [Fructose results in decreased expression of ABCC2 protein] |
CTD |
PMID:31005848 |
|
NCBI chr 1:242,664,657...242,723,239
Ensembl chr 1:242,664,657...242,723,238
|
|
G |
Acaca |
acetyl-CoA carboxylase alpha |
decreases expression |
ISO |
geraniol results in decreased expression of ACACA mRNA |
CTD |
PMID:26141755 |
|
NCBI chr10:69,014,261...69,276,453
Ensembl chr10:69,014,170...69,276,457
|
|
G |
Ache |
acetylcholinesterase |
multiple interactions |
EXP |
geraniol inhibits the reaction [Acrylamide results in increased activity of ACHE protein]; geraniol inhibits the reaction [Streptozocin results in increased activity of ACHE protein] |
CTD |
PMID:24752916 PMID:25199698 |
|
NCBI chr12:19,406,133...19,413,713
Ensembl chr12:19,407,360...19,413,651
|
|
G |
Acta2 |
actin alpha 2, smooth muscle |
multiple interactions |
EXP |
geraniol inhibits the reaction [[Methionine deficiency co-treated with Choline deficiency] results in increased expression of ACTA2 mRNA] |
CTD |
PMID:26695085 |
|
NCBI chr 1:231,746,527...231,759,307
Ensembl chr 1:231,746,548...231,759,554
|
|
G |
Actl6a |
actin-like 6A |
decreases expression |
ISO |
geraniol results in decreased expression of ACTL6A mRNA |
CTD |
PMID:27683099 |
|
NCBI chr 2:115,492,374...115,508,401
Ensembl chr 2:115,492,285...115,508,401
|
|
G |
Acvr1 |
activin A receptor type 1 |
increases expression |
ISO |
geraniol results in increased expression of ACVR1 mRNA |
CTD |
PMID:27683099 |
|
NCBI chr 3:42,978,558...43,097,892
Ensembl chr 3:42,978,561...43,098,241
|
|
G |
Adipoq |
adiponectin, C1Q and collagen domain containing |
multiple interactions |
EXP |
geraniol inhibits the reaction [Fructose results in decreased secretion of ADIPOQ protein]; geraniol promotes the reaction [Streptozocin results in decreased expression of ADIPOQ protein] |
CTD |
PMID:25679220 PMID:28178614 |
|
NCBI chr11:77,721,912...77,735,644
Ensembl chr11:77,721,912...77,735,564
|
|
G |
Aff4 |
ALF transcription elongation factor 4 |
increases expression |
ISO |
geraniol results in increased expression of AFF4 mRNA |
CTD |
PMID:27683099 |
|
NCBI chr10:37,498,825...37,579,751
Ensembl chr10:37,498,825...37,579,751
|
|
G |
Ager |
advanced glycosylation end product-specific receptor |
multiple interactions |
EXP |
geraniol inhibits the reaction [Fructose results in increased expression of AGER protein] |
CTD |
PMID:25679220 |
|
NCBI chr20:4,148,150...4,151,361
Ensembl chr20:4,147,890...4,151,078
|
|
G |
Ahctf1 |
AT hook containing transcription factor 1 |
decreases expression |
ISO |
geraniol results in decreased expression of AHCTF1 mRNA |
CTD |
PMID:27683099 |
|
NCBI chr13:91,481,936...91,536,391
Ensembl chr13:91,481,936...91,536,391
|
|
G |
Akr1c1 |
aldo-keto reductase family 1, member C1 |
increases expression |
ISO |
geraniol results in increased expression of AKR1C1 mRNA |
CTD |
PMID:30806763 |
|
NCBI chr17:65,810,474...65,837,385
Ensembl chr17:65,810,475...65,837,326
|
|
G |
Ap5z1 |
adaptor related protein complex 5 subunit zeta 1 |
increases expression |
ISO |
geraniol results in increased expression of AP5Z1 mRNA |
CTD |
PMID:27683099 |
|
NCBI chr12:12,093,834...12,109,043
Ensembl chr12:12,093,834...12,108,511
|
|
G |
Apbb2 |
amyloid beta precursor protein binding family B member 2 |
increases expression |
ISO |
geraniol results in increased expression of APBB2 mRNA |
CTD |
PMID:27683099 |
|
NCBI chr14:41,557,918...41,878,622
Ensembl chr14:41,557,972...41,877,495
|
|
G |
Appl1 |
adaptor protein, phosphotyrosine interacting with PH domain and leucine zipper 1 |
decreases expression |
ISO |
geraniol results in decreased expression of APPL1 mRNA |
CTD |
PMID:27683099 |
|
NCBI chr16:2,118,503...2,166,741
Ensembl chr16:2,121,255...2,166,692
|
|
G |
Atf3 |
activating transcription factor 3 |
increases expression |
ISO |
geraniol results in increased expression of ATF3 mRNA |
CTD |
PMID:27683099 |
|
NCBI chr13:102,751,278...102,800,520
Ensembl chr13:102,751,321...102,764,631
|
|
G |
Atf4 |
activating transcription factor 4 |
multiple interactions |
ISO |
geraniol inhibits the reaction [Rotenone results in increased expression of ATF4 protein] |
CTD |
PMID:30141137 |
|
NCBI chr 7:111,804,135...111,806,457
Ensembl chr 7:111,804,183...111,806,446
|
|
G |
Atf6 |
activating transcription factor 6 |
increases expression multiple interactions |
ISO |
geraniol results in increased expression of ATF6 mRNA geraniol inhibits the reaction [Rotenone results in increased expression of ATF6 protein] |
CTD |
PMID:27683099 PMID:30141137 |
|
NCBI chr13:82,927,579...83,106,381
Ensembl chr13:82,930,034...83,107,177
|
|
G |
Atg12 |
autophagy related 12 |
multiple interactions |
ISO |
geraniol inhibits the reaction [Rotenone results in decreased expression of ATG12 protein] |
CTD |
PMID:30141137 |
|
NCBI chr18:39,452,247...39,462,424
Ensembl chr18:39,452,191...39,462,418
|
|
G |
Atg5 |
autophagy related 5 |
multiple interactions |
ISO |
geraniol inhibits the reaction [Rotenone results in decreased expression of ATG5 protein] |
CTD |
PMID:30141137 |
|
NCBI chr20:47,798,217...47,889,216
Ensembl chr20:47,798,290...47,889,209
|
|
G |
Atg7 |
autophagy related 7 |
multiple interactions |
ISO |
geraniol inhibits the reaction [Rotenone results in decreased expression of ATG7 protein] |
CTD |
PMID:30141137 |
|
NCBI chr 4:147,718,663...147,925,656
Ensembl chr 4:147,718,752...147,925,593
|
|
G |
Bak1 |
BCL2-antagonist/killer 1 |
increases expression |
ISO |
geraniol results in increased expression of BAK1 protein |
CTD |
PMID:12530055 |
|
NCBI chr20:5,100,480...5,109,669
Ensembl chr20:5,100,480...5,109,264
|
|
G |
Bax |
BCL2 associated X, apoptosis regulator |
multiple interactions increases expression |
ISO EXP |
geraniol inhibits the reaction [[Probenecid co-treated with 1-Methyl-4-phenyl-1,2,3,6-tetrahydropyridine] results in increased expression of BAX mRNA]; geraniol inhibits the reaction [[Probenecid co-treated with 1-Methyl-4-phenyl-1,2,3,6-tetrahydropyridine] results in increased expression of BAX protein]; geraniol inhibits the reaction [[Tetradecanoylphorbol Acetate co-treated with 9,10-Dimethyl-1,2-benzanthracene] results in decreased expression of BAX protein]; geraniol inhibits the reaction [lipopolysaccharide, E coli O55-B5 results in increased expression of BAX protein] geraniol inhibits the reaction [Doxorubicin results in increased expression of BAX mRNA] geraniol results in increased expression of BAX mRNA; geraniol results in increased expression of BAX protein |
CTD |
PMID:21371438 PMID:22760862 PMID:24768735 PMID:29050341 PMID:29745075 PMID:30506710 PMID:34343525 More...
|
|
NCBI chr 1:95,940,001...95,945,407
Ensembl chr 1:95,938,808...95,945,368
|
|
G |
Baz1b |
bromodomain adjacent to zinc finger domain, 1B |
decreases expression |
ISO |
geraniol results in decreased expression of BAZ1B mRNA |
CTD |
PMID:27683099 |
|
NCBI chr12:21,431,985...21,489,956
Ensembl chr12:21,431,985...21,490,426
|
|
G |
Baz2b |
bromodomain adjacent to zinc finger domain, 2B |
increases expression |
ISO |
geraniol results in increased expression of BAZ2B mRNA |
CTD |
PMID:27683099 |
|
NCBI chr 3:44,384,282...44,681,619
Ensembl chr 3:44,385,474...44,592,908
|
|
G |
Bbx |
BBX high mobility group box domain containing |
increases expression |
ISO |
geraniol results in increased expression of BBX mRNA |
CTD |
PMID:27683099 |
|
NCBI chr11:50,381,249...50,628,934
Ensembl chr11:50,381,247...50,623,251
|
|
G |
Bcl11a |
BCL11 transcription factor A |
decreases expression |
ISO |
geraniol results in decreased expression of BCL11A mRNA |
CTD |
PMID:27683099 |
|
NCBI chr14:98,029,018...98,124,181
Ensembl chr14:98,030,461...98,124,180
|
|
G |
Bcl2 |
BCL2, apoptosis regulator |
multiple interactions decreases expression increases expression |
ISO EXP |
geraniol inhibits the reaction [[Probenecid co-treated with 1-Methyl-4-phenyl-1,2,3,6-tetrahydropyridine] results in decreased expression of BCL2 mRNA]; geraniol inhibits the reaction [[Probenecid co-treated with 1-Methyl-4-phenyl-1,2,3,6-tetrahydropyridine] results in decreased expression of BCL2 protein]; geraniol inhibits the reaction [[Tetradecanoylphorbol Acetate co-treated with 9,10-Dimethyl-1,2-benzanthracene] results in increased expression of BCL2 protein]; geraniol inhibits the reaction [lipopolysaccharide, E coli O55-B5 results in decreased expression of BCL2 protein] geraniol inhibits the reaction [Doxorubicin results in decreased expression of BCL2 mRNA] geraniol results in decreased expression of BCL2 mRNA; geraniol results in decreased expression of BCL2 protein geraniol results in increased expression of BCL2 protein |
CTD |
PMID:21371438 PMID:21445532 PMID:22760862 PMID:24768735 PMID:29050341 PMID:29745075 PMID:30506710 PMID:34343525 More...
|
|
NCBI chr13:22,689,783...22,853,920
Ensembl chr13:22,684,989...22,853,743 Ensembl chr13:22,684,989...22,853,743
|
|
G |
Bcl2l1 |
Bcl2-like 1 |
multiple interactions |
EXP |
geraniol inhibits the reaction [[Methionine deficiency co-treated with Choline deficiency] results in decreased expression of BCL2L1 protein]; geraniol inhibits the reaction [Isoproterenol results in decreased expression of BCL2L1 mRNA] |
CTD |
PMID:26695085 PMID:35608392 |
|
NCBI chr 3:141,253,508...141,304,582
Ensembl chr 3:141,253,523...141,303,479 Ensembl chr 1:141,253,523...141,303,479
|
|
G |
Bcl2l2 |
Bcl2-like 2 |
decreases expression |
ISO |
geraniol results in decreased expression of BCL2L2 protein |
CTD |
PMID:21371438 |
|
NCBI chr15:28,346,449...28,361,627
Ensembl chr15:28,356,807...28,361,624
|
|
G |
Bcl6 |
BCL6, transcription repressor |
increases expression |
ISO |
geraniol results in increased expression of BCL6 mRNA |
CTD |
PMID:27683099 |
|
NCBI chr11:76,854,090...76,877,389
Ensembl chr11:76,854,090...76,877,389
|
|
G |
Bclaf1 |
BCL2-associated transcription factor 1 |
decreases expression |
ISO |
geraniol results in decreased expression of BCLAF1 mRNA |
CTD |
PMID:27683099 |
|
NCBI chr 1:15,088,436...15,117,666
Ensembl chr 1:15,070,894...15,148,832
|
|
G |
Bdnf |
brain-derived neurotrophic factor |
multiple interactions |
ISO |
geraniol inhibits the reaction [1-Methyl-4-phenyl-1,2,3,6-tetrahydropyridine results in decreased expression of BDNF mRNA]; geraniol inhibits the reaction [1-Methyl-4-phenyl-1,2,3,6-tetrahydropyridine results in decreased expression of BDNF protein] |
CTD |
PMID:23943375 |
|
NCBI chr 3:96,165,042...96,215,621
Ensembl chr 3:96,165,042...96,215,615
|
|
G |
Birc5 |
baculoviral IAP repeat-containing 5 |
decreases expression |
ISO |
geraniol results in decreased expression of BIRC5 mRNA |
CTD |
PMID:27683099 |
|
NCBI chr10:103,072,530...103,081,382
Ensembl chr10:103,073,408...103,081,380
|
|
G |
Bmal1 |
basic helix-loop-helix ARNT like 1 |
increases expression |
ISO |
geraniol results in increased expression of BMAL1 mRNA |
CTD |
PMID:27683099 |
|
NCBI chr 1:167,331,756...167,430,235
Ensembl chr 1:167,331,633...167,430,231
|
|
G |
Bmp6 |
bone morphogenetic protein 6 |
increases expression |
ISO |
geraniol results in increased expression of BMP6 mRNA |
CTD |
PMID:27683099 |
|
NCBI chr17:26,318,121...26,469,691
Ensembl chr17:26,318,569...26,470,365
|
|
G |
Bnip3 |
BCL2 interacting protein 3 |
increases expression |
ISO |
geraniol results in increased expression of BNIP3 protein |
CTD |
PMID:21371438 |
|
NCBI chr 1:193,708,164...193,725,348
Ensembl chr 1:193,708,167...193,725,359
|
|
G |
Brca1 |
BRCA1, DNA repair associated |
decreases expression |
ISO |
geraniol results in decreased expression of BRCA1 mRNA |
CTD |
PMID:27683099 |
|
NCBI chr10:86,417,441...86,477,762
Ensembl chr10:86,418,000...86,477,304
|
|
G |
Brca2 |
BRCA2, DNA repair associated |
decreases expression |
ISO |
geraniol results in decreased expression of BRCA2 mRNA |
CTD |
PMID:27683099 |
|
NCBI chr12:59,492...103,789
Ensembl chr12:59,819...100,567
|
|
G |
Btf3 |
basic transcription factor 3 |
decreases expression |
ISO |
geraniol results in decreased expression of BTF3 mRNA |
CTD |
PMID:27683099 |
|
NCBI chr 2:29,659,764...29,666,898
Ensembl chr 2:29,659,231...29,666,879 Ensembl chr13:29,659,231...29,666,879
|
|
G |
Bub1 |
BUB1 mitotic checkpoint serine/threonine kinase |
decreases expression |
ISO |
geraniol results in decreased expression of BUB1 mRNA |
CTD |
PMID:27683099 |
|
NCBI chr 3:115,020,254...115,051,650
Ensembl chr 3:115,020,254...115,051,650
|
|
G |
Bub1b |
BUB1 mitotic checkpoint serine/threonine kinase B |
decreases expression |
ISO |
geraniol results in decreased expression of BUB1B mRNA |
CTD |
PMID:27683099 |
|
NCBI chr 3:105,563,089...105,615,547
Ensembl chr 3:105,563,138...105,615,547
|
|
G |
Casp3 |
caspase 3 |
multiple interactions increases activity increases expression |
EXP ISO |
[camphene co-treated with geraniol] inhibits the reaction [nimesulide results in increased cleavage of CASP3 protein]; geraniol inhibits the reaction [2-Acetylaminofluorene results in increased expression of CASP3 protein]; geraniol inhibits the reaction [[ferric nitrilotriacetate co-treated with Diethylnitrosamine] results in decreased cleavage of and results in decreased expression of CASP3 protein]; geraniol inhibits the reaction [[ferric nitrilotriacetate co-treated with Diethylnitrosamine] results in decreased expression of CASP3 mRNA]; geraniol inhibits the reaction [[Methionine deficiency co-treated with Choline deficiency] results in increased activity of CASP3 protein]; geraniol inhibits the reaction [Doxorubicin results in increased cleavage of CASP3 protein]; geraniol inhibits the reaction [Trinitrobenzenesulfonic Acid results in increased expression of CASP3 protein] geraniol results in increased activity of CASP3 protein geraniol results in increased expression of CASP3 mRNA; geraniol results in increased expression of CASP3 protein geraniol inhibits the reaction [lipopolysaccharide, E coli O55-B5 results in increased expression of CASP3 protein] geraniol results in increased expression of CASP3 protein modified form |
CTD |
PMID:21371438 PMID:21907755 PMID:22509279 PMID:24875281 PMID:26154255 PMID:26165751 PMID:26364502 PMID:26695085 PMID:29050341 PMID:30506710 PMID:34343525 More...
|
|
NCBI chr16:45,662,910...45,681,171
Ensembl chr16:45,662,910...45,684,648
|
|
G |
Casp8 |
caspase 8 |
multiple interactions increases expression |
EXP ISO |
geraniol inhibits the reaction [[ferric nitrilotriacetate co-treated with Diethylnitrosamine] results in decreased cleavage of and results in decreased expression of CASP8 protein]; geraniol inhibits the reaction [[ferric nitrilotriacetate co-treated with Diethylnitrosamine] results in decreased expression of CASP8 mRNA] geraniol results in increased expression of CASP8 mRNA; geraniol results in increased expression of CASP8 protein |
CTD |
PMID:21907755 PMID:30506710 |
|
NCBI chr 9:60,263,863...60,312,542
Ensembl chr 9:60,264,075...60,312,542
|
|
G |
Casp9 |
caspase 9 |
multiple interactions increases expression |
EXP ISO |
[camphene co-treated with geraniol] inhibits the reaction [nimesulide results in increased cleavage of CASP9 protein]; geraniol inhibits the reaction [2-Acetylaminofluorene results in increased expression of CASP9 protein]; geraniol inhibits the reaction [[ferric nitrilotriacetate co-treated with Diethylnitrosamine] results in decreased cleavage of and results in decreased expression of CASP9 protein]; geraniol inhibits the reaction [[ferric nitrilotriacetate co-treated with Diethylnitrosamine] results in decreased expression of CASP9 mRNA]; geraniol inhibits the reaction [[Methionine deficiency co-treated with Choline deficiency] results in increased activity of CASP9 protein]; geraniol inhibits the reaction [Doxorubicin results in increased cleavage of CASP9 protein] geraniol results in increased expression of CASP9 mRNA; geraniol results in increased expression of CASP9 protein geraniol inhibits the reaction [[Probenecid co-treated with 1-Methyl-4-phenyl-1,2,3,6-tetrahydropyridine] results in increased expression of CASP9 mRNA]; geraniol inhibits the reaction [[Probenecid co-treated with 1-Methyl-4-phenyl-1,2,3,6-tetrahydropyridine] results in increased expression of CASP9 protein] |
CTD |
PMID:21907755 PMID:22509279 PMID:24768735 PMID:26364502 PMID:26695085 PMID:30506710 PMID:34343525 More...
|
|
NCBI chr 5:154,108,872...154,126,628
Ensembl chr 5:154,109,046...154,126,626
|
|
G |
Cat |
catalase |
multiple interactions decreases activity increases activity |
ISO EXP |
geraniol inhibits the reaction [9,10-Dimethyl-1,2-benzanthracene results in decreased expression of CAT protein]; geraniol inhibits the reaction [[Probenecid co-treated with 1-Methyl-4-phenyl-1,2,3,6-tetrahydropyridine] results in increased activity of CAT protein]; geraniol inhibits the reaction [Tetradecanoylphorbol Acetate results in decreased activity of CAT protein]; geraniol inhibits the reaction [Tetradecanoylphorbol Acetate results in decreased expression of CAT protein] geraniol results in decreased activity of CAT protein geraniol results in increased activity of CAT protein geraniol inhibits the reaction [2-Acetylaminofluorene results in decreased activity of CAT protein]; geraniol inhibits the reaction [ferric nitrilotriacetate results in decreased activity of CAT protein]; geraniol inhibits the reaction [Isoproterenol results in decreased activity of CAT protein]; geraniol inhibits the reaction [Isoproterenol results in decreased expression of CAT mRNA]; geraniol inhibits the reaction [Streptozocin results in decreased activity of CAT protein] |
CTD |
PMID:21907755 PMID:22760862 PMID:23033690 PMID:23399806 PMID:24752916 PMID:24768735 PMID:25574396 PMID:26364502 PMID:28178614 PMID:32119866 PMID:35608392 More...
|
|
NCBI chr 3:89,842,393...89,874,577
Ensembl chr 3:89,842,399...89,874,478
|
|
G |
Cbfa2t2 |
CBFA2/RUNX1 partner transcriptional co-repressor 2 |
increases expression |
ISO |
geraniol results in increased expression of CBFA2T2 mRNA |
CTD |
PMID:27683099 |
|
NCBI chr 3:142,936,945...143,043,205
Ensembl chr 3:142,936,985...143,043,197
|
|
G |
Cbfb |
core-binding factor subunit beta |
decreases expression |
ISO |
geraniol results in decreased expression of CBFB mRNA |
CTD |
PMID:27683099 |
|
NCBI chr19:33,049,162...33,092,752
Ensembl chr19:33,049,172...33,092,751
|
|
G |
Ccl4 |
C-C motif chemokine ligand 4 |
increases secretion |
ISO |
geraniol results in increased secretion of CCL4 protein |
CTD |
PMID:30806763 |
|
NCBI chr10:68,466,394...68,468,229
Ensembl chr10:68,452,052...68,468,231
|
|
G |
Ccna2 |
cyclin A2 |
decreases expression |
ISO |
geraniol results in decreased expression of CCNA2 mRNA; geraniol results in decreased expression of CCNA2 protein |
CTD |
PMID:17138864 PMID:27683099 |
|
NCBI chr 2:119,427,239...119,433,645
Ensembl chr 2:119,426,089...119,433,577
|
|
G |
Ccnb1 |
cyclin B1 |
decreases expression |
ISO |
geraniol results in decreased expression of CCNB1 protein |
CTD |
PMID:17138864 PMID:21371438 |
|
NCBI chr 2:31,912,190...31,921,163
Ensembl chr 2:31,912,193...31,921,172
|
|
G |
Ccnd1 |
cyclin D1 |
decreases expression |
ISO |
geraniol results in decreased expression of CCND1 protein |
CTD |
PMID:15450939 |
|
NCBI chr 1:200,089,002...200,098,524
Ensembl chr 1:200,089,002...200,098,602
|
|
G |
Cd86 |
CD86 molecule |
increases expression |
ISO |
geraniol results in increased expression of CD86 protein |
CTD |
PMID:30806763 |
|
NCBI chr11:64,142,193...64,200,816
Ensembl chr11:64,163,828...64,200,818
|
|
G |
Cdc20 |
cell division cycle 20 |
decreases expression |
ISO |
geraniol results in decreased expression of CDC20 mRNA |
CTD |
PMID:27683099 |
|
NCBI chr 5:131,966,203...131,970,406
Ensembl chr 5:131,966,215...131,970,512
|
|
G |
Cdc25a |
cell division cycle 25A |
decreases expression |
ISO |
geraniol results in decreased expression of CDC25A mRNA |
CTD |
PMID:27683099 |
|
NCBI chr 8:109,864,356...109,882,734
Ensembl chr 8:109,864,478...109,882,701
|
|
G |
Cdc25c |
cell division cycle 25C |
decreases expression |
ISO |
geraniol results in decreased expression of CDC25C mRNA |
CTD |
PMID:27683099 |
|
NCBI chr18:26,335,156...26,356,199
Ensembl chr18:26,335,834...26,356,185
|
|
G |
Cdc45 |
cell division cycle 45 |
decreases expression |
ISO |
geraniol results in decreased expression of CDC45 mRNA |
CTD |
PMID:27683099 |
|
NCBI chr11:82,185,427...82,210,630
Ensembl chr11:82,185,473...82,210,619
|
|
G |
Cdc7 |
cell division cycle 7 |
decreases expression |
ISO |
geraniol results in decreased expression of CDC7 mRNA |
CTD |
PMID:27683099 |
|
NCBI chr14:2,804,660...2,824,796
Ensembl chr14:2,804,661...2,824,778
|
|
G |
Cdh1 |
cadherin 1 |
multiple interactions |
EXP |
geraniol inhibits the reaction [Methylnitronitrosoguanidine results in decreased expression of CDH1 protein] |
CTD |
PMID:28428697 |
|
NCBI chr19:34,492,371...34,561,775
Ensembl chr19:34,492,371...34,561,775
|
|
G |
Cdk1 |
cyclin-dependent kinase 1 |
decreases expression |
ISO |
geraniol results in decreased expression of CDK1 protein |
CTD |
PMID:21371438 |
|
NCBI chr20:19,266,226...19,281,417
Ensembl chr20:19,266,248...19,281,408
|
|
G |
Cdk2 |
cyclin dependent kinase 2 |
decreases expression multiple interactions |
ISO |
geraniol results in decreased expression of CDK2 mRNA; geraniol results in decreased expression of CDK2 protein geraniol promotes the reaction [CDKN1A protein binds to and results in decreased activity of CDK2 protein]; geraniol promotes the reaction [CDKN1B protein binds to and results in decreased activity of CDK2 protein] |
CTD |
PMID:15450939 PMID:17138864 PMID:27683099 |
|
NCBI chr 7:1,129,878...1,137,431
Ensembl chr 7:1,129,811...1,137,403
|
|
G |
Cdk4 |
cyclin-dependent kinase 4 |
decreases expression |
ISO |
geraniol results in decreased expression of CDK4 protein |
CTD |
PMID:15450939 PMID:21371438 |
|
NCBI chr 7:62,886,124...62,889,562
Ensembl chr 7:62,883,105...62,942,403
|
|
G |
Cdkn1a |
cyclin-dependent kinase inhibitor 1A |
increases expression multiple interactions increases response to substance |
ISO |
geraniol results in increased expression of CDKN1A protein geraniol promotes the reaction [CDKN1A protein binds to and results in decreased activity of CDK2 protein] CDKN1A protein results in increased susceptibility to geraniol |
CTD |
PMID:17138864 PMID:21371438 |
|
NCBI chr20:7,149,177...7,159,727
Ensembl chr20:7,149,217...7,159,585
|
|
G |
Cdkn1b |
cyclin-dependent kinase inhibitor 1B |
increases expression multiple interactions increases response to substance |
ISO |
geraniol results in increased expression of CDKN1B protein geraniol promotes the reaction [CDKN1B protein binds to and results in decreased activity of CDK2 protein] CDKN1B protein results in increased susceptibility to geraniol |
CTD |
PMID:17138864 PMID:21371438 |
|
NCBI chr 4:167,760,067...167,765,177
Ensembl chr 4:167,760,181...167,764,982
|
|
G |
Cdkn2c |
cyclin-dependent kinase inhibitor 2C |
decreases expression |
ISO |
geraniol results in decreased expression of CDKN2C mRNA |
CTD |
PMID:27683099 |
|
NCBI chr 5:124,411,123...124,416,278
Ensembl chr 5:124,411,124...124,416,278
|
|
G |
Cdkn3 |
cyclin-dependent kinase inhibitor 3 |
decreases expression |
ISO |
geraniol results in decreased expression of CDKN3 mRNA |
CTD |
PMID:27683099 |
|
NCBI chr15:20,022,522...20,033,948
Ensembl chr15:20,022,664...20,033,945
|
|
G |
Cdt1 |
chromatin licensing and DNA replication factor 1 |
decreases expression |
ISO |
geraniol results in decreased expression of CDT1 mRNA |
CTD |
PMID:27683099 |
|
NCBI chr19:50,620,713...50,625,659
Ensembl chr19:50,620,713...50,625,659
|
|
G |
Cebpb |
CCAAT/enhancer binding protein beta |
increases expression |
ISO |
geraniol results in increased expression of CEBPB mRNA |
CTD |
PMID:27683099 |
|
NCBI chr 3:156,398,035...156,399,466
Ensembl chr 3:156,397,052...156,399,473
|
|
G |
Cebpg |
CCAAT/enhancer binding protein gamma |
increases expression |
ISO |
geraniol results in increased expression of CEBPG mRNA |
CTD |
PMID:27683099 |
|
NCBI chr 1:87,683,060...87,692,772
Ensembl chr 1:87,684,019...87,694,569
|
|
G |
Cenpe |
centromere protein E |
decreases expression |
ISO |
geraniol results in decreased expression of CENPE mRNA |
CTD |
PMID:27683099 |
|
NCBI chr 2:223,637,035...223,695,692
Ensembl chr 2:223,636,998...223,695,669
|
|
G |
Cenpf |
centromere protein F |
decreases expression |
ISO |
geraniol results in decreased expression of CENPF mRNA |
CTD |
PMID:27683099 |
|
NCBI chr13:101,184,127...101,229,714
Ensembl chr13:101,184,127...101,229,669
|
|
G |
Chek1 |
checkpoint kinase 1 |
decreases expression |
ISO |
geraniol results in decreased expression of CHEK1 mRNA |
CTD |
PMID:27683099 |
|
NCBI chr 8:36,420,565...36,443,477
Ensembl chr 8:36,420,569...36,441,009
|
|
G |
Cit |
citron rho-interacting serine/threonine kinase |
decreases expression |
ISO |
geraniol results in decreased expression of CIT mRNA |
CTD |
PMID:27683099 |
|
NCBI chr12:40,603,073...40,764,846
Ensembl chr12:40,605,563...40,763,860
|
|
G |
Ckm |
creatine kinase, M-type |
multiple interactions |
EXP |
geraniol inhibits the reaction [Doxorubicin results in increased activity of CKM protein] |
CTD |
PMID:34343525 |
|
NCBI chr 1:79,061,390...79,071,721
Ensembl chr 1:79,061,456...79,071,720
|
|
G |
Cnbp |
CCHC-type zinc finger, nucleic acid binding protein |
decreases expression |
ISO |
geraniol results in decreased expression of CNBP mRNA |
CTD |
PMID:27683099 |
|
NCBI chr 4:120,302,768...120,311,694
Ensembl chr 4:120,302,771...120,311,637
|
|
G |
Cnga2 |
cyclic nucleotide gated channel subunit alpha 2 |
multiple interactions |
ISO |
CNGA2 mRNA promotes the reaction [geraniol results in increased secretion of GCG protein] |
CTD |
PMID:29070885 |
|
NCBI chr X:149,696,999...149,715,051
Ensembl chr X:149,696,997...149,715,051
|
|
G |
Col1a1 |
collagen type I alpha 1 chain |
multiple interactions |
EXP |
geraniol inhibits the reaction [[Methionine deficiency co-treated with Choline deficiency] results in increased expression of COL1A1 mRNA] |
CTD |
PMID:26695085 |
|
NCBI chr10:79,883,622...79,900,625
Ensembl chr10:79,883,622...79,900,624
|
|
G |
Cox7c |
cytochrome c oxidase subunit 7C |
multiple interactions |
ISO |
geraniol inhibits the reaction [[Probenecid co-treated with 1-Methyl-4-phenyl-1,2,3,6-tetrahydropyridine] results in increased expression of COX7C mRNA] |
CTD |
PMID:24768735 |
|
NCBI chr 2:16,841,771...16,843,796
Ensembl chr 2:16,840,837...16,843,760
|
|
G |
Creb3 |
cAMP responsive element binding protein 3 |
increases expression |
ISO |
geraniol results in increased expression of CREB3 mRNA |
CTD |
PMID:27683099 |
|
NCBI chr 5:57,817,865...57,823,233
Ensembl chr 5:57,817,832...57,824,390
|
|
G |
Creb3l2 |
cAMP responsive element binding protein 3-like 2 |
increases expression |
ISO |
geraniol results in increased expression of CREB3L2 mRNA |
CTD |
PMID:27683099 |
|
NCBI chr 4:65,907,570...66,112,078
Ensembl chr 4:65,907,655...66,023,763
|
|
G |
Crp |
C-reactive protein |
multiple interactions |
EXP |
geraniol inhibits the reaction [Isoproterenol results in increased expression of CRP protein] |
CTD |
PMID:35608392 |
|
NCBI chr13:85,135,384...85,175,178
Ensembl chr13:85,124,977...85,175,178
|
|
G |
Ctnnb1 |
catenin beta 1 |
multiple interactions |
EXP |
geraniol inhibits the reaction [Methylnitronitrosoguanidine results in increased expression of CTNNB1 mRNA]; geraniol inhibits the reaction [Trinitrobenzenesulfonic Acid results in increased expression of CTNNB1 mRNA]; geraniol inhibits the reaction [Trinitrobenzenesulfonic Acid results in increased expression of CTNNB1 protein] |
CTD |
PMID:26165751 PMID:28428697 |
|
NCBI chr 8:120,640,008...120,667,110
Ensembl chr 8:120,639,995...120,667,111
|
|
G |
Ctsd |
cathepsin D |
multiple interactions |
EXP |
geraniol inhibits the reaction [4-Nitroquinoline-1-oxide results in increased activity of CTSD protein] |
CTD |
PMID:23499697 |
|
NCBI chr 1:197,527,467...197,539,343
Ensembl chr 1:197,527,467...197,539,488
|
|
G |
Cyb5a |
cytochrome b5 type A |
multiple interactions |
EXP |
geraniol inhibits the reaction [4-Nitroquinoline-1-oxide results in increased activity of CYB5A protein] |
CTD |
PMID:23499697 |
|
NCBI chr18:78,213,067...78,245,677
Ensembl chr18:78,202,342...78,258,535 Ensembl chr18:78,202,342...78,258,535
|
|
G |
Cybb |
cytochrome b-245 beta chain |
multiple interactions |
ISO |
geraniol inhibits the reaction [Dietary Fats results in increased expression of CYBB protein] geraniol inhibits the reaction [Palmitic Acid results in increased expression of CYBB protein] |
CTD |
PMID:27107694 |
|
NCBI chr X:13,358,101...13,392,570
Ensembl chr X:13,359,430...13,392,586
|
|
G |
Cyc1 |
cytochrome c-1 |
multiple interactions |
ISO |
geraniol inhibits the reaction [[Probenecid co-treated with 1-Methyl-4-phenyl-1,2,3,6-tetrahydropyridine] results in increased expression of CYC1 protein] |
CTD |
PMID:24768735 |
|
NCBI chr 7:108,067,106...108,069,483
Ensembl chr 7:108,067,115...108,069,479
|
|
G |
Cyp1a1 |
cytochrome P450, family 1, subfamily a, polypeptide 1 |
multiple interactions increases metabolic processing |
ISO |
[[CYP1A1 protein co-treated with CYP1B1 protein co-treated with CYP2B6 protein co-treated with CYP2E1 protein co-treated with CYP3A5 protein] results in increased metabolism of geraniol] which results in increased chemical synthesis of citral; [[CYP1A1 protein co-treated with CYP1B1 protein co-treated with CYP2B6 protein co-treated with CYP2E1 protein co-treated with CYP3A5 protein] results in increased metabolism of geraniol] which results in increased chemical synthesis of citral metabolite; [[CYP1A1 protein co-treated with CYP1B1 protein co-treated with CYP2B6 protein co-treated with CYP2E1 protein co-treated with CYP3A5 protein] results in increased metabolism of geraniol] which results in increased chemical synthesis of geraniol metabolite; [CYP1A1 protein co-treated with CYP1B1 protein co-treated with CYP2B6 protein co-treated with CYP2E1 protein co-treated with CYP3A5 protein] results in increased metabolism of geraniol; [CYP1A1 protein results in increased metabolism of geraniol] which results in increased chemical synthesis of citral; [CYP1A1 protein results in increased metabolism of geraniol] which results in increased chemical synthesis of geraniol metabolite |
CTD |
PMID:18824010 |
|
NCBI chr 8:58,096,021...58,102,130
Ensembl chr 8:58,096,077...58,102,125
|
|
G |
Cyp1b1 |
cytochrome P450, family 1, subfamily b, polypeptide 1 |
multiple interactions |
ISO |
[[CYP1A1 protein co-treated with CYP1B1 protein co-treated with CYP2B6 protein co-treated with CYP2E1 protein co-treated with CYP3A5 protein] results in increased metabolism of geraniol] which results in increased chemical synthesis of citral; [[CYP1A1 protein co-treated with CYP1B1 protein co-treated with CYP2B6 protein co-treated with CYP2E1 protein co-treated with CYP3A5 protein] results in increased metabolism of geraniol] which results in increased chemical synthesis of citral metabolite; [[CYP1A1 protein co-treated with CYP1B1 protein co-treated with CYP2B6 protein co-treated with CYP2E1 protein co-treated with CYP3A5 protein] results in increased metabolism of geraniol] which results in increased chemical synthesis of geraniol metabolite; [CYP1A1 protein co-treated with CYP1B1 protein co-treated with CYP2B6 protein co-treated with CYP2E1 protein co-treated with CYP3A5 protein] results in increased metabolism of geraniol |
CTD |
PMID:18824010 |
|
NCBI chr 6:15,342,312...15,350,886
Ensembl chr 6:15,342,344...15,350,917
|
|
G |
Cyp2b3 |
cytochrome P450, family 2, subfamily b, polypeptide 3 |
multiple interactions increases metabolic processing |
ISO |
[[CYP1A1 protein co-treated with CYP1B1 protein co-treated with CYP2B6 protein co-treated with CYP2E1 protein co-treated with CYP3A5 protein] results in increased metabolism of geraniol] which results in increased chemical synthesis of citral; [[CYP1A1 protein co-treated with CYP1B1 protein co-treated with CYP2B6 protein co-treated with CYP2E1 protein co-treated with CYP3A5 protein] results in increased metabolism of geraniol] which results in increased chemical synthesis of citral metabolite; [[CYP1A1 protein co-treated with CYP1B1 protein co-treated with CYP2B6 protein co-treated with CYP2E1 protein co-treated with CYP3A5 protein] results in increased metabolism of geraniol] which results in increased chemical synthesis of geraniol metabolite; [CYP1A1 protein co-treated with CYP1B1 protein co-treated with CYP2B6 protein co-treated with CYP2E1 protein co-treated with CYP3A5 protein] results in increased metabolism of geraniol; [CYP2B6 protein results in increased metabolism of geraniol] which results in increased chemical synthesis of citral; geraniol inhibits the reaction [CYP2B6 protein results in increased hydrolysis of Bupropion] |
CTD |
PMID:18611395 PMID:18824010 |
|
NCBI chr 1:81,652,762...81,732,153
Ensembl chr 1:81,652,787...81,732,143
|
|
G |
Cyp2e1 |
cytochrome P450, family 2, subfamily e, polypeptide 1 |
multiple interactions |
EXP ISO |
geraniol inhibits the reaction [[Methionine deficiency co-treated with Choline deficiency] results in increased expression of CYP2E1 protein] [[CYP1A1 protein co-treated with CYP1B1 protein co-treated with CYP2B6 protein co-treated with CYP2E1 protein co-treated with CYP3A5 protein] results in increased metabolism of geraniol] which results in increased chemical synthesis of citral; [[CYP1A1 protein co-treated with CYP1B1 protein co-treated with CYP2B6 protein co-treated with CYP2E1 protein co-treated with CYP3A5 protein] results in increased metabolism of geraniol] which results in increased chemical synthesis of citral metabolite; [[CYP1A1 protein co-treated with CYP1B1 protein co-treated with CYP2B6 protein co-treated with CYP2E1 protein co-treated with CYP3A5 protein] results in increased metabolism of geraniol] which results in increased chemical synthesis of geraniol metabolite; [CYP1A1 protein co-treated with CYP1B1 protein co-treated with CYP2B6 protein co-treated with CYP2E1 protein co-treated with CYP3A5 protein] results in increased metabolism of geraniol |
CTD |
PMID:18824010 PMID:26695085 |
|
NCBI chr 1:195,840,330...195,850,728
Ensembl chr 1:195,840,058...195,864,023
|
|
G |
Cyp3a9 |
cytochrome P450, family 3, subfamily a, polypeptide 9 |
increases metabolic processing multiple interactions |
ISO |
CYP3A5 protein results in increased metabolism of geraniol [[CYP1A1 protein co-treated with CYP1B1 protein co-treated with CYP2B6 protein co-treated with CYP2E1 protein co-treated with CYP3A5 protein] results in increased metabolism of geraniol] which results in increased chemical synthesis of citral; [[CYP1A1 protein co-treated with CYP1B1 protein co-treated with CYP2B6 protein co-treated with CYP2E1 protein co-treated with CYP3A5 protein] results in increased metabolism of geraniol] which results in increased chemical synthesis of citral metabolite; [[CYP1A1 protein co-treated with CYP1B1 protein co-treated with CYP2B6 protein co-treated with CYP2E1 protein co-treated with CYP3A5 protein] results in increased metabolism of geraniol] which results in increased chemical synthesis of geraniol metabolite; [CYP1A1 protein co-treated with CYP1B1 protein co-treated with CYP2B6 protein co-treated with CYP2E1 protein co-treated with CYP3A5 protein] results in increased metabolism of geraniol; [CYP3A5 protein results in increased metabolism of geraniol] which results in increased chemical synthesis of citral; [CYP3A5 protein results in increased metabolism of geraniol] which results in increased chemical synthesis of geraniol metabolite |
CTD |
PMID:18824010 |
|
NCBI chr12:16,806,222...16,846,428
Ensembl chr12:16,806,207...16,846,422
|
|
G |
Dbf4 |
DBF4-CDC7 kinase regulatory subunit |
decreases expression |
ISO |
geraniol results in decreased expression of DBF4 mRNA |
CTD |
PMID:27683099 |
|
NCBI chr 4:25,676,570...25,701,152
Ensembl chr 4:25,676,634...25,701,066
|
|
G |
Ddit3 |
DNA-damage inducible transcript 3 |
increases expression multiple interactions |
ISO |
geraniol results in increased expression of DDIT3 mRNA geraniol inhibits the reaction [Rotenone results in increased expression of DDIT3 protein] |
CTD |
PMID:27683099 PMID:30141137 |
|
NCBI chr 7:63,115,645...63,121,203
Ensembl chr 7:63,116,380...63,121,201
|
|
G |
Dek |
DEK proto-oncogene |
decreases expression |
ISO |
geraniol results in decreased expression of DEK mRNA |
CTD |
PMID:27683099 |
|
NCBI chr17:17,580,804...17,602,825
Ensembl chr17:17,580,843...17,602,808
|
|
G |
Dmtf1 |
cyclin D binding myb-like transcription factor 1 |
increases expression |
ISO |
geraniol results in increased expression of DMTF1 mRNA |
CTD |
PMID:27683099 |
|
NCBI chr 4:24,909,937...24,950,786
Ensembl chr 4:24,910,534...24,950,967
|
|
G |
Dnajc1 |
DnaJ heat shock protein family (Hsp40) member C1 |
increases expression |
ISO |
geraniol results in increased expression of DNAJC1 mRNA |
CTD |
PMID:27683099 |
|
NCBI chr17:80,955,209...81,112,025
Ensembl chr17:80,955,237...81,111,988
|
|
G |
Dr1 |
down-regulator of transcription 1 |
decreases expression |
ISO |
geraniol results in decreased expression of DR1 mRNA |
CTD |
PMID:27683099 |
|
NCBI chr14:1,458,223...1,469,578
Ensembl chr14:1,458,223...1,469,638
|
|
G |
Dtymk |
deoxythymidylate kinase |
decreases expression |
ISO |
geraniol results in decreased expression of DTYMK mRNA |
CTD |
PMID:27683099 |
|
NCBI chr 9:94,315,552...94,324,386
Ensembl chr 9:94,315,552...94,324,870
|
|
G |
E2f1 |
E2F transcription factor 1 |
decreases expression |
ISO |
geraniol results in decreased expression of E2F1 mRNA |
CTD |
PMID:27683099 |
|
NCBI chr 3:143,064,535...143,075,362
Ensembl chr 3:143,049,478...143,075,361
|
|
G |
E2f8 |
E2F transcription factor 8 |
decreases expression |
ISO |
geraniol results in decreased expression of E2F8 mRNA; geraniol results in decreased expression of E2F8 protein |
CTD |
PMID:27683099 |
|
NCBI chr 1:98,565,717...98,584,265
Ensembl chr 1:98,565,717...98,584,098
|
|
G |
Ehf |
ets homologous factor |
decreases expression |
ISO |
geraniol results in decreased expression of EHF mRNA |
CTD |
PMID:27683099 |
|
NCBI chr 3:89,639,845...89,680,061
Ensembl chr 3:89,641,833...89,679,997
|
|
G |
Eif2ak3 |
eukaryotic translation initiation factor 2 alpha kinase 3 |
multiple interactions |
ISO |
geraniol inhibits the reaction [Rotenone results in increased expression of EIF2AK3 protein] |
CTD |
PMID:30141137 |
|
NCBI chr 4:102,805,495...102,866,914
Ensembl chr 4:102,805,510...102,866,911
|
|
G |
Eif2s1 |
eukaryotic translation initiation factor 2 subunit alpha |
multiple interactions |
ISO |
geraniol inhibits the reaction [Rotenone results in increased expression of EIF2S1 protein] |
CTD |
PMID:30141137 |
|
NCBI chr 6:97,672,829...97,697,499
Ensembl chr 6:97,672,766...97,706,225
|
|
G |
Elavl2 |
ELAV like RNA binding protein 2 |
decreases expression |
ISO |
geraniol results in decreased expression of ELAVL2 mRNA |
CTD |
PMID:27683099 |
|
NCBI chr 5:105,960,872...106,086,463
Ensembl chr 5:105,960,875...106,109,097
|
|
G |
Elf1 |
E74 like ETS transcription factor 1 |
increases expression |
ISO |
geraniol results in increased expression of ELF1 mRNA |
CTD |
PMID:27683099 |
|
NCBI chr15:54,890,644...54,986,721
Ensembl chr15:54,865,616...54,986,699
|
|
G |
Elk4 |
ETS transcription factor ELK4 |
increases expression |
ISO |
geraniol results in increased expression of ELK4 mRNA |
CTD |
PMID:27683099 |
|
NCBI chr13:43,451,130...43,475,035
Ensembl chr13:43,435,843...43,475,035
|
|
G |
Erc1 |
ELKS/RAB6-interacting/CAST family member 1 |
increases expression |
ISO |
geraniol results in increased expression of ERC1 mRNA |
CTD |
PMID:27683099 |
|
NCBI chr 4:152,763,664...153,055,724
Ensembl chr 4:152,767,419...153,055,639
|
|
G |
Ern1 |
endoplasmic reticulum to nucleus signaling 1 |
multiple interactions |
ISO |
geraniol inhibits the reaction [Rotenone results in increased expression of ERN1 protein] |
CTD |
PMID:30141137 |
|
NCBI chr10:91,326,889...91,421,201
Ensembl chr10:91,330,654...91,421,029
|
|
G |
Espl1 |
extra spindle pole bodies like 1, separase |
decreases expression |
ISO |
geraniol results in decreased expression of ESPL1 mRNA |
CTD |
PMID:27683099 |
|
NCBI chr 7:133,424,027...133,450,984
Ensembl chr 7:133,424,130...133,450,984
|
|
G |
Esr1 |
estrogen receptor 1 |
affects binding multiple interactions |
ISO |
geraniol binds to ESR1 protein geraniol inhibits the reaction [Estradiol binds to ESR1 protein] |
CTD |
PMID:12495555 |
|
NCBI chr 1:41,106,335...41,499,104
Ensembl chr 1:41,210,475...41,495,002
|
|
G |
Esr2 |
estrogen receptor 2 |
affects binding multiple interactions |
ISO |
geraniol binds to ESR2 protein geraniol inhibits the reaction [Estradiol binds to ESR2 protein] |
CTD |
PMID:12495555 |
|
NCBI chr 6:94,858,438...94,909,630
Ensembl chr 6:94,809,547...94,908,919
|
|
G |
Ets2 |
ETS proto-oncogene 2, transcription factor |
increases expression |
ISO |
geraniol results in increased expression of ETS2 mRNA |
CTD |
PMID:27683099 |
|
NCBI chr11:35,021,536...35,038,322
Ensembl chr11:35,021,596...35,038,319
|
|
G |
Etv1 |
ETS variant transcription factor 1 |
decreases expression |
ISO |
geraniol results in decreased expression of ETV1 mRNA |
CTD |
PMID:27683099 |
|
NCBI chr 6:55,590,149...55,681,784
Ensembl chr 6:55,590,234...55,681,775
|
|
G |
Ewsr1 |
EWS RNA-binding protein 1 |
decreases expression |
ISO |
geraniol results in decreased expression of EWSR1 mRNA |
CTD |
PMID:27683099 |
|
NCBI chr14:79,965,365...79,994,108
Ensembl chr14:79,965,368...79,994,544
|
|
G |
Ezh2 |
enhancer of zeste 2 polycomb repressive complex 2 subunit |
decreases expression |
ISO |
geraniol results in decreased expression of EZH2 mRNA |
CTD |
PMID:27683099 |
|
NCBI chr 4:76,624,399...76,687,362
Ensembl chr 4:76,624,399...76,687,362
|
|
G |
Fabp4 |
fatty acid binding protein 4 |
increases expression |
ISO |
geraniol results in increased expression of FABP4 mRNA |
CTD |
PMID:30806763 |
|
NCBI chr 2:91,580,879...91,585,567
Ensembl chr 2:91,580,885...91,585,578
|
|
G |
Fads1 |
fatty acid desaturase 1 |
multiple interactions decreases activity |
ISO |
[geraniol results in decreased activity of FADS1 protein] which results in decreased chemical synthesis of Arachidonic Acid; [geraniol results in decreased activity of FADS1 protein] which results in decreased metabolism of 8,11,14-Eicosatrienoic Acid |
CTD |
PMID:16462894 |
|
NCBI chr 1:206,827,724...206,842,734
Ensembl chr 1:206,827,765...206,842,734
|
|
G |
Fancg |
FA complementation group G |
decreases expression |
ISO |
geraniol results in decreased expression of FANCG mRNA |
CTD |
PMID:27683099 |
|
NCBI chr 5:57,230,287...57,240,067
Ensembl chr 5:57,231,685...57,240,029
|
|
G |
Fasn |
fatty acid synthase |
multiple interactions |
EXP |
geraniol promotes the reaction [[Methionine deficiency co-treated with Choline deficiency] results in decreased expression of FASN mRNA] |
CTD |
PMID:26695085 |
|
NCBI chr10:106,072,093...106,090,259
Ensembl chr10:106,072,091...106,090,261
|
|
G |
Fbxo5 |
F-box protein 5 |
decreases expression |
ISO |
geraniol results in decreased expression of FBXO5 mRNA |
CTD |
PMID:27683099 |
|
NCBI chr 1:42,196,068...42,202,437
Ensembl chr 1:42,196,068...42,202,437
|
|
G |
Fos |
Fos proto-oncogene, AP-1 transcription factor subunit |
increases expression |
ISO |
geraniol results in increased expression of FOS mRNA |
CTD |
PMID:27683099 |
|
NCBI chr 6:105,121,170...105,124,036
Ensembl chr 6:105,121,170...105,124,036
|
|
G |
Fosl1 |
FOS like 1, AP-1 transcription factor subunit |
decreases expression |
ISO |
geraniol results in decreased expression of FOSL1 mRNA |
CTD |
PMID:27683099 |
|
NCBI chr 1:202,754,549...202,763,057
Ensembl chr 1:202,754,529...202,764,930
|
|
G |
Fosl2 |
FOS like 2, AP-1 transcription factor subunit |
increases expression |
ISO |
geraniol results in increased expression of FOSL2 mRNA |
CTD |
PMID:27683099 |
|
NCBI chr 6:24,297,898...24,319,219
Ensembl chr 6:24,300,956...24,320,034
|
|
G |
Foxa2 |
forkhead box A2 |
decreases expression |
ISO |
geraniol results in decreased expression of FOXA2 mRNA |
CTD |
PMID:27683099 |
|
NCBI chr 3:135,470,123...135,474,326
Ensembl chr 3:135,470,131...135,474,326
|
|
G |
Foxj3 |
forkhead box J3 |
increases expression |
ISO |
geraniol results in increased expression of FOXJ3 mRNA |
CTD |
PMID:27683099 |
|
NCBI chr 5:133,140,344...133,228,489
Ensembl chr 5:133,140,884...133,228,489
|
|
G |
Foxm1 |
forkhead box M1 |
decreases expression |
ISO |
geraniol results in decreased expression of FOXM1 mRNA |
CTD |
PMID:27683099 |
|
NCBI chr 4:161,639,538...161,652,012
Ensembl chr 4:161,638,816...161,650,684
|
|
G |
Foxo4 |
forkhead box O4 |
increases expression |
ISO |
geraniol results in increased expression of FOXO4 mRNA |
CTD |
PMID:27683099 |
|
NCBI chr X:66,385,241...66,392,115
Ensembl chr X:66,385,558...66,392,115
|
|
G |
Fst |
follistatin |
increases expression |
ISO |
geraniol results in increased expression of FST mRNA |
CTD |
PMID:27683099 |
|
NCBI chr 2:46,123,260...46,130,584
Ensembl chr 2:46,123,439...46,130,571
|
|
G |
Fubp1 |
far upstream element binding protein 1 |
decreases expression |
ISO |
geraniol results in decreased expression of FUBP1 mRNA |
CTD |
PMID:27683099 |
|
NCBI chr 2:241,159,481...241,186,591
Ensembl chr 2:241,159,512...241,186,602
|
|
G |
G6pd |
glucose-6-phosphate dehydrogenase |
multiple interactions |
ISO EXP |
geraniol inhibits the reaction [Tetradecanoylphorbol Acetate results in decreased expression of G6PD protein] geraniol inhibits the reaction [Streptozocin results in decreased activity of G6PD protein] |
CTD |
PMID:23399806 PMID:28330423 |
|
NCBI chr X:152,201,081...152,220,863
Ensembl chr X:152,201,098...152,220,801
|
|
G |
Gatad1 |
GATA zinc finger domain containing 1 |
increases expression |
ISO |
geraniol results in increased expression of GATAD1 mRNA |
CTD |
PMID:27683099 |
|
NCBI chr 4:30,507,530...30,519,107
Ensembl chr 4:30,507,538...30,519,107
|
|
G |
Gbx2 |
gastrulation brain homeobox 2 |
decreases expression |
ISO |
geraniol results in decreased expression of GBX2 mRNA |
CTD |
PMID:27683099 |
|
NCBI chr 9:90,509,633...90,512,212
Ensembl chr 9:90,509,633...90,512,212
|
|
G |
Gcg |
glucagon |
multiple interactions increases secretion |
ISO |
9-(tetrahydro-2-furyl)-adenine inhibits the reaction [geraniol results in increased secretion of GCG protein]; CNGA2 mRNA promotes the reaction [geraniol results in increased secretion of GCG protein]; GNAL mRNA promotes the reaction [geraniol results in increased secretion of GCG protein]; OR1A1 mRNA promotes the reaction [geraniol results in increased secretion of GCG protein]; OR1G1 mRNA promotes the reaction [geraniol results in increased secretion of GCG protein] |
CTD |
PMID:29070885 |
|
NCBI chr 3:47,113,914...47,122,958
Ensembl chr 3:47,113,914...47,122,929
|
|
G |
Gdnf |
glial cell derived neurotrophic factor |
multiple interactions |
ISO |
geraniol inhibits the reaction [1-Methyl-4-phenyl-1,2,3,6-tetrahydropyridine results in decreased expression of GDNF mRNA]; geraniol inhibits the reaction [1-Methyl-4-phenyl-1,2,3,6-tetrahydropyridine results in decreased expression of GDNF protein] |
CTD |
PMID:23943375 |
|
NCBI chr 2:56,894,022...56,919,935
Ensembl chr 2:56,895,010...56,917,209
|
|
G |
Gmnn |
geminin, DNA replication inhibitor |
decreases expression |
ISO |
geraniol results in decreased expression of GMNN mRNA |
CTD |
PMID:27683099 |
|
NCBI chr17:40,301,771...40,310,054
Ensembl chr17:40,301,808...40,310,054
|
|
G |
Gna15 |
G protein subunit alpha 15 |
increases response to substance multiple interactions |
ISO |
GNA15 protein results in increased susceptibility to geraniol [GNA15 protein results in increased susceptibility to geraniol] which results in increased activity of OR1A1B protein |
CTD |
PMID:15598656 |
|
NCBI chr 7:8,184,632...8,205,508
Ensembl chr 7:8,184,861...8,205,508
|
|
G |
Gnal |
G protein subunit alpha L |
increases response to substance multiple interactions |
ISO |
GNAL protein results in increased susceptibility to geraniol [GNAL protein results in increased susceptibility to geraniol] which results in increased activity of OR1A1B protein; GNAL mRNA promotes the reaction [geraniol results in increased secretion of GCG protein] |
CTD |
PMID:15598656 PMID:29070885 |
|
NCBI chr18:60,622,311...60,762,599
Ensembl chr18:60,622,311...60,762,599
|
|
G |
Got1 |
glutamic-oxaloacetic transaminase 1 |
multiple interactions |
EXP |
geraniol inhibits the reaction [Doxorubicin results in increased activity of GOT1 protein] |
CTD |
PMID:34343525 |
|
NCBI chr 1:242,357,293...242,381,535
Ensembl chr 1:242,357,306...242,380,633
|
|
G |
Gpt |
glutamic--pyruvic transaminase |
multiple interactions |
EXP |
geraniol inhibits the reaction [Doxorubicin results in increased activity of GPT protein] |
CTD |
PMID:34343525 |
|
NCBI chr 7:108,416,646...108,419,495
Ensembl chr 7:108,416,642...108,419,494
|
|
G |
Gpx1 |
glutathione peroxidase 1 |
multiple interactions |
EXP |
[camphene co-treated with geraniol] inhibits the reaction [nimesulide results in decreased expression of GPX1 mRNA] |
CTD |
PMID:22509279 |
|
NCBI chr 8:109,026,905...109,028,031
Ensembl chr 8:109,026,905...109,028,024
|
|
G |
Gsk3b |
glycogen synthase kinase 3 beta |
multiple interactions |
EXP |
geraniol inhibits the reaction [Trinitrobenzenesulfonic Acid results in increased expression of GSK3B protein] |
CTD |
PMID:26165751 |
|
NCBI chr11:62,498,997...62,648,665
Ensembl chr11:62,504,316...62,648,646
|
|
G |
Gsr |
glutathione-disulfide reductase |
multiple interactions decreases activity |
ISO EXP |
geraniol inhibits the reaction [9,10-Dimethyl-1,2-benzanthracene results in decreased expression of GSR protein]; geraniol inhibits the reaction [Tetradecanoylphorbol Acetate results in decreased expression of GSR protein]; geraniol inhibits the reaction [Tetradecanoylphorbol Acetate results in increased activity of GSR protein] geraniol results in decreased activity of GSR protein [camphene co-treated with geraniol] inhibits the reaction [nimesulide results in decreased activity of GSR protein]; [camphene co-treated with geraniol] inhibits the reaction [nimesulide results in decreased expression of GSR mRNA]; geraniol inhibits the reaction [2-Acetylaminofluorene results in decreased activity of GSR protein]; geraniol inhibits the reaction [Streptozocin affects the activity of GSR protein] |
CTD |
PMID:22509279 PMID:22760862 PMID:23033690 PMID:23399806 PMID:24752916 PMID:26364502 PMID:28817314 More...
|
|
NCBI chr16:58,482,209...58,525,256
Ensembl chr16:58,482,505...58,525,661
|
|
G |
Gstp1 |
glutathione S-transferase pi 1 |
multiple interactions |
EXP |
geraniol inhibits the reaction [Diethylnitrosamine results in increased expression of GSTP1 protein] |
CTD |
PMID:27046949 |
|
NCBI chr 1:201,337,762...201,340,230
Ensembl chr 1:201,321,672...201,340,226
|
|
G |
Gtf2b |
general transcription factor IIB |
increases expression |
ISO |
geraniol results in increased expression of GTF2B mRNA |
CTD |
PMID:27683099 |
|
NCBI chr 2:231,767,317...231,785,626
Ensembl chr 2:231,767,238...231,785,651
|
|
G |
Gtf2h1 |
general transcription factor IIH subunit 1 |
increases expression |
ISO |
geraniol results in increased expression of GTF2H1 mRNA |
CTD |
PMID:27683099 |
|
NCBI chr 1:97,321,417...97,349,455
Ensembl chr 1:97,321,394...97,349,455
|
|
G |
Gtf2ird1 |
GTF2I repeat domain containing 1 |
increases expression |
ISO |
geraniol results in increased expression of GTF2IRD1 mRNA |
CTD |
PMID:27683099 |
|
NCBI chr12:22,254,113...22,361,052
Ensembl chr12:22,254,221...22,361,040
|
|
G |
Gtf3a |
general transcription factor III A |
decreases expression |
ISO |
geraniol results in decreased expression of GTF3A mRNA |
CTD |
PMID:27683099 |
|
NCBI chr12:8,136,746...8,144,690
Ensembl chr12:8,136,747...8,144,690
|
|
G |
Gtf3c1 |
general transcription factor IIIC subunit 1 |
increases expression |
ISO |
geraniol results in increased expression of GTF3C1 mRNA |
CTD |
PMID:27683099 |
|
NCBI chr 1:180,203,995...180,270,201
Ensembl chr 1:180,203,995...180,270,201
|
|
G |
Havcr1 |
hepatitis A virus cellular receptor 1 |
multiple interactions |
EXP |
geraniol inhibits the reaction [[ferric nitrilotriacetate co-treated with Diethylnitrosamine] results in increased expression of HAVCR1 mRNA]; geraniol inhibits the reaction [[ferric nitrilotriacetate co-treated with Diethylnitrosamine] results in increased expression of HAVCR1 protein] |
CTD |
PMID:21907755 |
|
NCBI chr10:31,118,667...31,151,730
Ensembl chr10:31,119,088...31,151,698
|
|
G |
Hbb |
hemoglobin subunit beta |
multiple interactions |
EXP |
geraniol inhibits the reaction [Fructose promotes the reaction [Glucose binds to HBB protein]] |
CTD |
PMID:25679220 |
|
NCBI chr 1:158,250,421...158,251,832
Ensembl chr 1:158,120,200...158,252,012
|
|
G |
Hbp1 |
HMG-box transcription factor 1 |
increases expression |
ISO |
geraniol results in increased expression of HBP1 mRNA |
CTD |
PMID:27683099 |
|
NCBI chr 6:48,529,633...48,555,775
Ensembl chr 6:48,529,372...48,555,787
|
|
G |
Hivep1 |
HIVEP zinc finger 1 |
increases expression |
ISO |
geraniol results in increased expression of HIVEP1 mRNA |
CTD |
PMID:27683099 |
|
NCBI chr17:22,585,016...22,714,517
Ensembl chr17:22,585,016...22,711,956
|
|
G |
Hlf |
HLF transcription factor, PAR bZIP family member |
decreases expression |
ISO |
geraniol results in decreased expression of HLF mRNA |
CTD |
PMID:27683099 |
|
NCBI chr10:75,154,244...75,211,884
Ensembl chr10:75,154,507...75,211,935
|
|
G |
Hmbox1 |
homeobox containing 1 |
increases expression |
ISO |
geraniol results in increased expression of HMBOX1 mRNA |
CTD |
PMID:27683099 |
|
NCBI chr15:39,067,805...39,200,633
Ensembl chr15:39,067,804...39,200,323
|
|
G |
Hmg20b |
high mobility group 20 B |
decreases expression |
ISO |
geraniol results in decreased expression of HMG20B mRNA |
CTD |
PMID:27683099 |
|
NCBI chr 7:8,368,934...8,373,650
Ensembl chr 7:8,368,990...8,373,640
|
|
G |
Hmgb2 |
high mobility group box 2 |
decreases expression |
ISO |
geraniol results in decreased expression of HMGB2 mRNA |
CTD |
PMID:27683099 |
|
NCBI chr16:32,710,651...32,713,230
Ensembl chr16:32,710,658...32,713,140 Ensembl chr 1:32,710,658...32,713,140
|
|
G |
Hmgb3 |
high mobility group box 3 |
decreases expression |
ISO |
geraniol results in decreased expression of HMGB3 mRNA |
CTD |
PMID:27683099 |
|
NCBI chr X:149,296,303...149,301,290
Ensembl chr X:149,296,375...149,301,292
|
|
G |
Hmgcr |
3-hydroxy-3-methylglutaryl-CoA reductase |
increases expression decreases expression affects expression decreases activity |
ISO |
geraniol results in increased expression of HMGCR mRNA geraniol results in decreased expression of HMGCR protein geraniol affects the expression of HMGCR mRNA geraniol results in decreased activity of HMGCR protein |
CTD |
PMID:12477733 PMID:15450939 PMID:16462894 PMID:23668785 PMID:24875281 PMID:26141755 More...
|
|
NCBI chr 2:27,997,523...28,018,983
Ensembl chr 2:27,997,525...28,019,703
|
|
G |
Hmgxb3 |
HMG-box containing 3 |
increases expression |
ISO |
geraniol results in increased expression of HMGXB3 mRNA |
CTD |
PMID:27683099 |
|
NCBI chr18:54,590,558...54,638,050
Ensembl chr18:54,590,560...54,638,155
|
|
G |
Hmgxb4 |
HMG-box containing 4 |
decreases expression |
ISO |
geraniol results in decreased expression of HMGXB4 mRNA |
CTD |
PMID:27683099 |
|
NCBI chr19:13,364,741...13,403,563
Ensembl chr19:13,364,807...13,403,563
|
|
G |
Hmox1 |
heme oxygenase 1 |
increases expression multiple interactions |
ISO EXP |
geraniol results in increased expression of HMOX1 mRNA geraniol promotes the reaction [Doxorubicin results in increased expression of HMOX1 mRNA]; geraniol promotes the reaction [Doxorubicin results in increased expression of HMOX1 protein] geraniol results in increased expression of HMOX1 protein |
CTD |
PMID:20713136 PMID:28334550 PMID:30806763 PMID:34343525 |
|
NCBI chr19:13,466,287...13,474,082
Ensembl chr19:13,467,244...13,474,079
|
|
G |
Hnrnpab |
heterogeneous nuclear ribonucleoprotein A/B |
decreases expression |
ISO |
geraniol results in decreased expression of HNRNPAB mRNA |
CTD |
PMID:27683099 |
|
NCBI chr10:35,857,040...35,862,935
Ensembl chr10:35,857,041...35,863,344
|
|
G |
Hoxa5 |
homeo box A5 |
increases expression |
ISO |
geraniol results in increased expression of HOXA5 mRNA |
CTD |
PMID:27683099 |
|
NCBI chr 4:81,302,341...81,306,234
Ensembl chr 4:81,302,353...81,306,234
|
|
G |
Hoxb13 |
homeo box B13 |
decreases expression |
ISO |
geraniol results in decreased expression of HOXB13 mRNA |
CTD |
PMID:27683099 |
|
NCBI chr10:81,160,498...81,162,777
Ensembl chr10:81,160,498...81,162,777
|
|
G |
Hoxc6 |
homeo box C6 |
increases expression |
ISO |
geraniol results in increased expression of HOXC6 mRNA |
CTD |
PMID:27683099 |
|
NCBI chr 7:134,138,017...134,148,899
Ensembl chr 7:134,135,502...134,148,392
|
|
G |
Hras |
HRas proto-oncogene, GTPase |
multiple interactions |
ISO |
[Tetradecanoylphorbol Acetate co-treated with 9,10-Dimethyl-1,2-benzanthracene co-treated with geraniol] affects the localization of HRAS protein |
CTD |
PMID:22760862 |
|
NCBI chr 1:196,290,127...196,299,823
Ensembl chr 1:196,296,263...196,300,615
|
|
G |
Hspa2 |
heat shock protein family A (Hsp70) member 2 |
decreases expression |
ISO |
geraniol results in decreased expression of HSPA2 mRNA |
CTD |
PMID:27683099 |
|
NCBI chr 6:95,128,504...95,131,281
Ensembl chr 6:95,128,350...95,131,287
|
|
G |
Htr3a |
5-hydroxytryptamine receptor 3A |
decreases activity |
ISO |
geraniol results in decreased activity of HTR3A protein |
CTD |
PMID:26456648 |
|
NCBI chr 8:49,242,018...49,254,475
Ensembl chr 8:49,242,020...49,254,389
|
|
G |
Icam1 |
intercellular adhesion molecule 1 |
multiple interactions |
ISO EXP |
geraniol inhibits the reaction [Dietary Fats results in increased expression of ICAM1 protein] geraniol inhibits the reaction [Palmitic Acid results in increased expression of ICAM1 protein] geraniol inhibits the reaction [Trinitrobenzenesulfonic Acid results in increased expression of ICAM1 protein] |
CTD |
PMID:26165751 PMID:27107694 |
|
NCBI chr 8:19,553,063...19,565,438
Ensembl chr 8:19,553,645...19,565,438
|
|
G |
Id1 |
inhibitor of DNA binding 1 |
increases expression |
ISO |
geraniol results in increased expression of ID1 mRNA |
CTD |
PMID:27683099 |
|
NCBI chr 3:141,210,666...141,212,420
Ensembl chr 3:141,211,267...141,212,419
|
|
G |
Id3 |
inhibitor of DNA binding 3 |
increases expression |
ISO |
geraniol results in increased expression of ID3 mRNA |
CTD |
PMID:27683099 |
|
NCBI chr 5:148,372,784...148,374,353
Ensembl chr 5:148,372,762...148,374,349
|
|
G |
Ifng |
interferon gamma |
multiple interactions |
ISO |
geraniol inhibits the reaction [Dextran Sulfate results in increased expression of IFNG protein] |
CTD |
PMID:26973525 |
|
NCBI chr 7:53,903,339...53,907,375
Ensembl chr 7:53,903,337...53,907,375
|
|
G |
Il10 |
interleukin 10 |
increases expression multiple interactions |
ISO |
geraniol results in increased expression of IL10 protein geraniol inhibits the reaction [Dextran Sulfate results in increased expression of IL10 protein] |
CTD |
PMID:24934659 PMID:26973525 |
|
NCBI chr13:42,472,625...42,477,308
Ensembl chr13:42,472,839...42,477,313
|
|
G |
Il16 |
interleukin 16 |
increases secretion |
ISO |
geraniol results in increased secretion of IL16 protein |
CTD |
PMID:30806763 |
|
NCBI chr 1:137,617,702...137,718,022
Ensembl chr 1:137,617,944...137,718,130
|
|
G |
Il17a |
interleukin 17A |
multiple interactions |
ISO |
geraniol inhibits the reaction [Dextran Sulfate results in increased expression of IL17A protein] |
CTD |
PMID:26973525 |
|
NCBI chr 9:23,144,402...23,147,889
Ensembl chr 9:23,144,402...23,147,889
|
|
G |
Il18 |
interleukin 18 |
multiple interactions |
ISO EXP |
geraniol inhibits the reaction [[Alendronate co-treated with Lovastatin co-treated with lipopolysaccharide, E coli O55-B5] results in increased secretion of IL18 protein]; geraniol promotes the reaction [lonafarnib inhibits the reaction [[Alendronate co-treated with Lovastatin co-treated with lipopolysaccharide, E coli O55-B5] results in increased secretion of IL18 protein]]; geraniol promotes the reaction [manumycin inhibits the reaction [[Alendronate co-treated with Lovastatin co-treated with lipopolysaccharide, E coli O55-B5] results in increased secretion of IL18 protein]]; geraniol promotes the reaction [tipifarnib inhibits the reaction [[Alendronate co-treated with Lovastatin co-treated with lipopolysaccharide, E coli O55-B5] results in increased secretion of IL18 protein]] geraniol inhibits the reaction [Doxorubicin results in increased expression of IL18 protein] |
CTD |
PMID:21430599 PMID:34343525 |
|
NCBI chr 8:50,904,630...50,932,887
Ensembl chr 8:50,906,960...50,932,887
|
|
G |
Il1a |
interleukin 1 alpha |
increases expression |
ISO |
geraniol results in increased expression of IL1A protein |
CTD |
PMID:19878710 |
|
NCBI chr 3:116,526,601...116,537,055
Ensembl chr 3:116,526,604...116,536,822
|
|
G |
Il1b |
interleukin 1 beta |
multiple interactions |
EXP ISO |
geraniol inhibits the reaction [4-Nitroquinoline-1-oxide results in increased expression of IL1B protein]; geraniol inhibits the reaction [Doxorubicin results in increased expression of IL1B protein]; geraniol inhibits the reaction [Fructose results in increased expression of IL1B protein]; geraniol inhibits the reaction [Fructose results in increased secretion of IL1B protein]; geraniol inhibits the reaction [Trinitrobenzenesulfonic Acid results in increased expression of IL1B protein] 2-chloro-5-nitrobenzanilide inhibits the reaction [geraniol inhibits the reaction [[lipopolysaccharide, E coli O55-B5 co-treated with Galactosamine] results in increased expression of IL1B protein]]; geraniol inhibits the reaction [[Alendronate co-treated with Lipopolysaccharides] results in increased expression of IL1B protein]; geraniol inhibits the reaction [[Alendronate co-treated with Lovastatin co-treated with lipopolysaccharide, E coli O55-B5] results in increased secretion of IL1B protein]; geraniol inhibits the reaction [[lipopolysaccharide, E coli O55-B5 co-treated with Galactosamine] results in increased expression of IL1B protein]; geraniol inhibits the reaction [[Pamidronate co-treated with Acetylmuramyl-Alanyl-Isoglutamine] results in increased secretion of IL1B protein]; geraniol inhibits the reaction [[Pamidronate co-treated with lipopolysaccharide, E coli O55-B5] results in increased secretion of IL1B protein]; geraniol inhibits the reaction [Dextran Sulfate results in increased expression of IL1B protein]; geraniol inhibits the reaction [lipopolysaccharide, E coli O55-B5 results in increased expression of IL1B mRNA]; geraniol inhibits the reaction [lipopolysaccharide, E coli O55-B5 results in increased expression of IL1B protein]; geraniol inhibits the reaction [ovalbumin-alum results in increased expression of and results in increased secretion of IL1B protein]; geraniol inhibits the reaction [Tetradecanoylphorbol Acetate results in increased expression of IL1B protein]; geraniol promotes the reaction [lonafarnib inhibits the reaction [[Alendronate co-treated with Lovastatin co-treated with lipopolysaccharide, E coli O55-B5] results in increased secretion of IL1B protein]]; geraniol promotes the reaction [manumycin inhibits the reaction [[Alendronate co-treated with Lovastatin co-treated with lipopolysaccharide, E coli O55-B5] results in increased secretion of IL1B protein]]; geraniol promotes the reaction [tipifarnib inhibits the reaction [[Alendronate co-treated with Lovastatin co-treated with lipopolysaccharide, E coli O55-B5] results in increased secretion of IL1B protein]] geraniol inhibits the reaction [[MVK gene mutant form results in increased susceptibility to Lipopolysaccharides] which results in increased expression of IL1B protein]; geraniol inhibits the reaction [[Tetradecanoylphorbol Acetate co-treated with Calcimycin] results in increased expression of and results in increased secretion of IL1B protein]; geraniol inhibits the reaction [[Tetradecanoylphorbol Acetate co-treated with Calcimycin] results in increased expression of IL1B mRNA] |
CTD |
PMID:20304105 PMID:21282739 PMID:21430599 PMID:23399806 PMID:25679220 PMID:26165751 PMID:26190278 PMID:26973525 PMID:28397014 PMID:29050341 PMID:30254419 PMID:30550845 PMID:31005848 PMID:34343525 More...
|
|
NCBI chr 3:116,577,005...116,583,386
Ensembl chr 3:116,577,010...116,583,415
|
|
G |
Il1r2 |
interleukin 1 receptor type 2 |
increases expression |
ISO |
geraniol results in increased expression of IL1R2 mRNA |
CTD |
PMID:30806763 |
|
NCBI chr 9:42,384,280...42,424,726
Ensembl chr 9:42,384,433...42,424,725
|
|
G |
Il6 |
interleukin 6 |
multiple interactions increases expression |
ISO EXP |
geraniol inhibits the reaction [Dextran Sulfate results in increased expression of IL6 protein]; geraniol inhibits the reaction [Dietary Fats results in increased expression of IL6 protein]; geraniol inhibits the reaction [lipopolysaccharide, E coli O55-B5 results in increased expression of IL6 mRNA]; geraniol inhibits the reaction [lipopolysaccharide, E coli O55-B5 results in increased expression of IL6 protein]; geraniol inhibits the reaction [Tetradecanoylphorbol Acetate results in increased expression of IL6 protein] geraniol inhibits the reaction [[Tetradecanoylphorbol Acetate co-treated with Calcimycin] results in increased expression of and results in increased secretion of IL6 protein]; geraniol inhibits the reaction [[Tetradecanoylphorbol Acetate co-treated with Calcimycin] results in increased expression of IL6 mRNA] geraniol inhibits the reaction [[Methionine deficiency co-treated with Choline deficiency] results in increased expression of IL6 protein]; geraniol inhibits the reaction [Fructose results in increased expression of IL6 protein]; geraniol inhibits the reaction [Isoproterenol results in increased expression of IL6 protein] geraniol results in increased expression of IL6 mRNA |
CTD |
PMID:23399806 PMID:26190278 PMID:26695085 PMID:26973525 PMID:27107694 PMID:28358702 PMID:29050341 PMID:30254419 PMID:31005848 PMID:35608392 More...
|
|
NCBI chr 4:5,214,602...5,219,178
Ensembl chr 4:5,213,394...5,219,178
|
|
G |
Il7r |
interleukin 7 receptor |
increases expression |
ISO |
geraniol results in increased expression of IL7R mRNA |
CTD |
PMID:20713136 |
|
NCBI chr 2:58,452,393...58,477,757
Ensembl chr 2:58,454,217...58,477,757
|
|
G |
Ilf2 |
interleukin enhancer binding factor 2 |
decreases expression |
ISO |
geraniol results in decreased expression of ILF2 mRNA |
CTD |
PMID:27683099 |
|
NCBI chr 2:175,952,174...175,971,191
Ensembl chr 2:175,952,186...175,971,337
|
|
G |
Ins1 |
insulin 1 |
increases secretion multiple interactions |
ISO EXP |
geraniol results in increased secretion of INS1 protein geraniol inhibits the reaction [Streptozocin results in decreased expression of and results in decreased secretion of INS1 protein] |
CTD |
PMID:28330423 PMID:29070885 |
|
NCBI chr 1:251,244,973...251,245,540
Ensembl chr 1:251,244,973...251,245,536
|
|
G |
Irf1 |
interferon regulatory factor 1 |
increases expression |
ISO |
geraniol results in increased expression of IRF1 mRNA |
CTD |
PMID:27683099 |
|
NCBI chr10:37,917,155...37,924,166
Ensembl chr10:37,916,670...37,924,166
|
|
G |
Irf6 |
interferon regulatory factor 6 |
increases expression |
ISO |
geraniol results in increased expression of IRF6 mRNA |
CTD |
PMID:27683099 |
|
NCBI chr13:104,672,179...104,691,386
Ensembl chr13:104,672,179...104,691,386
|
|
G |
Irf7 |
interferon regulatory factor 7 |
increases expression |
ISO |
geraniol results in increased expression of IRF7 mRNA |
CTD |
PMID:27683099 |
|
NCBI chr 1:196,367,380...196,370,943
Ensembl chr 1:196,367,361...196,370,832
|
|
G |
Irf9 |
interferon regulatory factor 9 |
increases expression |
ISO |
geraniol results in increased expression of IRF9 mRNA |
CTD |
PMID:27683099 |
|
NCBI chr15:29,095,474...29,101,924
Ensembl chr15:29,095,789...29,101,236
|
|
G |
Jarid2 |
jumonji and AT-rich interaction domain containing 2 |
increases expression |
ISO |
geraniol results in increased expression of JARID2 mRNA |
CTD |
PMID:27683099 |
|
NCBI chr17:19,777,487...19,957,696
Ensembl chr17:19,777,266...19,955,690
|
|
G |
Jmjd1c |
jumonji domain containing 1C |
increases expression |
ISO |
geraniol results in increased expression of JMJD1C mRNA |
CTD |
PMID:27683099 |
|
NCBI chr20:21,332,147...21,494,220
Ensembl chr20:21,332,147...21,463,122
|
|
G |
Jun |
Jun proto-oncogene, AP-1 transcription factor subunit |
increases expression |
ISO |
geraniol results in increased expression of JUN mRNA |
CTD |
PMID:27683099 |
|
NCBI chr 5:109,894,175...109,897,268
Ensembl chr 5:109,893,145...109,897,656
|
|
G |
Junb |
JunB proto-oncogene, AP-1 transcription factor subunit |
increases expression |
ISO |
geraniol results in increased expression of JUNB mRNA |
CTD |
PMID:27683099 |
|
NCBI chr19:23,176,265...23,178,049
Ensembl chr19:23,176,294...23,178,035
|
|
G |
Jund |
JunD proto-oncogene, AP-1 transcription factor subunit |
increases expression |
ISO |
geraniol results in increased expression of JUND mRNA |
CTD |
PMID:27683099 |
|
NCBI chr16:18,734,121...18,735,799
Ensembl chr16:18,734,122...18,735,799
|
|
G |
Kdr |
kinase insert domain receptor |
decreases expression |
ISO |
geraniol results in decreased expression of KDR protein |
CTD |
PMID:26154255 |
|
NCBI chr14:32,217,871...32,261,018
Ensembl chr14:32,217,871...32,261,018
|
|
G |
Khdrbs1 |
KH RNA binding domain containing, signal transduction associated 1 |
decreases expression |
ISO |
geraniol results in decreased expression of KHDRBS1 mRNA |
CTD |
PMID:27683099 |
|
NCBI chr 5:142,051,844...142,089,175
Ensembl chr 5:142,063,570...142,089,180
|
|
G |
Kif11 |
kinesin family member 11 |
decreases expression |
ISO |
geraniol results in decreased expression of KIF11 mRNA |
CTD |
PMID:27683099 |
|
NCBI chr 1:235,124,371...235,176,760
Ensembl chr 1:235,124,316...235,176,766
|
|
G |
Kif15 |
kinesin family member 15 |
decreases expression |
ISO |
geraniol results in decreased expression of KIF15 mRNA |
CTD |
PMID:27683099 |
|
NCBI chr 8:122,601,888...122,672,750
Ensembl chr 8:122,601,897...122,672,750
|
|
G |
Kif22 |
kinesin family member 22 |
decreases expression |
ISO |
geraniol results in decreased expression of KIF22 mRNA |
CTD |
PMID:27683099 |
|
NCBI chr 1:181,635,347...181,650,351
Ensembl chr 1:181,635,183...181,650,401
|
|
G |
Kif23 |
kinesin family member 23 |
decreases expression |
ISO |
geraniol results in decreased expression of KIF23 mRNA |
CTD |
PMID:27683099 |
|
NCBI chr 8:62,397,908...62,425,162
Ensembl chr 8:62,397,948...62,425,072
|
|
G |
Kif2c |
kinesin family member 2C |
decreases expression |
ISO |
geraniol results in decreased expression of KIF2C mRNA |
CTD |
PMID:27683099 |
|
NCBI chr 5:130,637,347...130,662,680
Ensembl chr 5:130,637,347...130,662,637
|
|
G |
Klf11 |
KLF transcription factor 11 |
increases expression |
ISO |
geraniol results in increased expression of KLF11 mRNA |
CTD |
PMID:27683099 |
|
NCBI chr 6:41,285,699...41,297,548
Ensembl chr 6:41,285,842...41,297,550
|
|
G |
Klf13 |
KLF transcription factor 13 |
increases expression |
ISO |
geraniol results in increased expression of KLF13 mRNA |
CTD |
PMID:27683099 |
|
NCBI chr 1:117,505,857...117,536,626
Ensembl chr 1:117,503,602...117,551,227
|
|
G |
Klf3 |
KLF transcription factor 3 |
increases expression |
ISO |
geraniol results in increased expression of KLF3 mRNA |
CTD |
PMID:27683099 |
|
NCBI chr14:43,474,767...43,505,801
Ensembl chr14:43,474,767...43,497,209
|
|
G |
Klf4 |
KLF transcription factor 4 |
increases expression |
ISO |
geraniol results in increased expression of KLF4 mRNA |
CTD |
PMID:27683099 |
|
NCBI chr 5:70,278,843...70,283,751
Ensembl chr 5:70,278,972...70,283,602
|
|
G |
Klf5 |
KLF transcription factor 5 |
increases expression |
ISO |
geraniol results in increased expression of KLF5 mRNA |
CTD |
PMID:27683099 |
|
NCBI chr15:76,060,320...76,079,445
Ensembl chr15:76,064,258...76,079,445
|
|
G |
Klf6 |
KLF transcription factor 6 |
increases expression |
ISO |
geraniol results in increased expression of KLF6 mRNA |
CTD |
PMID:27683099 |
|
NCBI chr17:64,539,456...64,548,451
Ensembl chr17:64,531,463...64,588,570
|
|
G |
Klf7 |
KLF transcription factor 7 |
increases expression |
ISO |
geraniol results in increased expression of KLF7 mRNA |
CTD |
PMID:27683099 |
|
NCBI chr 9:65,433,683...65,526,372
Ensembl chr 9:65,437,167...65,526,261
|
|
G |
Kntc1 |
kinetochore associated 1 |
decreases expression |
ISO |
geraniol results in decreased expression of KNTC1 mRNA |
CTD |
PMID:27683099 |
|
NCBI chr12:32,769,020...32,839,617
Ensembl chr12:32,769,020...32,839,561
|
|
G |
Kras |
KRAS proto-oncogene, GTPase |
multiple interactions |
EXP |
geraniol inhibits the reaction [Methylnitronitrosoguanidine results in increased expression of KRAS mRNA] |
CTD |
PMID:28428697 |
|
NCBI chr 4:178,185,418...178,218,484
|
|
G |
Ldlr |
low density lipoprotein receptor |
increases expression |
ISO |
geraniol results in increased expression of LDLR mRNA |
CTD |
PMID:26141755 |
|
NCBI chr 8:20,270,020...20,292,981
Ensembl chr 8:20,270,041...20,294,580
|
|
G |
Lif |
LIF, interleukin 6 family cytokine |
decreases expression |
ISO |
geraniol results in decreased expression of LIF protein |
CTD |
PMID:19878710 |
|
NCBI chr14:79,131,049...79,140,486
Ensembl chr14:79,134,574...79,140,482
|
|
G |
Lztfl1 |
leucine zipper transcription factor-like 1 |
increases expression |
ISO |
geraniol results in increased expression of LZTFL1 mRNA |
CTD |
PMID:27683099 |
|
NCBI chr 8:123,344,085...123,360,245
Ensembl chr 8:123,344,925...123,360,192
|
|
G |
Lztr1 |
leucine zipper like post translational regulator 1 |
increases expression |
ISO |
geraniol results in increased expression of LZTR1 mRNA |
CTD |
PMID:27683099 |
|
NCBI chr11:83,487,717...83,503,896
Ensembl chr11:83,487,717...83,503,633
|
|
G |
Mad2l1 |
mitotic arrest deficient 2 like 1 |
decreases expression |
ISO |
geraniol results in decreased expression of MAD2L1 mRNA |
CTD |
PMID:27683099 |
|
NCBI chr 4:95,906,692...95,918,885
Ensembl chr 4:95,906,817...95,913,470
|
|
G |
Maff |
MAF bZIP transcription factor F |
increases expression |
ISO |
geraniol results in increased expression of MAFF mRNA |
CTD |
PMID:27683099 |
|
NCBI chr 7:110,912,367...110,923,711
Ensembl chr 7:110,912,499...110,923,851
|
|
G |
Mafg |
MAF bZIP transcription factor G |
increases expression |
ISO |
geraniol results in increased expression of MAFG mRNA |
CTD |
PMID:27683099 |
|
NCBI chr10:105,903,307...105,911,808
Ensembl chr10:105,903,237...105,912,026
|
|
G |
Maob |
monoamine oxidase B |
multiple interactions |
ISO |
geraniol inhibits the reaction [1-Methyl-4-phenyl-1,2,3,6-tetrahydropyridine results in increased expression of MAOB protein] |
CTD |
PMID:24103762 |
|
NCBI chr X:5,907,327...6,010,996
Ensembl chr X:5,907,266...6,011,003
|
|
G |
Map2k1 |
mitogen activated protein kinase kinase 1 |
multiple interactions |
EXP |
geraniol inhibits the reaction [Methylnitronitrosoguanidine results in increased expression of MAP2K1 mRNA] |
CTD |
PMID:28428697 |
|
NCBI chr 8:64,683,449...64,754,900
Ensembl chr 8:64,683,449...64,755,147
|
|
G |
Mapk1 |
mitogen activated protein kinase 1 |
multiple interactions decreases phosphorylation |
ISO |
geraniol inhibits the reaction [[Tetradecanoylphorbol Acetate co-treated with 9,10-Dimethyl-1,2-benzanthracene] results in increased phosphorylation of MAPK1 protein] geraniol results in decreased phosphorylation of MAPK1 protein |
CTD |
PMID:12388655 PMID:22760862 PMID:26154255 |
|
NCBI chr11:83,957,813...84,023,629
Ensembl chr11:83,957,813...84,023,616
|
|
G |
Mapk3 |
mitogen activated protein kinase 3 |
multiple interactions decreases phosphorylation |
ISO EXP |
geraniol inhibits the reaction [[Tetradecanoylphorbol Acetate co-treated with 9,10-Dimethyl-1,2-benzanthracene] results in increased phosphorylation of MAPK3 protein] geraniol inhibits the reaction [Isoproterenol results in increased expression of MAPK3 mRNA]; geraniol inhibits the reaction [Isoproterenol results in increased phosphorylation of MAPK3 protein] geraniol results in decreased phosphorylation of MAPK3 protein |
CTD |
PMID:12388655 PMID:22760862 PMID:26154255 PMID:35608392 |
|
NCBI chr 1:181,366,646...181,372,863
Ensembl chr 1:181,366,637...181,372,863
|
|
G |
Mapk8 |
mitogen-activated protein kinase 8 |
multiple interactions |
EXP |
geraniol inhibits the reaction [Isoproterenol results in increased expression of MAPK8 mRNA]; geraniol inhibits the reaction [Isoproterenol results in increased phosphorylation of MAPK8 protein] |
CTD |
PMID:35608392 |
|
NCBI chr16:8,638,897...8,721,960
Ensembl chr16:8,638,924...8,721,981
|
|
G |
Mcm2 |
minichromosome maintenance complex component 2 |
decreases expression |
ISO |
geraniol results in decreased expression of MCM2 mRNA |
CTD |
PMID:27683099 |
|
NCBI chr 4:121,346,434...121,360,962
Ensembl chr 4:121,346,434...121,360,847
|
|
G |
Mef2a |
myocyte enhancer factor 2a |
increases expression |
ISO |
geraniol results in increased expression of MEF2A mRNA |
CTD |
PMID:27683099 |
|
NCBI chr 1:120,847,874...120,982,488
Ensembl chr 1:120,850,080...120,981,948
|
|
G |
Men1 |
menin 1 |
increases expression |
ISO |
geraniol results in increased expression of MEN1 mRNA |
CTD |
PMID:27683099 |
|
NCBI chr 1:203,638,905...203,644,871
Ensembl chr 1:203,639,000...203,644,871
|
|
G |
Mki67 |
marker of proliferation Ki-67 |
decreases expression |
ISO |
geraniol results in decreased expression of MKI67 mRNA geraniol results in decreased expression of MKI67 protein |
CTD |
PMID:26154255 PMID:27683099 |
|
NCBI chr 1:190,496,319...190,522,983
Ensembl chr 1:190,496,319...190,522,762
|
|
G |
Mmp2 |
matrix metallopeptidase 2 |
multiple interactions |
EXP |
geraniol inhibits the reaction [Isoproterenol results in increased expression of MMP2 mRNA] |
CTD |
PMID:35608392 |
|
NCBI chr19:14,154,657...14,182,870
Ensembl chr19:14,154,657...14,182,870
|
|
G |
Mmp3 |
matrix metallopeptidase 3 |
increases expression |
ISO |
geraniol results in increased expression of MMP3 mRNA |
CTD |
PMID:30806763 |
|
NCBI chr 8:4,640,397...4,653,963
Ensembl chr 8:4,640,416...4,653,961
|
|
G |
Mmp9 |
matrix metallopeptidase 9 |
multiple interactions |
EXP |
geraniol inhibits the reaction [Isoproterenol results in increased expression of MMP9 mRNA] |
CTD |
PMID:35608392 |
|
NCBI chr 3:153,684,158...153,692,118
Ensembl chr 3:153,683,858...153,692,120
|
|
G |
Mnt |
MAX network transcriptional repressor |
increases expression |
ISO |
geraniol results in increased expression of MNT mRNA |
CTD |
PMID:27683099 |
|
NCBI chr10:59,699,208...59,714,848
Ensembl chr10:59,699,585...59,714,835
|
|
G |
Mpo |
myeloperoxidase |
multiple interactions |
ISO EXP |
2-chloro-5-nitrobenzanilide inhibits the reaction [geraniol inhibits the reaction [[lipopolysaccharide, E coli O55-B5 co-treated with Galactosamine] results in increased activity of MPO protein]]; geraniol inhibits the reaction [[lipopolysaccharide, E coli O55-B5 co-treated with Galactosamine] results in increased activity of MPO protein]; geraniol inhibits the reaction [Dextran Sulfate results in increased expression of MPO protein] geraniol inhibits the reaction [[Oxygen deficiency co-treated with Blood Glucose deficiency] results in increased expression of MPO protein]; geraniol inhibits the reaction [Cysteamine results in increased expression of MPO protein]; geraniol inhibits the reaction [Ethanol results in increased expression of MPO protein]; geraniol inhibits the reaction [Trinitrobenzenesulfonic Acid results in increased expression of MPO protein] |
CTD |
PMID:24337826 PMID:26165751 PMID:26190278 PMID:30550845 |
|
NCBI chr10:72,594,883...72,608,862
Ensembl chr10:72,594,661...72,604,819
|
|
G |
Mtor |
mechanistic target of rapamycin kinase |
decreases activity multiple interactions |
ISO |
geraniol results in decreased activity of MTOR protein geraniol inhibits the reaction [Rotenone results in increased phosphorylation of MTOR protein] |
CTD |
PMID:22200837 PMID:30141137 |
|
NCBI chr 5:158,884,856...158,994,311
Ensembl chr 5:158,884,804...158,994,311
|
|
G |
Mvk |
mevalonate kinase |
multiple interactions |
ISO |
geraniol inhibits the reaction [[MVK gene mutant form results in increased susceptibility to Lipopolysaccharides] which results in increased expression of IL1B protein]; geraniol inhibits the reaction [MVK gene mutant form results in increased susceptibility to Lipopolysaccharides] |
CTD |
PMID:20304105 |
|
NCBI chr12:42,141,391...42,158,893
Ensembl chr12:42,141,384...42,158,882
|
|
G |
Mxd1 |
max dimerization protein 1 |
increases expression |
ISO |
geraniol results in increased expression of MXD1 mRNA |
CTD |
PMID:27683099 |
|
NCBI chr 4:119,097,353...119,118,080
Ensembl chr 4:119,097,353...119,117,751
|
|
G |
Mxd4 |
Max dimerization protein 4 |
increases expression |
ISO |
geraniol results in increased expression of MXD4 mRNA |
CTD |
PMID:27683099 |
|
NCBI chr14:76,562,105...76,576,224
Ensembl chr14:76,561,774...76,576,221
|
|
G |
Mxi1 |
MAX interactor 1, dimerization protein |
increases expression |
ISO |
geraniol results in increased expression of MXI1 mRNA |
CTD |
PMID:27683099 |
|
NCBI chr 1:252,323,915...252,383,682
Ensembl chr 1:252,323,303...252,383,681
|
|
G |
Myb |
MYB proto-oncogene, transcription factor |
decreases expression |
ISO |
geraniol results in decreased expression of MYB mRNA |
CTD |
PMID:27683099 |
|
NCBI chr 1:15,939,771...15,973,367
Ensembl chr 1:15,939,761...15,973,057
|
|
G |
Mybl1 |
MYB proto-oncogene like 1 |
decreases expression |
ISO |
geraniol results in decreased expression of MYBL1 mRNA |
CTD |
PMID:27683099 |
|
NCBI chr 5:9,582,905...9,618,179
Ensembl chr 5:9,582,934...9,618,183
|
|
G |
Mybl2 |
MYB proto-oncogene like 2 |
decreases expression |
ISO |
geraniol results in decreased expression of MYBL2 mRNA |
CTD |
PMID:27683099 |
|
NCBI chr 3:151,705,254...151,733,714
Ensembl chr 3:151,705,288...151,733,708
|
|
G |
Myo6 |
myosin VI |
increases expression |
ISO |
geraniol results in increased expression of MYO6 mRNA |
CTD |
PMID:27683099 |
|
NCBI chr 8:81,087,157...81,242,022
Ensembl chr 8:81,087,139...81,239,292
|
|
G |
Nasp |
nuclear autoantigenic sperm protein |
decreases expression |
ISO |
geraniol results in decreased expression of NASP mRNA |
CTD |
PMID:27683099 |
|
NCBI chr 5:130,057,363...130,083,003
Ensembl chr 5:130,057,363...130,082,928
|
|
G |
Ncaph |
non-SMC condensin I complex, subunit H |
decreases expression |
ISO |
geraniol results in decreased expression of NCAPH mRNA |
CTD |
PMID:27683099 |
|
NCBI chr 3:114,371,937...114,399,178
Ensembl chr 3:114,371,941...114,399,180
|
|
G |
Ncor1 |
nuclear receptor co-repressor 1 |
increases expression |
ISO |
geraniol results in increased expression of NCOR1 mRNA |
CTD |
PMID:27683099 |
|
NCBI chr10:46,999,536...47,142,294
Ensembl chr10:46,999,536...47,141,032
|
|
G |
Ndp |
norrin cystine knot growth factor NDP |
decreases expression |
ISO |
geraniol results in decreased expression of NDP mRNA |
CTD |
PMID:27683099 |
|
NCBI chr X:5,796,487...5,820,934
Ensembl chr X:5,796,487...5,820,934
|
|
G |
Nek2 |
NIMA-related kinase 2 |
decreases expression |
ISO |
geraniol results in decreased expression of NEK2 mRNA |
CTD |
PMID:27683099 |
|
NCBI chr13:103,405,818...103,419,063
Ensembl chr13:103,405,819...103,419,051
|
|
G |
Nfat5 |
nuclear factor of activated T-cells 5 |
increases expression |
ISO |
geraniol results in increased expression of NFAT5 mRNA |
CTD |
PMID:27683099 |
|
NCBI chr19:35,199,737...35,286,675
Ensembl chr19:35,199,016...35,286,675
|
|
G |
Nfe2l1 |
NFE2 like bZIP transcription factor 1 |
increases expression |
ISO |
geraniol results in increased expression of NFE2L1 mRNA |
CTD |
PMID:27683099 |
|
NCBI chr10:81,796,055...81,812,926
Ensembl chr10:81,800,366...81,832,318
|
|
G |
Nfe2l2 |
NFE2 like bZIP transcription factor 2 |
increases expression multiple interactions |
ISO EXP |
geraniol results in increased expression of NFE2L2 mRNA geraniol promotes the reaction [Doxorubicin results in increased expression of NFE2L2 mRNA]; geraniol promotes the reaction [Doxorubicin results in increased expression of NFE2L2 protein] geraniol results in increased expression of NFE2L2 protein |
CTD |
PMID:27683099 PMID:28334550 PMID:34343525 |
|
NCBI chr 3:60,594,239...60,621,712
Ensembl chr 3:60,594,242...60,621,737
|
|
G |
Nfil3 |
nuclear factor, interleukin 3 regulated |
increases expression |
ISO |
geraniol results in increased expression of NFIL3 mRNA |
CTD |
PMID:27683099 |
|
NCBI chr17:12,280,499...12,295,728
Ensembl chr17:12,280,484...12,295,858
|
|
G |
Nfkb1 |
nuclear factor kappa B subunit 1 |
multiple interactions |
EXP |
geraniol inhibits the reaction [[ferric nitrilotriacetate co-treated with Diethylnitrosamine] results in increased expression of NFKB1 mRNA]; geraniol inhibits the reaction [Trinitrobenzenesulfonic Acid results in increased expression of NFKB1 protein] |
CTD |
PMID:21907755 PMID:26165751 |
|
NCBI chr 2:224,016,214...224,132,135
Ensembl chr 2:224,016,214...224,110,404
|
|
G |
Nfkbia |
NFKB inhibitor alpha |
multiple interactions |
ISO EXP |
geraniol inhibits the reaction [[lipopolysaccharide, E coli O55-B5 co-treated with Galactosamine] results in increased expression of NFKBIA mRNA]; geraniol inhibits the reaction [[lipopolysaccharide, E coli O55-B5 co-treated with Galactosamine] results in increased expression of NFKBIA protein modified form]; geraniol inhibits the reaction [Dextran Sulfate results in increased phosphorylation of NFKBIA protein]; geraniol inhibits the reaction [lipopolysaccharide, E coli O55-B5 results in increased expression of NFKBIA protein modified form]; geraniol inhibits the reaction [Lipopolysaccharides results in increased degradation of NFKBIA protein] geraniol inhibits the reaction [Doxorubicin results in increased expression of and results in increased phosphorylation of NFKBIA protein] |
CTD |
PMID:20506077 PMID:26190278 PMID:29050341 PMID:30550845 PMID:34343525 |
|
NCBI chr 6:72,858,713...72,861,941
Ensembl chr 6:72,858,712...72,861,941
|
|
G |
Nfyb |
nuclear transcription factor Y subunit beta |
decreases expression |
ISO |
geraniol results in decreased expression of NFYB mRNA |
CTD |
PMID:27683099 |
|
NCBI chr 7:20,964,988...20,980,569
Ensembl chr 7:20,964,993...20,980,565
|
|
G |
Nos2 |
nitric oxide synthase 2 |
multiple interactions decreases expression |
EXP ISO |
[camphene co-treated with geraniol] inhibits the reaction [nimesulide results in increased expression of NOS2 mRNA]; [camphene co-treated with geraniol] inhibits the reaction [nimesulide results in increased expression of NOS2 protein]; geraniol inhibits the reaction [2-Acetylaminofluorene results in increased expression of NOS2 protein]; geraniol inhibits the reaction [4-Nitroquinoline-1-oxide results in increased expression of NOS2 protein]; geraniol inhibits the reaction [[Methionine deficiency co-treated with Choline deficiency] results in increased expression of NOS2 protein] geraniol results in decreased expression of NOS2 mRNA; geraniol results in decreased expression of NOS2 protein geraniol inhibits the reaction [Dextran Sulfate results in increased expression of NOS2 protein]; geraniol inhibits the reaction [lipopolysaccharide, E coli O55-B5 results in increased expression of NOS2 protein] |
CTD |
PMID:20506077 PMID:22509279 PMID:26190278 PMID:26364502 PMID:26695085 PMID:28397014 PMID:29050341 More...
|
|
NCBI chr10:63,815,308...63,851,208
Ensembl chr10:63,815,308...63,851,210
|
|
G |
Nox1 |
NADPH oxidase 1 |
multiple interactions |
ISO |
geraniol inhibits the reaction [Palmitic Acid results in increased expression of NOX1 protein] |
CTD |
PMID:27107694 |
|
NCBI chr X:97,279,058...97,332,291
Ensembl chr X:97,279,056...97,302,236
|
|
G |
Npm1 |
nucleophosmin 1 |
decreases expression |
ISO |
geraniol results in decreased expression of NPM1 mRNA |
CTD |
PMID:27683099 |
|
NCBI chr10:17,741,512...17,751,626
Ensembl chr10:17,739,941...17,751,645 Ensembl chr X:17,739,941...17,751,645
|
|
G |
Nqo1 |
NAD(P)H quinone dehydrogenase 1 |
multiple interactions |
EXP |
geraniol inhibits the reaction [4-Nitroquinoline-1-oxide results in decreased activity of NQO1 protein]; geraniol inhibits the reaction [Doxorubicin results in decreased expression of NQO1 protein] |
CTD |
PMID:23499697 PMID:34343525 |
|
NCBI chr19:35,295,633...35,310,528
Ensembl chr19:35,295,573...35,310,557
|
|
G |
Nr1d1 |
nuclear receptor subfamily 1, group D, member 1 |
increases expression |
ISO |
geraniol results in increased expression of NR1D1 mRNA |
CTD |
PMID:27683099 |
|
NCBI chr10:83,728,348...83,735,562
Ensembl chr10:83,728,318...83,735,705
|
|
G |
Nr1d2 |
nuclear receptor subfamily 1, group D, member 2 |
increases expression |
ISO |
geraniol results in increased expression of NR1D2 mRNA |
CTD |
PMID:27683099 |
|
NCBI chr15:7,524,257...7,550,553
Ensembl chr15:7,524,257...7,550,553
|
|
G |
Nr2f1 |
nuclear receptor subfamily 2, group F, member 1 |
decreases expression |
ISO |
geraniol results in decreased expression of NR2F1 mRNA |
CTD |
PMID:27683099 |
|
NCBI chr 2:8,040,375...8,050,123
Ensembl chr 2:8,040,377...8,050,123
|
|
G |
Nr3c1 |
nuclear receptor subfamily 3, group C, member 1 |
increases expression |
ISO |
geraniol results in increased expression of NR3C1 mRNA |
CTD |
PMID:27683099 |
|
NCBI chr18:31,271,681...31,393,320
Ensembl chr18:31,271,681...31,393,375
|
|
G |
Nr4a2 |
nuclear receptor subfamily 4, group A, member 2 |
increases expression |
ISO |
geraniol results in increased expression of NR4A2 mRNA |
CTD |
PMID:27683099 |
|
NCBI chr 3:41,689,847...41,707,036
Ensembl chr 3:41,689,851...41,697,877
|
|
G |
Nsd2 |
nuclear receptor binding SET domain protein 2 |
decreases expression |
ISO |
geraniol results in decreased expression of NSD2 mRNA |
CTD |
PMID:27683099 |
|
NCBI chr14:76,833,179...76,911,304
Ensembl chr14:76,835,637...76,913,641
|
|
G |
Nusap1 |
nucleolar and spindle associated protein 1 |
decreases expression |
ISO |
geraniol results in decreased expression of NUSAP1 mRNA |
CTD |
PMID:27683099 |
|
NCBI chr 3:106,603,273...106,633,428
Ensembl chr 3:106,603,289...106,633,624
|
|
G |
Odc1 |
ornithine decarboxylase 1 |
multiple interactions decreases activity |
ISO |
geraniol inhibits the reaction [Tetradecanoylphorbol Acetate results in increased expression of ODC1 protein] geraniol results in decreased activity of ODC1 protein |
CTD |
PMID:11408542 PMID:22760862 |
|
NCBI chr 6:40,329,831...40,336,444
Ensembl chr 6:40,329,964...40,336,440
|
|
G |
Ogg1 |
8-oxoguanine DNA glycosylase |
multiple interactions |
EXP |
[camphene co-treated with geraniol] inhibits the reaction [nimesulide results in increased expression of OGG1 protein] |
CTD |
PMID:22509279 |
|
NCBI chr 4:146,474,701...146,481,959
Ensembl chr 4:146,474,750...146,484,766
|
|
G |
Or1a1 |
olfactory receptor family 1 subfamily A member 1 |
multiple interactions |
ISO |
[GNA15 protein results in increased susceptibility to geraniol] which results in increased activity of OR1A1B protein; [GNAL protein results in increased susceptibility to geraniol] which results in increased activity of OR1A1B protein; OR1A1 mRNA promotes the reaction [geraniol results in increased secretion of GCG protein] |
CTD |
PMID:15598656 PMID:29070885 |
|
NCBI chr10:59,058,941...59,059,879
Ensembl chr10:59,052,828...59,060,676
|
|
G |
Or1ad5 |
olfactory receptor family 1 subfamily AD member 5 |
multiple interactions |
ISO |
OR1G1 mRNA promotes the reaction [geraniol results in increased secretion of GCG protein] |
CTD |
PMID:29070885 |
|
NCBI chr10:35,307,662...35,308,573
Ensembl chr10:35,304,703...35,308,919
|
|
G |
Pa2g4 |
proliferation-associated 2G4 |
decreases expression |
ISO |
geraniol results in decreased expression of PA2G4 mRNA |
CTD |
PMID:27683099 |
|
NCBI chr 7:984,795...992,264
Ensembl chr 7:983,971...992,331
|
|
G |
Pbx1 |
PBX homeobox 1 |
decreases expression |
ISO |
geraniol results in decreased expression of PBX1 mRNA |
CTD |
PMID:27683099 |
|
NCBI chr13:80,278,766...80,588,563
Ensembl chr13:80,278,770...80,588,594
|
|
G |
Pcna |
proliferating cell nuclear antigen |
multiple interactions decreases expression |
EXP ISO |
geraniol inhibits the reaction [2-Acetylaminofluorene results in increased expression of PCNA protein]; geraniol inhibits the reaction [[ferric nitrilotriacetate co-treated with Diethylnitrosamine] results in increased expression of PCNA mRNA]; geraniol inhibits the reaction [[ferric nitrilotriacetate co-treated with Diethylnitrosamine] results in increased expression of PCNA protein]; geraniol inhibits the reaction [Diethylnitrosamine results in increased expression of PCNA protein]; geraniol inhibits the reaction [Methylnitronitrosoguanidine results in increased expression of PCNA protein] geraniol results in decreased expression of PCNA protein |
CTD |
PMID:21907755 PMID:26154255 PMID:26364502 PMID:27046949 PMID:28428697 |
|
NCBI chr 3:119,499,039...119,502,911
Ensembl chr 3:119,498,810...119,502,995
|
|
G |
Pgr |
progesterone receptor |
multiple interactions |
EXP |
geraniol inhibits the reaction [Methylnitronitrosoguanidine results in decreased expression of PGR protein] |
CTD |
PMID:28428697 |
|
NCBI chr 8:6,072,673...6,131,552
Ensembl chr 8:6,072,673...6,131,344
|
|
G |
Phb1 |
prohibitin 1 |
decreases expression multiple interactions |
ISO EXP |
geraniol results in decreased expression of PHB1 mRNA geraniol inhibits the reaction [[Methionine deficiency co-treated with Choline deficiency] results in decreased expression of PHB1 protein] |
CTD |
PMID:26695085 PMID:27683099 |
|
NCBI chr10:80,605,268...80,618,043
Ensembl chr10:80,605,251...80,618,042
|
|
G |
Phf1 |
PHD finger protein 1 |
increases expression |
ISO |
geraniol results in increased expression of PHF1 mRNA |
CTD |
PMID:27683099 |
|
NCBI chr20:5,017,765...5,022,872
Ensembl chr20:5,017,893...5,022,871
|
|
G |
Phf21a |
PHD finger protein 21A |
increases expression |
ISO |
geraniol results in increased expression of PHF21A mRNA |
CTD |
PMID:27683099 |
|
NCBI chr 3:78,158,760...78,331,903
Ensembl chr 3:78,194,549...78,331,865
|
|
G |
Phtf1 |
putative homeodomain transcription factor 1 |
increases expression |
ISO |
geraniol results in increased expression of PHTF1 mRNA |
CTD |
PMID:27683099 |
|
NCBI chr 2:191,470,849...191,537,399
Ensembl chr 2:191,473,130...191,512,078
|
|
G |
Pik3r1 |
phosphoinositide-3-kinase regulatory subunit 1 |
multiple interactions |
EXP |
geraniol inhibits the reaction [Methylnitronitrosoguanidine results in increased expression of PIK3R1 mRNA] |
CTD |
PMID:28428697 |
|
NCBI chr 2:32,878,942...32,963,668
Ensembl chr 2:32,882,032...32,963,631
|
|
G |
Pkmyt1 |
protein kinase, membrane associated tyrosine/threonine 1 |
decreases expression |
ISO |
geraniol results in decreased expression of PKMYT1 mRNA |
CTD |
PMID:27683099 |
|
NCBI chr10:12,748,221...12,758,995
Ensembl chr10:12,748,237...12,758,995
|
|
G |
Plagl1 |
PLAG1 like zinc finger 1 |
increases expression |
ISO |
geraniol results in increased expression of PLAGL1 mRNA |
CTD |
PMID:27683099 |
|
NCBI chr 1:7,477,295...7,517,229
Ensembl chr 1:7,477,177...7,517,228
|
|
G |
Plk1 |
polo-like kinase 1 |
decreases expression |
ISO |
geraniol results in decreased expression of PLK1 mRNA |
CTD |
PMID:27683099 |
|
NCBI chr 1:176,716,420...176,726,400
Ensembl chr 1:176,716,420...176,726,400
|
|
G |
Pola1 |
DNA polymerase alpha 1, catalytic subunit |
decreases expression |
ISO |
geraniol results in decreased expression of POLA1 mRNA |
CTD |
PMID:27683099 |
|
NCBI chr X:58,034,617...58,348,612
Ensembl chr X:58,034,619...58,348,536
|
|
G |
Pole |
DNA polymerase epsilon, catalytic subunit |
decreases expression |
ISO |
geraniol results in decreased expression of POLE mRNA |
CTD |
PMID:27683099 |
|
NCBI chr12:46,345,420...46,393,984
Ensembl chr12:46,345,420...46,393,939
|
|
G |
Polr1g |
RNA polymerase I subunit G |
decreases expression |
ISO |
geraniol results in decreased expression of POLR1G mRNA |
CTD |
PMID:27683099 |
|
NCBI chr 1:79,007,490...79,010,766
Ensembl chr 1:79,007,490...79,010,766
|
|
G |
Por |
cytochrome p450 oxidoreductase |
multiple interactions |
EXP |
geraniol inhibits the reaction [4-Nitroquinoline-1-oxide results in increased activity of POR protein] |
CTD |
PMID:23499697 |
|
NCBI chr12:20,951,058...20,999,198
Ensembl chr12:20,951,058...20,999,245
|
|
G |
Ppara |
peroxisome proliferator activated receptor alpha |
multiple interactions increases activity |
EXP ISO |
geraniol inhibits the reaction [[Methionine deficiency co-treated with Choline deficiency] results in decreased expression of PPARA mRNA] geraniol results in increased activity of PPARA protein |
CTD |
PMID:21597168 PMID:26695085 |
|
NCBI chr 7:116,832,405...116,900,878
Ensembl chr 7:116,832,756...116,895,346
|
|
G |
Pparg |
peroxisome proliferator-activated receptor gamma |
decreases expression increases activity multiple interactions |
ISO EXP |
geraniol results in decreased expression of PPARG mRNA geraniol results in increased activity of PPARG protein geraniol inhibits the reaction [[lipopolysaccharide, E coli O55-B5 co-treated with Galactosamine] results in decreased expression of PPARG mRNA]; geraniol inhibits the reaction [[lipopolysaccharide, E coli O55-B5 co-treated with Galactosamine] results in decreased expression of PPARG protein] geraniol inhibits the reaction [Fructose results in decreased activity of PPARG protein]; geraniol inhibits the reaction [Trinitrobenzenesulfonic Acid results in decreased expression of PPARG mRNA]; geraniol inhibits the reaction [Trinitrobenzenesulfonic Acid results in decreased expression of PPARG protein] |
CTD |
PMID:21597168 PMID:25679220 PMID:26165751 PMID:27683099 PMID:30550845 |
|
NCBI chr 4:148,423,102...148,548,471
Ensembl chr 4:148,423,194...148,548,468
|
|
G |
Prc1 |
protein regulator of cytokinesis 1 |
decreases expression |
ISO |
geraniol results in decreased expression of PRC1 mRNA |
CTD |
PMID:27683099 |
|
NCBI chr 1:134,250,086...134,271,765
Ensembl chr 1:134,250,081...134,271,765
|
|
G |
Prdm4 |
PR/SET domain 4 |
increases expression |
ISO |
geraniol results in increased expression of PRDM4 mRNA |
CTD |
PMID:27683099 |
|
NCBI chr 7:17,953,832...17,980,489
Ensembl chr 7:17,954,019...17,980,489
|
|
G |
Prdx1 |
peroxiredoxin 1 |
multiple interactions |
EXP |
geraniol inhibits the reaction [Isoproterenol results in decreased expression of PRDX1 mRNA]; geraniol inhibits the reaction [Isoproterenol results in decreased expression of PRDX1 protein] |
CTD |
PMID:35608392 |
|
NCBI chr 5:130,147,258...130,162,856
Ensembl chr 5:130,147,204...130,162,856
|
|
G |
Prdx3 |
peroxiredoxin 3 |
decreases expression |
ISO |
geraniol results in decreased expression of PRDX3 mRNA |
CTD |
PMID:27683099 |
|
NCBI chr 1:260,001,642...260,014,064
Ensembl chr 1:260,001,637...260,014,111
|
|
G |
Prkaa1 |
protein kinase AMP-activated catalytic subunit alpha 1 |
multiple interactions |
ISO |
geraniol inhibits the reaction [Rotenone results in increased expression of PRKAA1 protein] |
CTD |
PMID:30141137 |
|
NCBI chr 2:54,240,298...54,275,978
Ensembl chr 2:54,240,137...54,275,978
|
|
G |
Pten |
phosphatase and tensin homolog |
multiple interactions |
EXP |
geraniol inhibits the reaction [Methylnitronitrosoguanidine results in decreased expression of PTEN protein] |
CTD |
PMID:28428697 |
|
NCBI chr 1:230,630,443...230,697,070
Ensembl chr 1:230,630,338...230,696,838
|
|
G |
Ptgs2 |
prostaglandin-endoperoxide synthase 2 |
multiple interactions |
ISO EXP |
geraniol inhibits the reaction [Dextran Sulfate results in increased expression of PTGS2 mRNA]; geraniol inhibits the reaction [Dextran Sulfate results in increased expression of PTGS2 protein]; geraniol inhibits the reaction [lipopolysaccharide, E coli O55-B5 results in increased expression of PTGS2 protein]; geraniol inhibits the reaction [Lipopolysaccharides results in increased expression of PTGS2 mRNA]; geraniol inhibits the reaction [Lipopolysaccharides results in increased expression of PTGS2 protein]; geraniol inhibits the reaction [Tetradecanoylphorbol Acetate results in increased expression of PTGS2 protein] geraniol inhibits the reaction [2-Acetylaminofluorene results in increased expression of PTGS2 protein]; geraniol inhibits the reaction [4-Nitroquinoline-1-oxide results in increased expression of PTGS2 protein] |
CTD |
PMID:20506077 PMID:21597168 PMID:22760862 PMID:23399806 PMID:26190278 PMID:26364502 PMID:26973525 PMID:28397014 PMID:29050341 More...
|
|
NCBI chr13:62,163,936...62,172,193
Ensembl chr13:62,163,932...62,172,188
|
|
G |
Pttg1 |
PTTG1 regulator of sister chromatid separation, securin |
decreases expression |
ISO |
geraniol results in decreased expression of PTTG1 mRNA |
CTD |
PMID:27683099 |
|
NCBI chr10:27,893,466...27,904,965
Ensembl chr10:27,893,689...27,904,837
|
|
G |
Pwp1 |
PWP1 homolog, endonuclein |
decreases expression |
ISO |
geraniol results in decreased expression of PWP1 mRNA |
CTD |
PMID:27683099 |
|
NCBI chr 7:17,982,730...17,998,728
Ensembl chr 7:17,982,235...17,998,731
|
|
G |
Racgap1 |
Rac GTPase-activating protein 1 |
decreases expression |
ISO |
geraniol results in decreased expression of RACGAP1 mRNA |
CTD |
PMID:27683099 |
|
NCBI chr 7:130,750,936...130,780,891
Ensembl chr 7:130,750,936...130,780,831
|
|
G |
Rad51 |
RAD51 recombinase |
decreases expression |
ISO |
geraniol results in decreased expression of RAD51 mRNA |
CTD |
PMID:27683099 |
|
NCBI chr 3:106,099,753...106,125,038
Ensembl chr 3:106,100,381...106,125,035
|
|
G |
Rad54b |
RAD54 homolog B |
decreases expression |
ISO |
geraniol results in decreased expression of RAD54B mRNA |
CTD |
PMID:27683099 |
|
NCBI chr 5:25,032,112...25,104,630
Ensembl chr 5:25,032,066...25,104,616
|
|
G |
Rad54l |
RAD54 like |
decreases expression |
ISO |
geraniol results in decreased expression of RAD54L mRNA |
CTD |
PMID:27683099 |
|
NCBI chr 5:129,575,431...129,605,100
Ensembl chr 5:129,575,378...129,605,070
|
|
G |
Raf1 |
Raf-1 proto-oncogene, serine/threonine kinase |
multiple interactions |
ISO |
geraniol inhibits the reaction [[Tetradecanoylphorbol Acetate co-treated with 9,10-Dimethyl-1,2-benzanthracene] results in increased expression of RAF1 protein] |
CTD |
PMID:22760862 |
|
NCBI chr 4:148,679,534...148,740,265
Ensembl chr 4:148,679,530...148,740,317
|
|
G |
Rcan1 |
regulator of calcineurin 1 |
increases expression |
ISO |
geraniol results in increased expression of RCAN1 mRNA |
CTD |
PMID:27683099 |
|
NCBI chr11:31,622,208...31,702,150
Ensembl chr11:31,622,210...31,702,045
|
|
G |
Rcor3 |
REST corepressor 3 |
increases expression |
ISO |
geraniol results in increased expression of RCOR3 mRNA |
CTD |
PMID:27683099 |
|
NCBI chr13:103,624,966...103,665,565
Ensembl chr13:103,624,971...103,665,565
|
|
G |
Rela |
RELA proto-oncogene, NF-kB subunit |
multiple interactions |
ISO EXP |
geraniol inhibits the reaction [[lipopolysaccharide, E coli O55-B5 co-treated with Galactosamine] results in increased expression of RELA mRNA]; geraniol inhibits the reaction [[lipopolysaccharide, E coli O55-B5 co-treated with Galactosamine] results in increased expression of RELA protein modified form]; geraniol inhibits the reaction [Dextran Sulfate results in increased expression of and affects the localization of and results in increased activity of RELA protein]; geraniol inhibits the reaction [lipopolysaccharide, E coli O55-B5 results in increased expression of RELA protein modified form]; geraniol inhibits the reaction [Tetradecanoylphorbol Acetate results in increased expression of RELA protein] geraniol inhibits the reaction [2-Acetylaminofluorene results in increased expression of RELA protein]; geraniol inhibits the reaction [4-Nitroquinoline-1-oxide results in increased expression of and affects the localization of RELA protein]; geraniol inhibits the reaction [Doxorubicin results in increased expression of RELA protein] |
CTD |
PMID:23399806 PMID:26190278 PMID:26364502 PMID:28397014 PMID:29050341 PMID:30550845 PMID:34343525 More...
|
|
NCBI chr 1:202,925,001...202,935,484
Ensembl chr 1:202,924,945...202,935,484
|
|
G |
Rfx5 |
regulatory factor X5 |
increases expression |
ISO |
geraniol results in increased expression of RFX5 mRNA |
CTD |
PMID:27683099 |
|
NCBI chr 2:182,521,191...182,528,720
Ensembl chr 2:182,521,202...182,528,717
|
|
G |
Rnf19a |
ring finger protein 19A, RBR E3 ubiquitin protein ligase |
increases expression |
ISO |
geraniol results in increased expression of RNF19A mRNA |
CTD |
PMID:27683099 |
|
NCBI chr 7:67,425,833...67,465,214
Ensembl chr 7:67,425,837...67,465,222
|
|
G |
Ruvbl1 |
RuvB-like AAA ATPase 1 |
decreases expression |
ISO |
geraniol results in decreased expression of RUVBL1 mRNA |
CTD |
PMID:27683099 |
|
NCBI chr 4:120,932,486...120,967,400
Ensembl chr 4:120,932,417...121,029,384
|
|
G |
Ruvbl2 |
RuvB-like AAA ATPase 2 |
decreases expression |
ISO |
geraniol results in decreased expression of RUVBL2 mRNA |
CTD |
PMID:27683099 |
|
NCBI chr 1:95,902,014...95,915,247
Ensembl chr 1:95,901,701...95,915,342
|
|
G |
Satb1 |
SATB homeobox 1 |
increases expression |
ISO |
geraniol results in increased expression of SATB1 mRNA |
CTD |
PMID:27683099 |
|
NCBI chr 9:4,677,817...4,773,061
Ensembl chr 9:4,680,920...4,753,251
|
|
G |
Serpinb3 |
serpin family B member 3 |
increases expression |
ISO |
geraniol results in increased expression of SERPINB3 mRNA |
CTD |
PMID:30806763 |
|
NCBI chr13:23,274,120...23,280,660
Ensembl chr13:23,274,484...23,313,682
|
|
G |
Sim2 |
SIM bHLH transcription factor 2 |
increases expression |
ISO |
geraniol results in increased expression of SIM2 mRNA |
CTD |
PMID:27683099 |
|
NCBI chr11:33,414,218...33,453,663
Ensembl chr11:33,414,218...33,453,663
|
|
G |
Sirt1 |
sirtuin 1 |
increases expression |
ISO |
geraniol results in increased expression of SIRT1 mRNA |
CTD |
PMID:27683099 |
|
NCBI chr20:25,307,225...25,329,273
Ensembl chr20:25,306,917...25,329,260
|
|
G |
Skp2 |
S-phase kinase associated protein 2 |
decreases expression |
ISO |
geraniol results in decreased expression of SKP2 mRNA |
CTD |
PMID:27683099 |
|
NCBI chr 2:58,161,226...58,189,293
Ensembl chr 2:58,161,229...58,189,338
|
|
G |
Slc18a2 |
solute carrier family 18 member A2 |
multiple interactions |
ISO |
geraniol inhibits the reaction [1-Methyl-4-phenyl-1,2,3,6-tetrahydropyridine results in decreased expression of SLC18A2 protein] |
CTD |
PMID:23943375 |
|
NCBI chr 1:258,413,748...258,449,143
Ensembl chr 1:258,413,959...258,448,325
|
|
G |
Slc2a4rg |
SLC2A4 regulator |
decreases expression |
ISO |
geraniol results in decreased expression of SLC2A4RG mRNA |
CTD |
PMID:27683099 |
|
NCBI chr 3:168,493,975...168,497,616
|
|
G |
Slc6a3 |
solute carrier family 6 member 3 |
multiple interactions |
ISO |
geraniol inhibits the reaction [1-Methyl-4-phenyl-1,2,3,6-tetrahydropyridine results in decreased expression of SLC6A3 protein] |
CTD |
PMID:23943375 |
|
NCBI chr 1:29,709,443...29,750,413
Ensembl chr 1:29,709,443...29,750,413
|
|
G |
Smad3 |
SMAD family member 3 |
decreases expression |
ISO |
geraniol results in decreased expression of SMAD3 mRNA |
CTD |
PMID:27683099 |
|
NCBI chr 8:64,126,829...64,236,960
Ensembl chr 8:64,110,039...64,236,960
|
|
G |
Smad6 |
SMAD family member 6 |
decreases expression |
ISO |
geraniol results in decreased expression of SMAD6 mRNA |
CTD |
PMID:27683099 |
|
NCBI chr 8:64,450,114...64,519,673
Ensembl chr 8:64,450,114...64,519,763
|
|
G |
Smad7 |
SMAD family member 7 |
increases expression |
ISO |
geraniol results in increased expression of SMAD7 mRNA |
CTD |
PMID:27683099 |
|
NCBI chr18:68,988,429...69,016,774
Ensembl chr18:68,988,429...69,016,765
|
|
G |
Smarca2 |
SWI/SNF related BAF chromatin remodeling complex subunit ATPase 2 |
decreases expression |
ISO |
geraniol results in decreased expression of SMARCA2 mRNA |
CTD |
PMID:27683099 |
|
NCBI chr 1:224,191,125...224,358,640
Ensembl chr 1:224,191,125...224,358,684
|
|
G |
Smarcal1 |
SNF2 related chromatin remodeling annealing helicase 1 |
increases expression |
ISO |
geraniol results in increased expression of SMARCAL1 mRNA |
CTD |
PMID:27683099 |
|
NCBI chr 9:74,239,718...74,286,156
Ensembl chr 9:74,240,241...74,286,146
|
|
G |
Smc4 |
structural maintenance of chromosomes 4 |
decreases expression |
ISO |
geraniol results in decreased expression of SMC4 mRNA |
CTD |
PMID:27683099 |
|
NCBI chr 2:153,240,243...153,268,722
Ensembl chr 2:153,240,283...153,271,571
|
|
G |
Snca |
synuclein alpha |
multiple interactions |
ISO |
geraniol inhibits the reaction [1-Methyl-4-phenyl-1,2,3,6-tetrahydropyridine results in increased expression of SNCA mRNA]; geraniol inhibits the reaction [1-Methyl-4-phenyl-1,2,3,6-tetrahydropyridine results in increased expression of SNCA protein] geraniol inhibits the reaction [Rotenone results in increased expression of SNCA protein]; geraniol inhibits the reaction [SNCA protein results in decreased abundance of Dopamine]; geraniol inhibits the reaction [SNCA protein results in decreased abundance of Glutathione]; geraniol inhibits the reaction [SNCA protein results in increased abundance of Thiobarbituric Acid Reactive Substances] |
CTD |
PMID:24103762 PMID:27026137 PMID:30141137 |
|
NCBI chr 4:89,696,420...89,797,240
Ensembl chr 4:89,696,420...89,796,262
|
|
G |
Sod1 |
superoxide dismutase 1 |
multiple interactions |
EXP ISO |
[camphene co-treated with geraniol] inhibits the reaction [nimesulide results in decreased expression of SOD1 mRNA] geraniol inhibits the reaction [Rotenone results in decreased activity of SOD1 protein] |
CTD |
PMID:22509279 PMID:30141137 |
|
NCBI chr11:29,456,673...29,462,249
Ensembl chr11:29,456,558...29,462,249
|
|
G |
Sod2 |
superoxide dismutase 2 |
multiple interactions |
EXP ISO |
[camphene co-treated with geraniol] inhibits the reaction [nimesulide results in decreased expression of SOD2 mRNA]; [camphene co-treated with geraniol] inhibits the reaction [nimesulide results in decreased expression of SOD2 protein] geraniol inhibits the reaction [Rotenone results in decreased activity of SOD2 protein] |
CTD |
PMID:22509279 PMID:30141137 |
|
NCBI chr 1:47,638,318...47,645,163
Ensembl chr 1:47,636,528...47,645,189
|
|
G |
Sox9 |
SRY-box transcription factor 9 |
decreases expression |
ISO |
geraniol results in decreased expression of SOX9 mRNA |
CTD |
PMID:27683099 |
|
NCBI chr10:97,806,485...97,811,994
Ensembl chr10:97,806,485...97,811,994
|
|
G |
Sp100 |
SP100 nuclear antigen |
increases expression |
ISO |
geraniol results in increased expression of SP100 mRNA |
CTD |
PMID:27683099 |
|
NCBI chr 9:86,310,990...86,377,036
Ensembl chr 9:86,311,032...86,377,034
|
|
G |
Sqstm1 |
sequestosome 1 |
increases expression multiple interactions |
ISO |
geraniol results in increased expression of SQSTM1 mRNA geraniol inhibits the reaction [Rotenone results in decreased expression of SQSTM1 protein] |
CTD |
PMID:27683099 PMID:30141137 |
|
NCBI chr10:34,525,517...34,536,670
Ensembl chr10:34,525,519...34,536,673
|
|
G |
Srebf1 |
sterol regulatory element binding transcription factor 1 |
multiple interactions |
EXP |
geraniol promotes the reaction [[Methionine deficiency co-treated with Choline deficiency] results in decreased expression of SREBF1 mRNA] |
CTD |
PMID:26695085 |
|
NCBI chr10:45,007,637...45,029,650
Ensembl chr10:45,007,637...45,029,650
|
|
G |
Srebf2 |
sterol regulatory element binding transcription factor 2 |
increases expression |
ISO |
geraniol results in increased expression of SREBF2 mRNA |
CTD |
PMID:23668785 |
|
NCBI chr 7:113,663,202...113,720,850
Ensembl chr 7:113,663,202...113,720,848
|
|
G |
Stat1 |
signal transducer and activator of transcription 1 |
increases expression |
ISO |
geraniol results in increased expression of STAT1 mRNA |
CTD |
PMID:27683099 |
|
NCBI chr 9:49,419,561...49,459,969
Ensembl chr 9:49,419,340...49,588,540
|
|
G |
Stat2 |
signal transducer and activator of transcription 2 |
increases expression |
ISO |
geraniol results in increased expression of STAT2 mRNA |
CTD |
PMID:27683099 |
|
NCBI chr 7:702,565...718,349
Ensembl chr 7:702,495...718,967
|
|
G |
Stat6 |
signal transducer and activator of transcription 6 |
increases expression |
ISO |
geraniol results in increased expression of STAT6 mRNA |
CTD |
PMID:27683099 |
|
NCBI chr 7:63,480,229...63,497,551
Ensembl chr 7:63,479,642...63,498,495
|
|
G |
Stmn1 |
stathmin 1 |
decreases expression |
ISO |
geraniol results in decreased expression of STMN1 mRNA |
CTD |
PMID:27683099 |
|
NCBI chr 5:146,680,757...146,687,154
Ensembl chr 5:146,681,436...146,687,154
|
|
G |
Sub1 |
SUB1 regulator of transcription |
decreases expression |
ISO |
geraniol results in decreased expression of SUB1 mRNA |
CTD |
PMID:27683099 |
|
NCBI chr 2:61,005,646...61,020,486
Ensembl chr 2:61,005,666...61,020,436 Ensembl chr 2:61,005,666...61,020,436
|
|
G |
Supt16h |
SPT16 homolog, facilitates chromatin remodeling subunit |
decreases expression |
ISO |
geraniol results in decreased expression of SUPT16H mRNA |
CTD |
PMID:27683099 |
|
NCBI chr15:24,867,697...24,904,818
Ensembl chr15:24,866,489...24,904,846
|
|
G |
Supt5h |
SPT5 homolog, DSIF elongation factor subunit |
increases expression |
ISO |
geraniol results in increased expression of SUPT5H mRNA |
CTD |
PMID:27683099 |
|
NCBI chr 1:83,586,713...83,616,971
Ensembl chr 1:83,586,718...83,616,892
|
|
G |
Tardbp |
TAR DNA binding protein |
decreases expression |
ISO |
geraniol results in decreased expression of TARDBP mRNA |
CTD |
PMID:27683099 |
|
NCBI chr 5:159,050,518...159,062,218
Ensembl chr 5:159,051,799...159,062,055
|
|
G |
Tceal1 |
transcription elongation factor A like 1 |
increases expression |
ISO |
geraniol results in increased expression of TCEAL1 mRNA |
CTD |
PMID:27683099 |
|
NCBI chr X:100,058,485...100,060,439
Ensembl chr X:100,058,132...100,060,551
|
|
G |
Tcf12 |
transcription factor 12 |
increases expression |
ISO |
geraniol results in increased expression of TCF12 mRNA |
CTD |
PMID:27683099 |
|
NCBI chr 8:72,490,447...72,799,265
Ensembl chr 8:72,492,567...72,799,201
|
|
G |
Tcf25 |
TCF25 ribosome quality control complex subunit |
increases expression |
ISO |
geraniol results in increased expression of TCF25 mRNA |
CTD |
PMID:27683099 |
|
NCBI chr19:51,415,341...51,449,725
Ensembl chr19:51,415,543...51,449,723
|
|
G |
Tcf4 |
transcription factor 4 |
decreases expression |
ISO |
geraniol results in decreased expression of TCF4 mRNA |
CTD |
PMID:27683099 |
|
NCBI chr18:62,941,739...63,288,126
Ensembl chr18:62,943,782...63,284,425
|
|
G |
Tcf7l2 |
transcription factor 7 like 2 |
decreases expression |
ISO |
geraniol results in decreased expression of TCF7L2 mRNA |
CTD |
PMID:27683099 |
|
NCBI chr 1:254,785,956...254,978,967
Ensembl chr 1:254,786,091...254,978,967
|
|
G |
Terf1 |
telomeric repeat binding factor 1 |
decreases expression |
ISO |
geraniol results in decreased expression of TERF1 mRNA |
CTD |
PMID:27683099 |
|
NCBI chr 5:3,443,103...3,472,377
Ensembl chr 5:3,443,106...3,472,340
|
|
G |
Tfap2a |
transcription factor AP-2 alpha |
increases expression |
ISO |
geraniol results in increased expression of TFAP2A mRNA |
CTD |
PMID:27683099 |
|
NCBI chr17:24,028,716...24,047,507
Ensembl chr17:24,024,432...24,047,507
|
|
G |
Tfcp2 |
transcription factor CP2 |
decreases expression |
ISO |
geraniol results in decreased expression of TFCP2 mRNA |
CTD |
PMID:27683099 |
|
NCBI chr 7:131,616,777...131,658,995
Ensembl chr 7:131,616,785...131,658,939
|
|
G |
Tfdp1 |
transcription factor Dp-1 |
decreases expression |
ISO |
geraniol results in decreased expression of TFDP1 mRNA |
CTD |
PMID:27683099 |
|
NCBI chr16:76,162,040...76,200,871
Ensembl chr16:76,162,043...76,200,817
|
|
G |
Tgfb1 |
transforming growth factor, beta 1 |
multiple interactions |
EXP |
geraniol inhibits the reaction [Methylnitronitrosoguanidine results in increased expression of TGFB1 mRNA] |
CTD |
PMID:28428697 |
|
NCBI chr 1:81,196,532...81,212,848
Ensembl chr 1:81,196,532...81,212,847
|
|
G |
Tgif1 |
TGFB-induced factor homeobox 1 |
increases expression |
ISO |
geraniol results in increased expression of TGIF1 mRNA |
CTD |
PMID:27683099 |
|
NCBI chr 9:110,748,094...110,757,714
Ensembl chr 9:110,720,921...110,757,802
|
|
G |
Th |
tyrosine hydroxylase |
multiple interactions |
ISO |
geraniol inhibits the reaction [1-Methyl-4-phenyl-1,2,3,6-tetrahydropyridine results in decreased expression of TH protein] |
CTD |
PMID:23943375 |
|
NCBI chr 1:198,071,500...198,078,832
Ensembl chr 1:198,071,503...198,109,767
|
|
G |
Timeless |
timeless circadian regulator |
decreases expression |
ISO |
geraniol results in decreased expression of TIMELESS mRNA |
CTD |
PMID:27683099 |
|
NCBI chr 7:654,804...678,769
Ensembl chr 7:654,822...678,738
|
|
G |
Tk1 |
thymidine kinase 1 |
decreases expression multiple interactions |
ISO |
geraniol results in decreased expression of TK1 mRNA Fluorouracil promotes the reaction [geraniol results in decreased expression of TK1 mRNA] |
CTD |
PMID:15374632 |
|
NCBI chr10:103,034,755...103,046,125
Ensembl chr10:103,031,521...103,046,920
|
|
G |
Tle1 |
TLE family member 1, transcriptional corepressor |
increases expression |
ISO |
geraniol results in increased expression of TLE1 mRNA |
CTD |
PMID:27683099 |
|
NCBI chr 5:85,851,827...85,934,806
Ensembl chr 5:85,851,827...85,934,774
|
|
G |
Tlr4 |
toll-like receptor 4 |
multiple interactions |
ISO |
geraniol inhibits the reaction [lipopolysaccharide, E coli O55-B5 results in increased expression of TLR4 mRNA]; geraniol inhibits the reaction [lipopolysaccharide, E coli O55-B5 results in increased expression of TLR4 protein] |
CTD |
PMID:29050341 |
|
NCBI chr 5:80,145,867...80,159,501
Ensembl chr 5:80,145,826...80,159,628
|
|
G |
Tnf |
tumor necrosis factor |
multiple interactions increases expression |
ISO EXP |
geraniol inhibits the reaction [[Tetradecanoylphorbol Acetate co-treated with Calcimycin] results in increased expression of and results in increased secretion of TNF protein]; geraniol inhibits the reaction [[Tetradecanoylphorbol Acetate co-treated with Calcimycin] results in increased expression of TNF mRNA] 2-chloro-5-nitrobenzanilide inhibits the reaction [geraniol inhibits the reaction [[lipopolysaccharide, E coli O55-B5 co-treated with Galactosamine] results in increased expression of TNF protein]]; geraniol inhibits the reaction [[Alendronate co-treated with Lovastatin co-treated with lipopolysaccharide, E coli O55-B5] results in increased secretion of TNF protein]; geraniol inhibits the reaction [[lipopolysaccharide, E coli O55-B5 co-treated with Galactosamine] results in increased expression of TNF protein]; geraniol inhibits the reaction [Dextran Sulfate results in increased expression of TNF protein]; geraniol inhibits the reaction [lipopolysaccharide, E coli O55-B5 results in increased expression of TNF mRNA]; geraniol inhibits the reaction [lipopolysaccharide, E coli O55-B5 results in increased expression of TNF protein]; geraniol inhibits the reaction [Tetradecanoylphorbol Acetate results in increased expression of TNF protein]; geraniol promotes the reaction [lonafarnib inhibits the reaction [[Alendronate co-treated with Lovastatin co-treated with lipopolysaccharide, E coli O55-B5] results in increased secretion of TNF protein]]; geraniol promotes the reaction [manumycin inhibits the reaction [[Alendronate co-treated with Lovastatin co-treated with lipopolysaccharide, E coli O55-B5] results in increased secretion of TNF protein]]; geraniol promotes the reaction [tipifarnib inhibits the reaction [[Alendronate co-treated with Lovastatin co-treated with lipopolysaccharide, E coli O55-B5] results in increased secretion of TNF protein]] geraniol results in increased expression of TNF mRNA geraniol inhibits the reaction [4-Nitroquinoline-1-oxide results in increased expression of TNF protein]; geraniol inhibits the reaction [[Methionine deficiency co-treated with Choline deficiency] results in increased expression of TNF protein]; geraniol inhibits the reaction [Doxorubicin results in increased expression of TNF protein]; geraniol inhibits the reaction [Fructose results in increased secretion of TNF protein]; geraniol inhibits the reaction [Isoproterenol results in increased expression of TNF protein] |
CTD |
PMID:21430599 PMID:23399806 PMID:25679220 PMID:26190278 PMID:26695085 PMID:26973525 PMID:28358702 PMID:28397014 PMID:29050341 PMID:30254419 PMID:30550845 PMID:34343525 PMID:35608392 More...
|
|
NCBI chr20:3,622,011...3,624,629
Ensembl chr20:3,622,011...3,624,629
|
|
G |
Tp53 |
tumor protein p53 |
multiple interactions increases expression |
EXP ISO |
geraniol inhibits the reaction [[ferric nitrilotriacetate co-treated with Diethylnitrosamine] results in increased expression of TP53 mRNA]; geraniol inhibits the reaction [[ferric nitrilotriacetate co-treated with Diethylnitrosamine] results in increased expression of TP53 protein] geraniol results in increased expression of TP53 mRNA |
CTD |
PMID:21907755 PMID:27683099 |
|
NCBI chr10:54,300,070...54,311,525
Ensembl chr10:54,300,048...54,311,524
|
|
G |
Tpx2 |
TPX2, microtubule nucleation factor |
decreases expression |
ISO |
geraniol results in decreased expression of TPX2 mRNA |
CTD |
PMID:27683099 |
|
NCBI chr 3:141,318,428...141,360,684
Ensembl chr 3:141,318,455...141,360,468
|
|
G |
Traip |
TRAF-interacting protein |
decreases expression |
ISO |
geraniol results in decreased expression of TRAIP mRNA |
CTD |
PMID:27683099 |
|
NCBI chr 8:108,641,860...108,661,640
Ensembl chr 8:108,641,852...108,661,638
|
|
G |
Trak1 |
trafficking kinesin protein 1 |
increases expression |
ISO |
geraniol results in increased expression of TRAK1 mRNA |
CTD |
PMID:27683099 |
|
NCBI chr 8:120,984,445...121,139,357
Ensembl chr 8:120,984,431...121,139,367
|
|
G |
Trim29 |
tripartite motif-containing 29 |
increases expression |
ISO |
geraniol results in increased expression of TRIM29 mRNA |
CTD |
PMID:27683099 |
|
NCBI chr 8:43,682,221...43,706,992
Ensembl chr 8:43,682,221...43,706,992
|
|
G |
Trps1 |
transcriptional repressor GATA binding 1 |
increases expression |
ISO |
geraniol results in increased expression of TRPS1 mRNA |
CTD |
PMID:27683099 |
|
NCBI chr 7:81,916,668...82,142,733
Ensembl chr 7:81,921,601...82,141,905
|
|
G |
Trpv1 |
transient receptor potential cation channel, subfamily V, member 1 |
multiple interactions |
ISO |
geraniol binds to and results in increased activity of TRPV1 protein |
CTD |
PMID:20686244 |
|
NCBI chr10:57,851,428...57,876,513
Ensembl chr10:57,851,428...57,876,513
|
|
G |
Tsc22d3 |
TSC22 domain family, member 3 |
increases expression |
ISO |
geraniol results in increased expression of TSC22D3 mRNA |
CTD |
PMID:27683099 |
|
NCBI chr X:104,217,898...104,277,886
Ensembl chr X:104,217,925...104,276,861
|
|
G |
Ttk |
Ttk protein kinase |
decreases expression |
ISO |
geraniol results in decreased expression of TTK mRNA |
CTD |
PMID:27683099 |
|
NCBI chr 8:84,754,329...84,792,653
Ensembl chr 8:84,754,315...84,792,651
|
|
G |
Tulp3 |
TUB like protein 3 |
increases expression |
ISO |
geraniol results in increased expression of TULP3 mRNA |
CTD |
PMID:27683099 |
|
NCBI chr 4:161,590,478...161,632,244
Ensembl chr 4:161,590,479...161,632,149
|
|
G |
Tulp4 |
TUB like protein 4 |
increases expression |
ISO |
geraniol results in increased expression of TULP4 mRNA |
CTD |
PMID:27683099 |
|
NCBI chr 1:46,682,416...46,813,167
Ensembl chr 1:46,682,863...46,809,688
|
|
G |
Tyms |
thymidylate synthetase |
multiple interactions decreases expression |
ISO |
Fluorouracil promotes the reaction [geraniol results in decreased expression of TYMS mRNA] |
CTD |
PMID:15374632 |
|
NCBI chr 9:113,313,454...113,329,551
Ensembl chr 9:113,313,452...113,329,536
|
|
G |
Ube2c |
ubiquitin-conjugating enzyme E2C |
decreases expression |
ISO |
geraniol results in decreased expression of UBE2C mRNA |
CTD |
PMID:27683099 |
|
NCBI chr 3:153,506,636...153,509,036
Ensembl chr 3:153,506,636...153,513,339
|
|
G |
Ube2n |
ubiquitin-conjugating enzyme E2N |
decreases expression |
ISO |
geraniol results in decreased expression of UBE2N mRNA |
CTD |
PMID:27683099 |
|
NCBI chr 7:30,154,330...30,184,373
Ensembl chr 7:30,154,616...30,184,355
|
|
G |
Ubp1 |
upstream binding protein 1 |
decreases expression |
ISO |
geraniol results in decreased expression of UBP1 mRNA |
CTD |
PMID:27683099 |
|
NCBI chr 8:113,869,771...113,915,625
Ensembl chr 8:113,869,979...113,915,625
|
|
G |
Ucp2 |
uncoupling protein 2 |
multiple interactions |
EXP |
geraniol inhibits the reaction [[Methionine deficiency co-treated with Choline deficiency] results in increased expression of UCP2 protein] |
CTD |
PMID:26695085 |
|
NCBI chr 1:154,839,242...154,845,612
Ensembl chr 1:154,839,209...154,845,611
|
|
G |
Vcam1 |
vascular cell adhesion molecule 1 |
multiple interactions |
ISO |
geraniol inhibits the reaction [Palmitic Acid results in increased expression of VCAM1 protein] geraniol inhibits the reaction [Dietary Fats results in increased expression of VCAM1 protein] |
CTD |
PMID:27107694 |
|
NCBI chr 2:204,038,120...204,057,852
Ensembl chr 2:204,038,114...204,057,958
|
|
G |
Vegfa |
vascular endothelial growth factor A |
multiple interactions |
EXP |
geraniol inhibits the reaction [2-Acetylaminofluorene results in increased expression of VEGFA protein] |
CTD |
PMID:26364502 |
|
NCBI chr 9:14,955,300...14,970,641
Ensembl chr 9:14,955,300...14,970,641
|
|
G |
Vldlr |
very low density lipoprotein receptor |
increases expression |
ISO |
geraniol results in increased expression of VLDLR mRNA |
CTD |
PMID:26141755 |
|
NCBI chr 1:224,813,539...224,850,400
Ensembl chr 1:224,814,377...224,845,920
|
|
G |
Xbp1 |
X-box binding protein 1 |
increases expression |
ISO |
geraniol results in increased expression of XBP1 mRNA |
CTD |
PMID:27683099 |
|
NCBI chr14:80,390,629...80,395,713
Ensembl chr14:80,390,643...80,395,693
|
|
G |
Zbtb1 |
zinc finger and BTB domain containing 1 |
increases expression |
ISO |
geraniol results in increased expression of ZBTB1 mRNA |
CTD |
PMID:27683099 |
|
NCBI chr 6:95,096,838...95,125,811
Ensembl chr 6:95,096,387...95,118,996
|
|
G |
Zbtb10 |
zinc finger and BTB domain containing 10 |
increases expression |
ISO |
geraniol results in increased expression of ZBTB10 mRNA |
CTD |
PMID:27683099 |
|
NCBI chr 2:92,475,254...92,509,892
Ensembl chr 2:92,479,014...92,512,515
|
|
G |
Zbtb11 |
zinc finger and BTB domain containing 11 |
decreases expression |
ISO |
geraniol results in decreased expression of ZBTB11 mRNA |
CTD |
PMID:27683099 |
|
NCBI chr11:44,598,694...44,652,559
Ensembl chr11:44,616,289...44,651,050
|
|
G |
Zbtb20 |
zinc finger and BTB domain containing 20 |
increases expression |
ISO |
geraniol results in increased expression of ZBTB20 mRNA |
CTD |
PMID:27683099 |
|
NCBI chr11:57,052,129...57,791,214
Ensembl chr11:57,072,880...57,510,210
|
|
G |
Zfp110 |
zinc finger protein 110 |
increases expression |
ISO |
geraniol results in increased expression of ZNF274 mRNA |
CTD |
PMID:27683099 |
|
NCBI chr 1:73,445,303...73,461,112
Ensembl chr 1:73,445,336...73,461,086
|
|
G |
Zfp189 |
zinc finger protein 189 |
increases expression |
ISO |
geraniol results in increased expression of ZNF189 mRNA |
CTD |
PMID:27683099 |
|
NCBI chr 5:63,872,596...63,884,348
Ensembl chr 5:63,872,738...63,884,121
|
|
G |
Zfp207 |
zinc finger protein 207 |
decreases expression |
ISO |
geraniol results in decreased expression of ZNF207 mRNA |
CTD |
PMID:27683099 |
|
NCBI chr10:65,385,807...65,398,086
Ensembl chr10:65,385,740...65,397,386
|
|
G |
Zfp248 |
zinc finger protein 248 |
decreases expression |
ISO |
geraniol results in decreased expression of ZNF248 mRNA |
CTD |
PMID:27683099 |
|
NCBI chr 4:151,605,433...151,630,249
Ensembl chr 4:151,606,495...151,629,850
|
|
G |
Zfp263 |
zinc finger protein 263 |
increases expression |
ISO |
geraniol results in increased expression of ZNF263 mRNA |
CTD |
PMID:27683099 |
|
NCBI chr10:11,764,424...11,774,324
Ensembl chr10:11,764,427...11,771,235
|
|
G |
Zfp281 |
zinc finger protein 281 |
increases expression |
ISO |
geraniol results in increased expression of ZNF281 mRNA |
CTD |
PMID:27683099 |
|
NCBI chr13:48,096,103...48,104,265
Ensembl chr13:48,037,286...48,104,888
|
|
G |
Zfp329 |
zinc finger protein 329 |
increases expression |
ISO |
geraniol results in increased expression of ZNF329 mRNA |
CTD |
PMID:27683099 |
|
NCBI chr 1:73,403,067...73,498,349
Ensembl chr 1:73,402,972...73,422,037
|
|
G |
Zfp334 |
zinc finger protein 334 |
increases expression |
ISO |
geraniol results in increased expression of ZNF334 mRNA |
CTD |
PMID:27683099 |
|
NCBI chr 3:154,112,537...154,125,087
Ensembl chr 3:154,113,561...154,125,057
|
|
G |
Zfp354a |
zinc finger protein 354A |
increases expression |
ISO |
geraniol results in increased expression of ZNF354A mRNA |
CTD |
PMID:27683099 |
|
NCBI chr10:35,396,242...35,408,069
Ensembl chr10:35,396,231...35,408,068
|
|
G |
Zfp394 |
zinc finger protein 394 |
increases expression |
ISO |
geraniol results in increased expression of ZNF394 mRNA |
CTD |
PMID:27683099 |
|
NCBI chr12:9,409,047...9,417,228
Ensembl chr12:9,409,078...9,417,246
|
|
G |
Zfp410 |
zinc finger protein 410 |
increases expression |
ISO |
geraniol results in increased expression of ZNF410 mRNA |
CTD |
PMID:27683099 |
|
NCBI chr 6:103,963,265...103,990,252
Ensembl chr 6:103,964,060...103,990,225
|
|
G |
Zfp455l1 |
zinc finger protein 455 like 1 |
increases expression |
ISO |
geraniol results in increased expression of KRBOX4 mRNA |
CTD |
PMID:27683099 |
|
NCBI chr 1:34,866,934...34,944,939
Ensembl chr 1:34,927,303...34,944,121
|
|
G |
Zfp467 |
zinc finger protein 467 |
increases expression |
ISO |
geraniol results in increased expression of ZNF467 mRNA |
CTD |
PMID:27683099 |
|
NCBI chr 4:77,385,752...77,394,709
Ensembl chr 4:77,385,758...77,392,229
|
|
G |
Zfp606 |
zinc finger protein 606 |
increases expression |
ISO |
geraniol results in increased expression of ZNF606 mRNA |
CTD |
PMID:27683099 |
|
NCBI chr 1:72,981,920...73,022,423
Ensembl chr 1:72,981,989...73,008,072
|
|
G |
Zfp612 |
zinc finger protein 612 |
increases expression |
ISO |
geraniol results in increased expression of ZNF23 mRNA |
CTD |
PMID:27683099 |
|
NCBI chr19:38,053,953...38,071,196
Ensembl chr19:38,053,967...38,067,455
|
|
G |
Zfp68 |
zinc finger protein 68 |
increases expression |
ISO |
geraniol results in increased expression of ZNF84 mRNA |
CTD |
PMID:27683099 |
|
NCBI chr12:16,026,058...16,040,995
Ensembl chr12:16,026,079...16,040,995
|
|
G |
Zfp75d |
zinc finger protein 75D |
increases expression |
ISO |
geraniol results in increased expression of ZNF75D mRNA |
CTD |
PMID:27683099 |
|
NCBI chr X:134,035,116...134,053,765
Ensembl chr X:134,036,143...134,051,519
|
|
G |
Zfp768 |
zinc finger protein 768 |
increases expression |
ISO |
geraniol results in increased expression of ZNF768 mRNA |
CTD |
PMID:27683099 |
|
NCBI chr 1:181,966,314...181,968,950
Ensembl chr 1:181,966,316...181,969,147
|
|
G |
Zhx2 |
zinc fingers and homeoboxes 2 |
increases expression |
ISO |
geraniol results in increased expression of ZHX2 mRNA |
CTD |
PMID:27683099 |
|
NCBI chr 7:89,226,358...89,374,266
Ensembl chr 7:89,226,463...89,374,378
|
|
G |
Zmiz1 |
zinc finger, MIZ-type containing 1 |
increases expression |
ISO |
geraniol results in increased expression of ZMIZ1 mRNA |
CTD |
PMID:27683099 |
|
NCBI chr16:1,027,083...1,232,616
Ensembl chr16:1,027,325...1,232,597
|
|
G |
Zmym4 |
zinc finger MYM-type containing 4 |
increases expression |
ISO |
geraniol results in increased expression of ZMYM4 mRNA |
CTD |
PMID:27683099 |
|
NCBI chr 5:139,146,782...139,264,387
Ensembl chr 5:139,146,665...139,264,421
|
|
G |
Zmynd11 |
zinc finger, MYND-type containing 11 |
increases expression |
ISO |
geraniol results in increased expression of ZMYND11 mRNA |
CTD |
PMID:27683099 |
|
NCBI chr17:60,542,669...60,631,913
Ensembl chr17:60,543,077...60,631,902
|
|
G |
Zscan18 |
zinc finger and SCAN domain containing 18 |
increases expression |
ISO |
geraniol results in increased expression of ZSCAN18 mRNA |
CTD |
PMID:27683099 |
|
NCBI chr 1:73,332,883...73,349,846
Ensembl chr 1:73,332,889...73,345,897
|
|
G |
Zzz3 |
zinc finger, ZZ-type containing 3 |
increases expression |
ISO |
geraniol results in increased expression of ZZZ3 mRNA |
CTD |
PMID:27683099 |
|
NCBI chr 2:241,330,366...241,397,308
Ensembl chr 2:241,331,022...241,397,307
|
|
|
G |
Bax |
BCL2 associated X, apoptosis regulator |
increases expression |
ISO |
geranyl acetate results in increased expression of BAX protein |
CTD |
PMID:29745075 |
|
NCBI chr 1:95,940,001...95,945,407
Ensembl chr 1:95,938,808...95,945,368
|
|
G |
Bcl2 |
BCL2, apoptosis regulator |
decreases expression |
ISO |
geranyl acetate results in decreased expression of BCL2 protein |
CTD |
PMID:29745075 |
|
NCBI chr13:22,689,783...22,853,920
Ensembl chr13:22,684,989...22,853,743 Ensembl chr13:22,684,989...22,853,743
|
|
|
G |
Hmgcr |
3-hydroxy-3-methylglutaryl-CoA reductase |
multiple interactions increases abundance |
ISO |
[geranylgeraniol co-treated with geranyl pyrophosphate] results in decreased expression of HMGCR protein; Lovastatin inhibits the reaction [HMGCR protein results in increased abundance of geranyl diphosphate] |
CTD |
PMID:19819230 PMID:19856009 |
|
NCBI chr 2:27,997,523...28,018,983
Ensembl chr 2:27,997,525...28,019,703
|
|
G |
Mvk |
mevalonate kinase |
decreases activity multiple interactions |
ISO |
geranyl diphosphate results in decreased activity of MVK protein geranyl diphosphate inhibits the reaction [MVK protein results in increased hydrolysis of Adenosine Triphosphate]; geranyl diphosphate inhibits the reaction [MVK protein results in increased phosphorylation of Mevalonic Acid] |
CTD |
PMID:9392419 |
|
NCBI chr12:42,141,391...42,158,893
Ensembl chr12:42,141,384...42,158,882
|
|
G |
Rap1a |
RAP1A, member of RAS oncogene family |
multiple interactions |
ISO |
[geranylgeraniol co-treated with geranyl pyrophosphate] results in decreased expression of RAP1A protein modified form |
CTD |
PMID:19819230 |
|
NCBI chr 2:193,208,631...193,286,513
Ensembl chr 2:193,208,635...193,286,501
|
|
|
G |
Akr1b10 |
aldo-keto reductase family 1 member B10 |
increases chemical synthesis |
ISO |
AKR1B10 protein results in increased chemical synthesis of geranylgeraniol |
CTD |
PMID:21187079 |
|
NCBI chr 4:63,038,459...63,060,336
Ensembl chr 4:63,040,169...63,053,852
|
|
G |
Akr1c3 |
aldo-keto reductase family 1, member C3 |
increases chemical synthesis |
ISO |
AKR1C3 protein results in increased chemical synthesis of geranylgeraniol |
CTD |
PMID:21187079 |
|
NCBI chr17:66,110,970...66,127,867
Ensembl chr17:66,110,963...66,127,873
|
|
G |
Casp3 |
caspase 3 |
increases activity |
ISO |
geranylgeraniol results in increased activity of CASP3 protein |
CTD |
PMID:9175767 |
|
NCBI chr16:45,662,910...45,681,171
Ensembl chr16:45,662,910...45,684,648
|
|
G |
Cav1 |
caveolin 1 |
multiple interactions |
ISO |
geranylgeraniol inhibits the reaction [rosiglitazone results in increased expression of CAV1 mRNA] |
CTD |
PMID:15314095 |
|
NCBI chr 4:45,640,624...45,673,708
Ensembl chr 4:45,634,918...45,673,705
|
|
G |
Ccn1 |
cellular communication network factor 1 |
multiple interactions |
ISO |
geranylgeraniol inhibits the reaction [Zoledronic Acid results in decreased expression of CCN1 protein] |
CTD |
PMID:19530242 |
|
NCBI chr 2:234,562,410...234,565,370
Ensembl chr 2:234,562,408...234,565,484
|
|
G |
Egf |
epidermal growth factor |
multiple interactions |
ISO |
geranylgeraniol analog inhibits the reaction [EGF protein results in increased phosphorylation of RHOA protein] |
CTD |
PMID:24587105 |
|
NCBI chr 2:218,219,408...218,302,359
Ensembl chr 2:218,219,415...218,302,064
|
|
G |
F3 |
coagulation factor III, tissue factor |
multiple interactions |
ISO |
geranylgeraniol inhibits the reaction [Fluvastatin results in decreased expression of F3 protein]; geranylgeraniol inhibits the reaction [Simvastatin results in decreased expression of F3] |
CTD |
PMID:9081680 PMID:12753293 |
|
NCBI chr 2:209,827,061...209,838,666
Ensembl chr 2:209,826,959...209,838,668
|
|
G |
Hmgcr |
3-hydroxy-3-methylglutaryl-CoA reductase |
multiple interactions decreases activity |
ISO |
[geranylgeraniol co-treated with geranyl pyrophosphate] results in decreased expression of HMGCR protein; [MVK gene mutant form results in increased activity of HMGCR protein] which results in increased susceptibility to geranylgeraniol; MVK gene mutant form promotes the reaction [geranylgeraniol results in decreased activity of HMGCR protein] |
CTD |
PMID:12477733 PMID:19819230 |
|
NCBI chr 2:27,997,523...28,018,983
Ensembl chr 2:27,997,525...28,019,703
|
|
G |
Ibsp |
integrin-binding sialoprotein |
multiple interactions |
ISO |
geranylgeraniol inhibits the reaction [zoledronic acid results in increased expression of IBSP mRNA] |
CTD |
PMID:15324309 |
|
NCBI chr14:5,439,825...5,452,570
Ensembl chr14:5,439,829...5,452,693
|
|
G |
Il1b |
interleukin 1 beta |
multiple interactions |
ISO |
geranylgeraniol inhibits the reaction [[MVK gene mutant form results in increased susceptibility to Lipopolysaccharides] which results in increased expression of IL1B protein] geranylgeraniol inhibits the reaction [[Alendronate co-treated with Lipopolysaccharides] results in increased expression of IL1B protein] |
CTD |
PMID:20304105 |
|
NCBI chr 3:116,577,005...116,583,386
Ensembl chr 3:116,577,010...116,583,415
|
|
G |
Itga2 |
integrin subunit alpha 2 |
multiple interactions |
ISO EXP |
geranylgeraniol inhibits the reaction [Atorvastatin results in increased expression of [ITGA2 protein binds to ITGB1 protein]]; geranylgeraniol inhibits the reaction [Pravastatin results in increased expression of [ITGA2 protein binds to ITGB1 protein]] |
CTD |
PMID:12500026 |
|
NCBI chr 2:46,520,345...46,621,487
Ensembl chr 2:46,523,948...46,621,481
|
|
G |
Itgb1 |
integrin subunit beta 1 |
multiple interactions |
ISO EXP |
geranylgeraniol inhibits the reaction [Atorvastatin results in increased expression of [ITGA2 protein binds to ITGB1 protein]]; geranylgeraniol inhibits the reaction [Pravastatin results in increased expression of [ITGA2 protein binds to ITGB1 protein]] |
CTD |
PMID:12500026 |
|
NCBI chr19:56,705,123...56,753,199
Ensembl chr19:56,705,171...56,753,195
|
|
G |
Mvk |
mevalonate kinase |
multiple interactions |
ISO |
[MVK gene mutant form results in increased activity of HMGCR protein] which results in increased susceptibility to geranylgeraniol; geranylgeraniol inhibits the reaction [[MVK gene mutant form results in increased susceptibility to Lipopolysaccharides] which results in increased expression of IL1B protein]; geranylgeraniol inhibits the reaction [MVK gene mutant form results in increased susceptibility to Lipopolysaccharides]; MVK gene mutant form promotes the reaction [geranylgeraniol results in decreased activity of HMGCR protein] |
CTD |
PMID:12477733 PMID:20304105 |
|
NCBI chr12:42,141,391...42,158,893
Ensembl chr12:42,141,384...42,158,882
|
|
G |
Myl9 |
myosin light chain 9 |
multiple interactions |
ISO |
geranylgeraniol analog inhibits the reaction [lysophosphatidic acid results in increased phosphorylation of MYL9 protein] |
CTD |
PMID:24587105 |
|
NCBI chr 3:145,281,943...145,288,333
Ensembl chr 3:145,281,937...145,288,333
|
|
G |
Plat |
plasminogen activator, tissue type |
multiple interactions |
ISO |
geranylgeraniol inhibits the reaction [Simvastatin results in increased expression of PLAT mRNA]; geranylgeraniol inhibits the reaction [Simvastatin results in increased expression of PLAT] |
CTD |
PMID:12371961 PMID:12753293 |
|
NCBI chr16:69,240,582...69,265,177
Ensembl chr16:69,240,585...69,268,223
|
|
G |
Ppara |
peroxisome proliferator activated receptor alpha |
multiple interactions |
ISO |
geranylgeraniol inhibits the reaction [cerivastatin promotes the reaction [Bezafibrate results in increased activity of [PPARA protein binds to RXRA protein]]] |
CTD |
PMID:11779144 |
|
NCBI chr 7:116,832,405...116,900,878
Ensembl chr 7:116,832,756...116,895,346
|
|
G |
Ppp1r12a |
protein phosphatase 1, regulatory subunit 12A |
multiple interactions |
EXP |
geranylgeraniol inhibits the reaction [Simvastatin inhibits the reaction [Phenylephrine results in increased phosphorylation of PPP1R12A protein]] |
CTD |
PMID:24449418 |
|
NCBI chr 7:43,482,808...43,593,689
Ensembl chr 7:43,482,803...43,593,425
|
|
G |
Ppp1r14a |
protein phosphatase 1, regulatory (inhibitor) subunit 14A |
multiple interactions |
EXP |
geranylgeraniol inhibits the reaction [Simvastatin inhibits the reaction [Phenylephrine results in increased phosphorylation of PPP1R14A protein]] |
CTD |
PMID:24449418 |
|
NCBI chr 1:84,583,127...84,590,743
Ensembl chr 1:84,586,627...84,590,671
|
|
G |
Rac1 |
Rac family small GTPase 1 |
multiple interactions |
ISO |
geranylgeraniol inhibits the reaction [Lovastatin affects the localization of RAC1 protein] Geranylgeraniol inhibits the reaction [Ropivacaine decreases activity of RAC1 protein in esophageal carcinoma cells] |
CTD RGD |
PMID:12933658 PMID:29777701 |
RGD:155230817 |
NCBI chr12:11,037,028...11,057,251
Ensembl chr12:11,036,698...11,057,251
|
|
G |
Rap1a |
RAP1A, member of RAS oncogene family |
multiple interactions |
ISO |
[geranylgeraniol co-treated with geranyl pyrophosphate] results in decreased expression of RAP1A protein modified form; geranylgeraniol inhibits the reaction [zoledronic acid results in decreased geranoylation of RAP1A protein] |
CTD |
PMID:16539721 PMID:19819230 |
|
NCBI chr 2:193,208,631...193,286,513
Ensembl chr 2:193,208,635...193,286,501
|
|
G |
Rhoa |
ras homolog family member A |
multiple interactions |
ISO EXP |
geranylgeraniol analog inhibits the reaction [EGF protein results in increased phosphorylation of RHOA protein]; geranylgeraniol analog inhibits the reaction [lysophosphatidic acid results in increased activity of RHOA protein]; geranylgeraniol inhibits the reaction [Lovastatin affects the localization of RHOA protein]; geranylgeraniol inhibits the reaction [Simvastatin results in decreased geranoylation of and affects the localization of RHOA protein]; geranylgeraniol inhibits the reaction [Zoledronic Acid results in decreased expression of and affects the localization of RHOA protein] geranylgeraniol inhibits the reaction [Lovastatin affects the localization of RHOA protein]; geranylgeraniol inhibits the reaction [Simvastatin inhibits the reaction [Phenylephrine results in increased activity of RHOA protein]] |
CTD |
PMID:9398081 PMID:12477733 PMID:12933658 PMID:15324309 PMID:24449418 PMID:24587105 More...
|
|
NCBI chr 8:108,991,926...109,025,746
Ensembl chr 8:108,991,954...109,025,746
|
|
G |
Rhoc |
ras homolog family member C |
multiple interactions |
ISO |
geranylgeraniol analog inhibits the reaction [lysophosphatidic acid results in increased activity of RHOC protein] |
CTD |
PMID:24587105 |
|
NCBI chr 2:192,287,065...192,293,292
Ensembl chr 2:192,287,130...192,295,306
|
|
G |
Rxra |
retinoid X receptor alpha |
multiple interactions |
ISO |
geranylgeraniol inhibits the reaction [cerivastatin promotes the reaction [Bezafibrate results in increased activity of [PPARA protein binds to RXRA protein]]] |
CTD |
PMID:11779144 |
|
NCBI chr 3:10,989,832...11,076,366
Ensembl chr 3:10,989,832...11,073,712
|
|
G |
Sele |
selectin E |
multiple interactions |
ISO |
geranylgeraniol inhibits the reaction [Simvastatin promotes the reaction [TNF protein results in increased expression of SELE protein]] |
CTD |
PMID:16740276 |
|
NCBI chr13:76,402,841...76,412,741
Ensembl chr13:76,403,304...76,412,741
|
|
G |
Tnf |
tumor necrosis factor |
multiple interactions |
ISO |
geranylgeraniol inhibits the reaction [Simvastatin promotes the reaction [TNF protein results in increased expression of SELE protein]] |
CTD |
PMID:16740276 |
|
NCBI chr20:3,622,011...3,624,629
Ensembl chr20:3,622,011...3,624,629
|
|
|
G |
Casp3 |
caspase 3 |
multiple interactions |
ISO |
2-phenylacetylenesulfonamide inhibits the reaction [solanesol inhibits the reaction [Ethanol results in increased cleavage of CASP3 protein]]; solanesol inhibits the reaction [Ethanol results in increased cleavage of CASP3 protein]; solanesol promotes the reaction [2-tert-butylhydroquinone inhibits the reaction [Ethanol results in increased cleavage of CASP3 protein]]; tin protoporphyrin IX inhibits the reaction [solanesol inhibits the reaction [Ethanol results in increased cleavage of CASP3 protein]] |
CTD |
PMID:25645596 |
|
NCBI chr16:45,662,910...45,681,171
Ensembl chr16:45,662,910...45,684,648
|
|
G |
Cat |
catalase |
multiple interactions |
ISO |
solanesol inhibits the reaction [Glucose results in decreased activity of CAT protein] |
CTD |
PMID:37586544 |
|
NCBI chr 3:89,842,393...89,874,577
Ensembl chr 3:89,842,399...89,874,478
|
|
G |
Cul3 |
cullin 3 |
multiple interactions |
ISO |
solanesol inhibits the reaction [KEAP1 protein binds to CUL3 protein binds to RBX1 protein] |
CTD |
PMID:25645596 |
|
NCBI chr 9:81,592,641...81,670,428
Ensembl chr 9:81,592,641...81,670,462
|
|
G |
Gpt |
glutamic--pyruvic transaminase |
multiple interactions |
ISO |
solanesol inhibits the reaction [Glucose results in increased secretion of GPT protein] |
CTD |
PMID:37586544 |
|
NCBI chr 7:108,416,646...108,419,495
Ensembl chr 7:108,416,642...108,419,494
|
|
G |
Hmox1 |
heme oxygenase 1 |
multiple interactions increases expression |
ISO |
geldanamycin inhibits the reaction [solanesol results in increased expression of HMOX1 mRNA]; geldanamycin inhibits the reaction [solanesol results in increased expression of HMOX1 protein]; solanesol inhibits the reaction [Glucose results in decreased expression of HMOX1 mRNA]; solanesol inhibits the reaction [Glucose results in decreased expression of HMOX1 protein] solanesol results in increased expression of HMOX1 mRNA; solanesol results in increased expression of HMOX1 protein |
CTD |
PMID:25645596 PMID:37586544 |
|
NCBI chr19:13,466,287...13,474,082
Ensembl chr19:13,467,244...13,474,079
|
|
G |
Hsf1 |
heat shock transcription factor 1 |
multiple interactions affects localization |
ISO |
2-phenylacetylenesulfonamide inhibits the reaction [solanesol promotes the reaction [HSF1 protein binds to STUB1 protein]]; geldanamycin inhibits the reaction [solanesol promotes the reaction [HSF1 protein binds to STUB1 protein]]; N2-(1H-indazole-5-yl)-N6-methyl-3-nitropyridine-2,6-diamine inhibits the reaction [solanesol promotes the reaction [HSF1 protein binds to STUB1 protein]]; solanesol promotes the reaction [HSF1 protein binds to STUB1 protein] solanesol affects the localization of HSF1 protein |
CTD |
PMID:25645596 |
|
NCBI chr 7:108,196,040...108,223,011
Ensembl chr 7:108,196,056...108,223,011
|
|
G |
Keap1 |
Kelch-like ECH-associated protein 1 |
multiple interactions |
ISO |
solanesol inhibits the reaction [Glucose results in increased expression of KEAP1 mRNA]; solanesol inhibits the reaction [Glucose results in increased expression of KEAP1 protein]; solanesol inhibits the reaction [KEAP1 protein binds to CUL3 protein binds to RBX1 protein]; solanesol inhibits the reaction [KEAP1 protein binds to NFE2L2 protein] |
CTD |
PMID:25645596 PMID:37586544 |
|
NCBI chr 8:19,768,375...19,777,862
Ensembl chr 8:19,768,375...19,777,862
|
|
G |
Nfe2l2 |
NFE2 like bZIP transcription factor 2 |
multiple interactions |
ISO |
solanesol affects the localization of and results in increased activity of NFE2L2 protein; solanesol inhibits the reaction [Glucose results in decreased expression of NFE2L2 mRNA]; solanesol inhibits the reaction [Glucose results in decreased expression of NFE2L2 protein]; solanesol inhibits the reaction [KEAP1 protein binds to NFE2L2 protein]; solanesol results in decreased ubiquitination of and results in decreased degradation of NFE2L2 protein |
|